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Abstract 
 
This thesis describes the application pteridine chemistry in various aspects of methodology 
development and natural product synthesis. The introductory chapter sets the scene by describing 
naturally occurring pteridines, their applications in biological systems, and recent synthetic 
strategies.  
Firstly, Sonogashira coupling reactions employing benzenesulfonyloxy-O-pteridine (27) and 
terminal alkynes to give various 6-substituted pteridines are described. This methodology 
allowed for the total synthesis of a natural occurring pteridine, Sepiapterin-C (46). 
Negishi coupling reactions involving benzenesulfonyloxy-O-pteridine (27) and various Zn-
reagents are also reported. This methodology, representing the first Negishi coupling on a 
pteridine nucleus, allowed for the introduction of both aryl- and heteroaryl- substituents at the 6-
position of the pteridine ring. The use of methanesulfonyloxy-O-pteridine (26) as a coupling 
partner is also described. 
Selective deprotection and hydrolysis of the formamidine protecting groups to give either the 6-
substituted 2,4-diaminopterine or 2-amino-4-oxo-pteridine (pterin), is described. 
The synthesized structures are supported by NMR and mass spectral data and melting points 
where applicable. Novel compounds are verified by NMR spectroscopy, infrared and mass 
spectrometry. 
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Chapter 1              Introduction 
 
The work described in this Thesis deals with approaches to the synthesis of 6-substituted pterins 
and pteridines. This chapter reviews different types of naturally occurring pterins and their roles 
in biological systems, and the development of various pteridine derivatives which have found 
applications in medicinal chemistry. The chapter also describes the various methods developed 
for the synthesis of pterin molecules, their scope and limitations. 
In the chapters to follow, novel routes to the synthesis of 6-substituted pterins are discussed, 
starting with Sonogashira coupling chemistry in Chapter 2 and Negishi coupling in Chapter 3.  
 
1.1 Nomenclature and Literature 
Pteridines are a group of heterocyclic compounds composed of fused pyrimidine and pyrazine 
rings and with the numbering system shown below (Figure 1.1).1 There are three main classes of 
naturally occurring pteridines namely, lumazines, isoalloxazine and pterins. Lumazines and 
isoalloxazines have oxo-substituents at the 2- and 4- positions with the difference being a phenyl 
ring annealed in the 6- and 7- position on the isoalloxazine. The most common class of naturally 
occurring pteridines are the pterins which have an amino group at the 2-position and an oxo-
group at the 4-position. 
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Figure 1.1 
Pteridines have been known to exist from as early as the 19th century, with the first synthesis and 
isolation reported in 1857 and 1889, respectively. However, the exact structure of these 
pteridines were only resolved in 1940 and this discovery subsequently led to (a) the isolation, 
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characterization and synthesis of natural occurring pteridines; (b) the synthesis of derivatives of 
natural pteridines used as drugs for various diseases; and (c) the initiation of interdisciplinary 
collaboration between synthetic chemistry and biological chemistry, giving birth to medicinal 
chemistry. 
A number of books and many publications in the field of pteridine chemistry come the from 
medical and biochemical area of research where the pteridines are first isolated from natural 
sources and their functions well understood before their total synthesis is achieved. A recent 
Web of Science search (January 2011) revealed over 1629 publications describing the chemistry 
and biology of pteridines with 958 of these publications coming from the biochemistry and 
molecular biology journals, while 751 publications were from chemistry journals. Due to the 
complex nature of pteridine chemistry, the thesis will generally refer to secondary literature in 
the introduction sections describing the functions of pteridines, and more emphasis will be given 
to the synthetic chemistry of these compounds. 
 
1.2 Introduction to the natural occurrence of pteridines 
Long before their structures were fully resolved, pteridines were identified as yellow pigments in 
butterflies and insects due to their brightly colored nature.  In 1889, two natural pteridines were 
isolated by Frederick Hopkins from wings of Brimstone butterflies.1 The structure of these 
pteridines were later resolved to be xanthopterin and leucopterin (Figure 1.2). Further 
investigation of the Brimstone butterflies pigments led to the isolation of a third pteridine, 
isoxanthopterin in 1933. However, due to difficulties with elemental analysis, the constitution of 
all three compounds remained unknown until 1940 when the pteridine nucleus was finally 
resolved. The total synthesis of these pteridines were achieved shortly after by Robert 
Purrmann.2 
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Figure 1.2 
Since then over 50 other naturally occurring pteridines have been isolated and characterised, and 
the total synthesis of some have been achieved. Naturally occurring pteridines have been isolated 
from (a) insects, examples include xanthopterin and isoxanthopterin; (b) plants, an example 
being folic acid; and (c) mammals, an example being neopterin.1 Most of the pteridines isolated 
belonged to the pterin family and some were realised to be incorporated in a number of redox 
cofactors. The remainder of this chapter will focus more on the pterin family of pteridines. 
 
1.2.1 Non-redox active pterins 
Many natural occurring pterins are incorporated in a number of redox active cofactors and are 
believed to be redox active themselves, although the mechanism is not fully understood. There 
are however, pterins that have not been associated with redox reactions and their biological 
functions, if any, are largely unknown. In some cases these pterins have been classified as 
pigments. Examples of these pigments are xanthopterin and sepiapterin-C (isolated from insects, 
Figure 1.3). More recently, xanthopterin, oncopterin and neopterin have been identified as useful 
bio-markers for human disease states.3 
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Figure 1.3 
Xanthopterin has been found in butterfly wings and in the urine of mammals. It is the end 
product of a non-conjugated pteridine compound and inhibits the growth of lymphocytes 
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produced by concanovalin.3 High levels of xanthopterin are found in patients with liver diseases 
and hemolysis, and can be used to detect the presence of these diseases. 
Sepiapterin -C is found along with biopterin (Figure 1.4) and is believed to be a by-product in the 
biopterin metabolic pathway4. No biochemical function of sepiapterin-C has been reported to 
date. 
Neopterin has been found to serve as a bio-marker of mammalian cellular immune system 
activation.5 High levels of neopterin are associated with increased production of reactive oxygen 
species, commonly found in diseases like HIV, cancer, arthritis and bacterial infections. 
Measuring the amount of neopterin in blood fluids or urine gives an indication on the 
progression of these diseases. There are a large number of non redox active pterins which will 
not be discussed in this chapter due to the complex nature of field. 
 
1.2.2 Redox cofactors incorporating pterins  
Pterins are incorporated in a number of redox active cofactors which are essential to all life, 
examples include tetrahydrobiopterin (BH4), the molybdenum cofactors (Moco), flavin and folic 
acid (Figure 1.4). All these pterins have a rich redox chemistry which take place mainly at the 
pyrazine ring, where the 5,6- and 7,8- positions can be reduced and oxidised to facilitate electron 
transfer reactions forming new products. Folic acid, for an example, undergoes reduction at the 
7,8-position to dihydrofolate which can also be reduced at the 5,6-position to tetrahydrofolate.  
However, the redox chemistry of most pterins is still not clear as to whether it goes via a 2-
electron or 1-electron transfer pathway and this is still being investigated to date.  
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Figure 1.4 
Tetrahydrobiopterin (BH4) is the reduced form of biopterin which is biosynthesised from 
guanosine triphosphate (GTP) in an enzyme catalysed reaction. Tetrahydrobiopterin functions as 
the cofactor in enzymes responsible for the production of monoamine neurotransmitters 
(epinephrine, norepeniphrine, dopamine, serotonin) and nitric oxide production.6-7 Conditions 
such as Alzheimer’s disease, Parkinson’s disease, depression, autism and schizophrenia are 
believed to arise due to deficiency in BH4. Patients suffering from these diseases are treated with 
synthetic BH4.   
The molybdenum cofactor is biosynthesised from guanosine triphosphate (GTP) and is required 
in human sulfite oxidase, xanthine oxidoreductase and aldehyde reductase enzymes.8 These 
enzymes are found in all forms of life, except streptomyces, and are responsible for the oxidation 
of toxic substances into less toxic and easily excretable compounds. Sulfite oxidase is 
responsible for the oxidation of sulfites into sulfates which are easily excreted. Absence of Moco 
results in accumulation of toxic levels of sulfites and this results in death within months of birth, 
underlying the vital role of the pterin. People suffering from molybdenum cofactor deficiency 
have recently been treated with a daily dose of cyclic pyranopterin monophosphate (cPMP) 
which is the precursor in the biosynthesis of Moco. 
Folic acid, which is not biosynthesised by humans, is an essential vitamin responsible for 
mediating the transfer of one-carbon units. It acts as both the acceptor and donor of one-carbon 
units in a variety of reactions critical in the metabolism of nucleic acids and amino acids.9-10 In 
7 
 
nucleic acid metabolism, folic acid is vital for the synthesis of DNA from its precursors, 
thymidine and purines, it is also involved in the methylation of various sites within DNA and 
RNA. Folic acid is by far the most widely studied and understood pteridine to date and its 
metabolic pathway is well understood. 
  
1.2.2.1 The biochemistry of folic acid 
The chemistry of folic acid is as follows: Folic acid or folate is converted to dihydrofolate (DHF) 
in the presence of Nicotinamide adenine dinucleotide phosphate (NADPH), dihydrofolate is then 
converted to tetrahydrofolate by the enzyme dihydrofolate reductase (DHFR). Tetrahydrofolate 
(FH4) is the most active form of the folate family and is responsible for the production and 
maintenance of new cells, for DNA synthesis and RNA synthesis (Scheme 1.1).9-11  
Tetrahydrofolate is a substrate in a number of single-carbon-transfer reactions. FH4 is converted 
to methylene-FH4 by the addition of a methylene group from one of three carbon donors; 
formaldehyde, serine or glycine. The methylene-FH4 is then converted to methyl-FH4 by 
reduction with NADPH. The methyl group is then transferred to Vitamin-B12 cobalamin which in 
turn is transferred to another acceptor, homocysteine, generating methionine which is an amino 
acid. The methylene-FH4 is also used to methylate the pyrimidine base uracil to thymine which is 
essential for DNA synthesis (Scheme 1.2). 
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FH4 is very essential in DNA and amino acid synthesis and its concentration is regulated by the 
presence of folate and also the activity of DHFR. Folate deficiency (FD) results in many health 
problems such as neural tube defects in developing embryos and also cancer formation due to 
lack of nucleotides required for DNA synthesis and repair. During early stages of pregnancy, 
FH4 is required for proper development of the brain, skull and spinal cord.  
The association of neural birth defects with FD have long been realised and folic acid 
supplements are given to pregnant women, and women who plan to get pregnant are advised to 
take folic acid supplements three months in advance. Research studies have shown a sharp 
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decrease in birth defects in women who took folic acid supplements during or before pregnancy 
when compared to the control.12-13 The success of these studies led to treatment of other diseases 
associated with FD. 
 Folate deficiency can be avoided by taking folic acid supplements along with the daily diet, 
however, this is limited to first world countries as many people in developing countries cannot 
afford to buy these supplements or folate rich food products. Another approach to avoiding FD is 
by fortification, where folic acid is added to flour in order to increase the levels of folic acid in 
the diet. Studies have shown that people who eat folate fortified food generally have an increased 
level of folic acid and are less likely to suffer from diseases associated with FD.13-18 Although 
fortification of flour and or grains has proved success in a number of countries, not all countries 
are performing this practice. 
The practice of fortification is so far limited to first world countries, primarily due to cost 
implications, but other countries are refusing to fortify their food products as there are concerns 
which link cancer to high levels of folic acid. Studies have shown that different race groups 
absorb folic acid differently and as a result high levels of folic acid are found in their blood 
streams.19 Although there is no conclusive evidence, high levels of folic acid have been shown to 
worsen the vitamin B12 deficiency.
20 Other studies have also shown that high levels of folic acid 
in late pregnant women resulted in an increase number of babies developing childhood asthma.21 
Because folic acid or folate is essential for cell growth and development, diseases such as cancer, 
bacterial infection and viral infections also require folate to grow and spread, and in these cases, 
the down regulation of folate is required. All these diseases are characterized by high rates of cell 
division and growth and thus requires large quantities of folate. Unlike humans, microorganisms 
and plants have a biosynthetic pathway for folate (Scheme 1.3) and it came as no surprise that 
the synthetic compounds to inhibit the production of folate were some of the first therapeutic 
antibacterial agents. 
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Scheme 1.3 
The first generations of drugs targeting the folic acid pathway were the sulphonamides, which 
were the first synthetic anti-bacterial drugs (Figure 1.5).22 The sulphonamides inhibit the 
synthesis of folic acid in bacteria thus hindering its growth. These drugs act by competing with 
para-aminobenzoic acid (PABA), effectively blocking the addition of L-glutamate which is the 
final step in the formation of folate. The sulphonamides are still used till this date and over 1000 
variations of sulphonamides have been prepared and are used for various bacterial infections. 
                                       
SO2NHR
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Figure 1.5 
The sulphonamides were ineffective in treatment of cancer since cancer cells are almost identical 
to normal human cells and do not have a folate biosynthetic pathway. Cancer cells differ from 
normal cells in that they have a high rate of cell division and growth, and these require relatively 
large quantities of folate. Down regulation of folate in these cells will result in reduced cell 
growth and division. The second generation of drugs targeting the folic acid pathway were the 
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anti-folates which were targeting the conversion of DHF to the active FH4 and are commonly 
known as dihydrofolate reductase inhibitors (DHFR inhibitors). 
 
1.2.2.2 Antifolates as DHFR inhibitors 
Antifolates act by competing with DHF for the binding site in the DHFR enzyme and thus reduce 
the amount of FH4 that can be produced. For antifolates to be effective competitors of DHF, they 
must have similar structural features that enable them to bind to the active site of the enzyme. 
Once these antifolates bind the active site, DHF is prevented from binding and therefore no FH4 
can be produced. The first antifolate drug prepared was methotrexate (MXT) which has close 
structural resemblance to folic acid but is biologically inactive in the folic acid metabolism 
pathway (Figure 1.6).23Methotrexate has since been used for the treatment of various cancer 
diseases and it is still used till this day. 
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Figure 1.6   
The success story of MXT led to the development of various antifolates which resembled folic 
acid, some of the compounds being aminopterin and alimta (Figure 1.7). However these 
compounds were shown to have severe side effects and this led to development of antifolates that 
resemble folic acid on the pyrimidine ring. Examples of these new generation drugs are 
pyrimethamine and trimethoprim (Figure 1.7), which were shown to be effective antifolates and 
are used for the treatment of malaria and bacterial infections respectively.24 
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Figure 1.7 
While it has been shown that understanding the structure and function of naturally occurring 
pterins can lead to improvement of life, folic acid still receive the lion’s share of the research 
where most of the synthesised pteridines are folic acid derivatives. This is primarily due to the 
fact that the total synthesis of folic acid is well established and hence it is easy to introduce 
variations into the synthesis leading to folic acid derivatives. The synthesis starts with 6-
formylpterin (6FP) as the starting material, similar to the bacterial biosynthesis of folate, and the 
pterin ring is reacted with various nucleophiles leading to folic acid or its derivatives (Scheme 
1.4). 
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Scheme 1.4 
Synthesis of other naturally occurring pterins could not be achieved via the folic acid synthetic 
route and this led many research groups around the world to come up with synthetic strategies 
that will lead to the synthesis of different naturally occurring pterins and their derivatives. Most 
naturally occurring pterins have substituents at the 6-position, thus a synthetic strategy that lead 
to 6-substituted pterins is of paramount importance. 
 
1.3 Synthetic pteridines 
The synthesis of heterocyclic systems can be considered to be best divided into those where an 
existing ring is functionalized or the ring is constructed from acyclic components (“classical ring 
synthesis”). In addition to the already established procedure which uses 6FP as starting material, 
few methods have been developed leading to 6-substituted pterins. 
1.3.1 Current methodology 
Of the few synthetic approaches leading to 6-substituted pterins, the most notable method is the 
one developed by E.C. Taylor. Oxidation of pterin with trifluoroacetic acid/ hydrogen peroxide 
(TFA/H2O2) and treatment of the resultant 8-oxide with trifluoroacetic acid/acetyl chloride 
(TFA/AcCl) gives good yields of 6-chloropterin25 in an unusual Katada rearrangement (Scheme 
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1.5). The chloride is displaced by thiols via nucleophilic substitution reactions and acetylenes 
under Sonagishira coupling conditions, giving 6-substituted pterins. 
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The most classical synthetic approach to 6-substituted pterins is of the “ring synthesis” variety, 
in which an existing ring, usually the pyrimidone or pyrimidine, is used for the construction of 
the appropriately substituted pyrazine ring. The original classic ring synthesis can be divided into 
three main reactions, named after their inventors.  
The Gabriel-Colman synthesis involves the condensation of a 2,4,5,6-tetraaminopyrimidine ring 
with dialdehyde, glyoxal, aldehydoketone and diketones, giving rise to a wide range of 6- and 7- 
substituted pteridines.1 The problems encountered in this route are the mixture of products in 
which both the 6- and 7-substituted pterins are obtained (Scheme 1.6a). 
The Timmis synthesis entails the condensation of 5-nitroso-2,4,6-pyrimidinetriamine with an α-
carbonylmethylene compound to give substituted pteridines (Scheme 1.6 b). The products 
obtained from this route are normally unambiguous, but the need to prepare the 5-nitroso group 
is the drawback.1 
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The Boon synthesis involve the condensation of aminoacetone with 2-amino-6-chloro-5-
phenylazo-4(3H)-pyrimidinone. Reduction of the azo group to an amine, spontaneously leads to 
cyclization, and oxidation with oxygen gives 6-methylpterin (Scheme 1.6c). Products are 
obtained having an unambiguously assigned structure.1 
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Scheme 1.6 
Modifications into the classical ring synthesis have been reported recently and the scope has 
been extended to total synthesis of natural products.26-30 Natural pterin compounds synthesised 
from this procedure are from the biopterin family which include limipterin, tepidopterin (both 
pterin glycosides), Sepiapterin and Sepiapterin-C (Figure 1.8).31 
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Figure 1.8 
Other modifications to the classical ring synthesis include the method pioneered by Taylor et.al. 
which start by making the substituted pyrazine ring then reacting it with guanidine to give 
exclusively the 6-substituted pterin (Scheme 1.7).32-35 Substituents such as aryl, alkyl and 
heterocycles were introduced exclusively at the 6-position using this method.   
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Scheme 1.7 
Pterin derivatives can also be made from pteridine (2,4-diaminopteridine) derivatives which are 
easily hydrolysed to the desired pterin under hydrolytic conditions (Scheme 1.8).30,31 The 
pteridine ring can be constructed by a method similar to the way pterin ring is constructed, i.e. 
using the above mentioned methods.  
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Scheme 1.8 
The route which provides the starting point for the work described in this thesis was pioneered 
by Dinsmore and Joule et al.36 The initial proof of concept involved the readily available 2,4-
diamino-6-oxopteridine 2, which can be made from tetra-aminopyrimidine and glyoxylic acid 
(Scheme 1.9). The oxopteridine 2 can be converted into the corresponding pterin, xanthopterin 3.  
However oxopteridine 2 also has readily differentiated substituents at the 4 and 6-positions.  
Taking advantage of this, the next step in the synthesis was easily accomplished by tosylation of 
the 6-oxo group. Thus oxopteridine 2 can be viewed as a masked form of xanthopterin 3, in 
which differentiation between the (masked) 4-oxo and 6-oxo groups has been achieved. The 
regio-selective tosylation also provided a potential leaving group, an O-tosylate at the 6-position.  
The solubility problems associated with 2 can be overcome by adding an N-protecting group, the 
Bredereck’s reagent, to give dimethylformamidine derivative 4. Once the tosyl group is on the 6-
position, the resulting 6-tosyloxypterin 5 was shown to undergo a Stille type coupling reaction 
with 1-ethoxyvinyl-1-tributylstannane. The intention for this route was to complete the synthesis 
of the natural product sepiapterin-C, but the final step was never achieved. 
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Scheme 1.9 
The above mentioned synthetic routes had to overcome the solubility problems associated with 
pteridines. The extensive H-bonding within pterin molecules, related as they are to DNA base 
guanosine, is responsible for their insoluble properties. The combination of the amide function 
and an amino group which are considered weakly acidic and weakly basic, respectively, promote 
favourable interactions.37 Consequently, protection of the N- or O- atom of the amide function 
and the N-atom of the amino group increases their solubility in water and few organic solvents.  
Pterin has a water solubility of 1: 57000 g/ml at room temperature, whereas the N(3)-methyl 
derivative has water solubility of 1: 100 g/ml. Acylation of the C(2)-NH2 group leading to 2-
(acetylamino) derivative gives solubility of 1: 450 g/ml at room temperature. Similarly, pteridine 
has a water solubility of 1:1350 g/ml and successive substitution of the NH2 group in the 2- and 
4- positions increases the solubility to 1: 320 g/ml and 1: 2.5 g/ml, respectively.37 Although the 
methyl protecting groups are good solubilising agents, they are not easily removed and there is 
thus a need to develop better protecting groups. 
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1.3.2 Choice of protecting groups 
Pterin has two sites available for protection i.e. C(2)-NH2 , N(3)-  which are reacted with various 
protecting groups to enhance their solubility. The C(2)-NH2-position is acylated with acetic 
anhydride (Ac2O) to give the 2-(acetylamino) derivative (Scheme 1.10) 
37,38. Pivaloyl chloride is 
also used leading to 2-pivaloyl derivatives.29,30 More recently 2-dimethylformamide dimethyl 
acetal has been used as a the protecting group generating 2-(N,N-
dimethylaminomethyleneamino) derivatives. These can also be achieved by protection with tert-
butoxy-bis(dimethylamino)-methane known as the Bredereck’s reagent. 
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Scheme 1.10 
In addition, the pterin ring possesses an oxygen atom at the 4-position available for protection. 
The most common protecting groups for the N(3)- and O- atoms are the butyl and p-
nitrophenylethyl NPE groups (Figure 1.9), introduced using  Mitsunobu conditions. These 
groups are easily removed under basic conditions.26,27,37   
                                              
                                                       
O2N
CH2CH2
NPE  
Figure 1.9 
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2,4-Diaminopteridine has two sites available for protection, i.e. N(2)- and N(4)-position. Because 
both sites contain NH2 groups, one protection group can be used for both sites and this limits the 
number of steps during synthesis. Dinsmore and Joule et al36 used Bredereck’s reagent for the 
pteridine protection (Scheme 1.9). An observation, made from the work of Joule, is that the two 
N-protected groups have different stability where one protecting group was shown to fall off 
during the coupling reaction, no explanation has been given for this observation.36 
As already mentioned, pterin molecules are synthesised using various methods: (i) a pterin or 
pteridine ring is functionalised and substituents added thereafter (Scheme 1.5 and 1.9) and (ii) a 
pterin or pteridine ring is constructed from its precursors with the substituent already attached to 
the reactants (Scheme 1.6 and 1.7). Conventional C-C bond forming reactions are readily 
performed in the latter method since most of the substrates e.g. pyrazine, are soluble in organic 
solvents. In the former method, however, a limited number of C-C bond forming reactions have 
been reported. Sonogashira coupling was reported on 6-chloropterin (Scheme 1.5) by Taylor et 
al,
30 while Joule et al36 reported the Stille coupling (Scheme 1.9), these reactions suffer from a 
limitation in the number of substituents that can be attached and hence a need to explore the 
scope of C-C bond forming reactions is required.  
 
1.3.3 Modelling of pteridines 
The insoluble character of pterin and pteridine has rendered them difficult molecules to work 
with and as a result simple models that resemble part of the pterin ring have been developed. 
Most of pterin reactions occur at the pyrazine ring so the pyrimidone ring can replaced by an 
organic soluble ring. Joule et al36,39-41  and Goswami et al42  have used quinoxaline as a model for 
the pterin ring (Figure 1.10). The quinoxaline ring has a benzene ring fused with a pyrazine ring 
and it soluble in common organic solvents. 
                                                          
N
N
quinoxaline  
Figure 1.10 
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The quinoxaline ring system has been used to model the total synthesis of molybdenum cofactor 
(Moco) using various reactions. Sonogashira and Stille coupling (Scheme 1.11 A) were reported 
by Joule et al36,39 while condensation of 2-aminoanaline with an appropriate substrate leading to 
quinoxaline ring formation (Scheme 1.11 B) has been reported by Goswami et al.42 
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Scheme 1.11 
The chemistry of quinoxaline and pterin is not always identical, some reactions are possible in 
the quinoxaline ring but cannot be extended to the pterin ring. The total synthesis of Moco has 
not been reported to date while the quinoxaline analogue has been reported using various 
methods (Figure 1.11). The most reported problems with the total synthesis of Moco have been 
in the formation of pyran ring and the reduction step at the 5,6 and 7,8-positions.  
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Figure 1.11 
 Modelling of the pterin ring is still a useful approach in an effort to widen the scope of C-C 
bond forming reactions due to the ease of working with these organic soluble compounds and 
ease of characterization when compared to pterins.  
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1.4 Characterisation of pteridines 
Pteridine molecules are generally characterised by conventional methods, e.g. nuclear magnetic 
resonance (NMR) spectroscopy, infra-red spectroscopy (IR), ultra violet-visible spectroscopy 
(Uv-Vis), fluorescence spectroscopy and mass spectroscopy. Because the pterin ring has an equal 
number of carbons and heteroatoms i.e. six carbons, five nitrogen and one oxygen, it is 
sometimes difficult to get much information from NMR spectroscopy. There are few hydrogen 
atoms present in the pterin ring and some are involved in hydrogen bonding. The solubility 
problems associated with pterin limit the number of deuteriated solvents that can be used for 
NMR analysis.  
The most common solvent used is dimethyl sulfoxide (DMSO) which has a disadvantage of 
being hygroscopic, the presence of moisture in the solvent diminishes the N-H signals due to 
hydrogen bonding and thus few signals are observed. Other solvents used are either basic solvent 
such as sodium methoxide (NaOMe) or acidic solvent such as triflouroacetic acid (TFA). These 
solvents also attract moisture and also diminish signals of protons involved in hydrogen bonding. 
The 1H NMR spectra of Sepiapterin-C in TFA only has two hydrogen enviroments.31 
The use of IR spectroscopy is limited to pterin molecules having functional groups such as –OH, 
-NH2 and carbonyl groups. Infra-red is also used to follow reactions which undergo functional 
group addition or elimination. Not much information regarding the exact structure of the pterin 
can be obtained from an IR spectrum.   
Pterins are characterised by their bright colours, usually yellow, and are good chromophores i.e. 
able to absorb wavelengths of visible light. Molecules are known to have unique absorption 
properties and the same apply to pterin molecules. Absorption spectra can also be used to 
monitor the reactions of pterin by observing the change in the absorbance peaks. UV-vis studies 
are also used to determine the rate of a reaction e.g. the reduction or oxidation of pterin. The use 
of UV-vis spectroscopy is one of the oldest techniques that was and still is used to characterise 
pterin molecules. UV-vis spectroscopy can be used to measure the ionisation constants of pterin 
molecules since neutral pterin molecules have different absorption spectra to charged pterins. 
Fluorescence spectroscopy is used to detect fully oxidised pteridines in solution. It is the most 
sensitive detective method (limit of detection ~10-18M, in some cases) and is often used to detect 
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pterins which serve as biomarkers for certain diseases states e.g. neopterin. A number of 
fluorescent spectra have been reported for pure pterins and this serves as a reference for 
detecting pterins in solution even at low concentrations. 
 Mass spectroscopy is mainly used to confirm the presence of pterin in the pure sample or 
solution where the molecular ion peak corresponding to the mass of compound is obtained. Due 
to the high melting point associated with pterins, usually >300oC, there is low volatility of these 
compounds and less information can be obtained from this technique. Fragmentation of the 
molecular ion is rarely observed. High energy ionisation techniques such as electron impact (EI) 
and fast atom bombardment (FAB), and Low ionisation techniques such as atmospheric pressure 
chemical ionisation (APCI) and electro spray ionisation (ESI) are commonly used as mass 
detection instruments.  
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Chapter 2        Sonogashira coupling of heterocyclic sulfonates 
2.1 Introduction 
The Sonogashira coupling, first reported in 1975 by Sonogashira and Hagihara, involves the 
coupling of terminal alkynes with an aryl, heteroaryl or vinyl group possessing a good leaving 
group, mainly halogens and trifluoromethanesulfonyl (triflates).1 The scope of the reaction has 
been widely investigated and over 24 000 hits were found involving Sonogashira coupling 
reactions (Reaxys search engine, February 2011). The reactions are performed on electron rich 
ring systems and also electron deficient ring systems.         
Aryl or Vinyl X R R Aryl or Vinyl+
Pd
Scheme 2.1 
The Sonogashira coupling is one of the most common methods for C-C bond formation and has 
been widely used in organic synthesis. The resultant di-substituted acetylene can be 
functionalized in different ways, e.g. reduced to an alkene or alkane, halogenated and 
hydrolyzed, leading to a variety of products (Scheme 2.2).  
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Scheme 2.2 
The acetylene also serves as a substrate to ring forming reactions like (a) Diels-Alder reaction, 
where a 6-membered ring is formed (Scheme 2.2); (b) the Larock indole synthesis, where an 
indole can be constructed from an aniline possessing an ortho-acetylene (Scheme 2.3 A); (c) 
more recently, in a one pot reaction procedure, the Sonogashira coupling reactions has been 
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coupled with the carbopalladative cyclization reaction, where the acetylene substrate is cyclized 
to form a variety substituted indene substrates (Scheme 2.3 B).2,3 Also, alkynes have been found 
incorporated into natural products (the ene-di-ynes) which have significant antibiotic and 
antitumor activity. 
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Scheme 2.3 
The reactions are catalyzed by palladium (Pd) and copper (Cu) in the presence of mild base, 
usually amines, under inert conditions.1-10 Recent developments have shown that  a nickel (Ni) 
catalyst can also be used in place of Pd,11-12 but the reactions require high temperatures (reflux in 
dioxane). Another modification on the Sonogashira coupling conditions is the Cu-free 
conditions, which has shown the reactions to proceed without affecting the yield.1 The use of a 
copper catalyst alone has also been reported but high temperatures are required.13-14 Metal free 
Sonogashira coupling reactions have been reported to occur under UV radiation.15 
Table 2.1 lists the coupling partners employed in Sonogashira coupling reactions arranged in 
order of the conjugate acid strength and with the number of published occurrences shown in row 
three (Reaxys database January 2011).The most common halogens are chlorine (Cl), bromine 
(Br) and iodine (I), no mention of fluorine (F) as a leaving group was found. Atoms or groups 
that are good leaving groups are usually conjugates of strong acids16, hydrogen iodide (Pka -10) 
is a strong acid while hydrochloric acid (Pka -6) is a relatively weak acid, and hence iodide is a 
better leaving group than chloride. Triflate, the conjugate anion of trifluoromethanesulfonic acid 
(Pka -14.9) and is a better leaving group than the methanesulfonyl (mesylate) group, the 
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conjugate of methanesulfonic acid (Pka -1.9). Recently, though not shown in Table 2.1,the 
Sonogashira coupling reaction has been reported with an aryl-sulfonyl chloride.3,4 
Table 2.1 
Leaving 
group 
-OSO2CF3 -I -Br -Cl -OSO2Ph -OSO2Tol -OSO2Me 
Pka of 
conjugate 
acid 
-14.9 -10 -8 -6 -5.9 -5.3 -1.9 
Number of 
reported 
SC* 
12973 6144 1578 2400 0 120 6 
*Sonogashira reactions found by a Reaxys database search Jan 2011 
Triflates are the most common in the sulfonyl group family (12973 reactions) while the mesylate 
group has been rarely employed in Sonogashira coupling reactions (six reactions). The 
toluenesulfonyl (tosylate) group has gained much attention recently and has been shown to 
undergo Sonogashira coupling on many aryl systems (over 100 reactions reported on Reaxys 
database). The yields are lower when compared to most triflate system but are comparable to the 
halogenated aryl systems. Triflates are used for both electron rich and deficient aryls,2-5 while 
tosylate groups have only been reported to work on electron rich aryl groups.6 and 9 The presence 
of an electron-withdrawing group or atom in the aryl or vinyl substrate enhances the leaving 
group ability, hence electron deficient systems readily undergo Sonogashira coupling.1 
The chlorine leaving group, which is a conjugate of HCl, which has a Pka of -6 comparable to the 
Pka of benzenesulfonic acid -5.9. It comes as a surprise that the use of benzenesulfonate as a 
leaving group has not been exploited while there are a number of examples that employ a 
tosylate leaving group in coupling reactions (Reaxys database search September 2010). 
Sonogashira coupling reactions have been reported on pterin and pteridine ring systems on four 
occasions by Taylor et al,17-19  (Chapter 1, Scheme 1.4, page 14) and Joule et al.20 Three of the 
reactions were towards the total synthesis of Moco but attempts to functionalize the acetylene 
group were unsuccessful.17-20 In all the reactions, the pterin ring had a chlorine leaving group and 
moderate to good yields were reported. A pteridine ring system with a tosylate leaving group has 
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been reported by Joule et al,21 but the substrate was never used for Sonogashira coupling, and 
shown to undergo a Stille coupling.  
A drawback associated with Sonogashira coupling reactions and which has limited the industrial 
applications, is the need to prepare the R-Hal or R-OSO2R’ substrates. The halogens are usually 
prepared by one of three common methods. 
Treating the aryl or vinyl group with a strong base, often a lithium alky or amide, and quenching 
the resulting Li-organometallic with a halogen (Hal+) source (Scheme 2.4 A). This may require 
an ortho-directing and metallating (DOM) group to facilitate a clean reaction. Halogen sources 
commonly include iodine, di-iodoethane, N-iodo-, bromo-, chloro-succinimide, TMS-iodide or 
CCl4. Organo-lithium intermediates require the use of low temperature and inert atmosphere and 
have poor functional group tolerance. 
 When feasible, halogens can be activated by for instance PPh3 or a halophilic Lewis acid such as 
AlCl3 to form species that are attacked by some moderately rich electron systems such as 
pyrroles, furans and sometimes benzene (Scheme 2.4 B). 
Amides and suitable heterocyclic systems can be converted to halides using reagents such as 
PCl5, POCl3, SOCl2 or oxalyl chloride/DMF (Scheme 2.4 C). The requirements for expensive 
and often hazardous bases and high molecular weight halogen containing reagents, limit the atom 
economy of the reactions and often come at a high cost. 
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Scheme 2.4 
Aryl and vinyl sulfonates are usually prepared by reacting a sulfonic acid chloride or sulfonic 
anhydride with a phenol, ketone or amide (Scheme 2.5). These reactions also require the 
presence of base. The current cost of, for instance, triflic anhydride (~R14 per gram for an order 
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of 1 Kg, source Aldrich chemical catalogue, Feb. 2011) limits the industrial application, and is 
considerably higher than that of mesyl or benzenesulfonyl chloride (~R1 and R0.37 per gram 
respectively, for orders of 1 Kg). 
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Scheme 2.5 
With the advantages and disadvantages of the Sonogashira coupling reactions identified, we 
were interested in investigating the potential of pteridine-6-sulfonates as coupling partners in the 
Sonogashira reactions. Quinoxaline-2-sulfonate, a pteridine model, has been shown to undergo 
Sonogashira coupling by Joule et al22 towards the modeling of the total synthesis of Moco. The 
reactions employed a triflate leaving group however, and no mention of other sulfonates attached 
to the quinoxaline or pteridine ring systems have been reported. 
In this chapter, we report Sonogashira coupling reactions on pteridine ring system possessing 
both a benzenesulfonyl and a mesylate leaving group. The discussions start with the modeling of 
the pteridine ring with the quinoxaline, developing the methodology and then extending to a 
pteridine. The chapter also discusses the conversion of 2,4-diaminopteridines to the pterins. 
Finally we discuss the total synthesis of Sepiapterin-C, a natural compound, employing our 
Sonogashira coupling pathway. 
 
2.2 Results and Discussion 
2.2.1 Sonogashira coupling of sulfonyloxy-quinoxaline 
Quinoxaline was chosen as a model for the pteridine ring system because it is soluble in common 
organic solvents and possesses the pyrazine ring of pteridine. The work began by preparing 
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quinoxalinone 6 from o-phenylenediamine and glyoxylic acid in acetic acid to give the desired 
product in 70% yield, following recrystallization of the crude product from DMF (Scheme 2.6). 
The melting point and IR spectra were consistent with those previously reported.22 By this route, 
quinoxalinone 6 was readily prepared in gram quantities. 
We initially investigated the benzenesulfonate as potential leaving group in Sonogashira 
coupling. No previous synthesis of quinoxaline-2-benzenesulfonate has been reported. The 
synthesis of the corresponding tosylate has however been reported by reaction of quinoxalinone 
6 with tosylchloride in the presence of triethyl amine (Et3N) and dimethylamino pyridine 
(DMAP).23 Employing these conditions, substituting benzenesulfonyl chloride for tosyl chloride, 
stirring the reaction for 1 hour and monitoring the reaction on TLC. The reaction was stopped by 
quenching with sat. NaHCO3 after TLC showed full consumption of starting material and 
formation of one new less polar compound. Purification of the crude products on flash silica 
gave the desired 2-benzenesulfonyloxyquinoxaline 7 in 95% yield. 
The product was characterized using NMR and mass spectrometry and was easily prepared in 
gram quantities. When comparing the characterization spectra of the previously reported 
quinoxaline-2-tosylate with that of the product isolated from our reaction, strong similarities 
were observed. The presence of a downfield singlet, at δ 8.67 ppm, was assigned to the 3-H 
proton. The tosylate-quinoxaline is reported as exhibiting a 3-H shift at 8.65 ppm.23  This peak, 
at δ 8.67 ppm, was used to integrate the other signals and the 1H NMR spectra showed the 
presence of 10H, consistent with our proposed structure. The mass spectrum of the sample gave 
a peak at m/z 262 (M+), consistent with the calculated mass of the desired sulfonate 7.  
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Scheme 2.6 
With a potential coupling partner in hand, we investigated the ability of the quinoxaline-2-
benzenesulfonate to undergo Sonogashira coupling. Typical Sonogashira coupling conditions, 
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employing catalytic Pd and Cu catalysts and Et3N, were selected based on their applications in a 
wide range of substrates.1-12 Treatment of sulfonate 7 with phenylacetylene in the presence of 
palladium (PdCl2PPh3, 5 mol%), CuI (5 mol%) and Et3N (2 eq.) in DMF at 80
oC under an Ar 
atmosphere for 90 minutes, after which TLC showed no trace of starting material and one new 
product formed (Scheme 2.7 and Table 2.2, entry 1). The reaction mixture was concentrated in 
vacuo and purification of the crude on flash silica to give 2(2-phenylethynyl)quinoxaline 8 in 
95% yield. The 1H NMR spectra of the product was consistent with that of previously reported 
8,24 with the 3-H protons at δ 8.99 ppm used as a basis for the integration of the signals. The total 
number of protons integrated to be 10H. The mass spectrum of the product gave a peak at m/z 
230 (M+) consistent with previously reported data.24  
The success of this reaction was an encouraging result and we set about exploring the scope of 
the benzenesulfonate-quinoxaline 8 in Sonogashira coupling with various terminal acetylenes. 
The results are discussed below. 
Treatment of sulfonate 7 with ethynyltrimethylsilane under the above mentioned conditions gave 
2-[2-(trimethylsilyl)ethynyl]quinoxaline 9 in 74% yield (Table 2.2, entry 2). The product was 
obtained as oil due to the presence of the silyl group, also reported in previous publications.  The 
1H NMR spectra obtained was identical to those previously reported with the silyl peak in the 
upfield position of δ 0.34 ppm and the 3-H proton downfield at δ 8.90 ppm. The mass spectrum 
of the sample was in agreement with literature and calculated value, where a peak at m/z 226 was 
observed. 
The use of THF as alternative solvent in the Sonogashira coupling reactions was then 
investigated. Tetrahydrofuran (THF) is a low boiling, hydrophobic and relatively cheap solvent 
and this makes it a relatively easy solvent to work with compared to DMF. Applying our 
Sonogashira coupling conditions but changing the solvent from DMF to THF in the coupling of 
phenylacetylene with sulfonate 7 gave the quinoxaline 8 in 96% yield when the reaction was 
refluxed for two hours and monitored on TLC. The 1H NMR and mass spectra of the product was 
identical to that previously obtained and literature data24 
When applying the Sonogashira coupling on sulfonate 7 with TMS-acetylene in THF, refluxing 
for two hours and monitoring the reaction on TLC gave the TMS-quinoxaline 9 in 72%. From 
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these results, it was concluded that changing the solvent from DMF to THF does not affect the 
yield of the reactions and therefore the cheaper and low boiling THF can be used for Sonogashira 
couplings. We then investigated Sonogashira coupling reactions of the sulfonate 7 with various 
terminal acetylenes in THF, and the results are summarized below and Table 2.2.  
Treatment of sulfonate 7 with propargyl alcohol under the above mentioned conditions gave 3-
(quinoxalin-2-yl)prop-2-yl-1-ol 10 in 70% yield, following  recrystallization of the crude product 
in acetone (Table 2.2, entry 3).  No starting material was visible on TLC after 90 minutes, and 
the mass balance of the product could have been lost during the crystallization step. The 1H 
NMR spectra of the product was consistent with previously reported data, with the downfield 
proton at δ 8.90 ppm and the alcohol proton at δ 2.96 ppm. 
Table 2.2 lists the different products 8-14 of the Sonogashira coupling with different substrates. 
The NMR spectra, melting points and mass spectra of all but two were in agreement with those 
previously reported.24,25 There is no previous mention of  quinoxalines 11 (Table 2.2, entry 4) 
and 12 (entry 5) suggesting that the compounds are novel.  
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Table 2.2 
Entry    
R= 
  
Product  (yield)
a
  
     
 
    1                           
N
N
Ph
8 (96) 
 
 
    2 
                       
Si
 
N
N
SiMe3
9 (72) 
 
 
    3 
                      OH  
N
N
OH
10 (70) 
 
 
    4 
                     O  
N
N
O
11 (95) 
   
 
    5                      OH  
N
N
OH
 12 (83) 
 
 
    6                      OH  
N
N
OH
13 (79) 
 
 
   7 
                      
H2N  
N
N
NH2
14 (74) 
a
THF used as solvent  
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Quinoxaline 11 differs from quinoxaline 10 (entry 3) by a methyl group on the oxygen atom and 
their 1H NMR spectra are very similar. The downfield protons are at 8.90 ppm for 10 and 8.83 
ppm for 11, while the –OH proton at 2.96ppm  is replaced by –CH3 group at 3.45 ppm as shown 
by integration with the 3H proton. The melting point of product 11 is 61oC which is much lower 
than that of the alcohol 10 (139oC), consistent with loss of hydrogen bonding. Accurate mass 
measurement of the molecular ion evident in the EI mass spectrum of quinoxaline 11 gave a 
value of 198.07978 amu. This compared well to the calculated value of 198.07930 (C12H10N2O) 
and confirms the composition of our proposed structure. These results led us to conclude that the 
desired product has been synthesized. 
Quinoxaline 12 is very similar to quinoxaline 13 (entry 6) and they only differ by one –CH2- 
group. The downfield protons are very similar, with quinoxaline 12 at δ 8.84 ppm and 
quinoxaline 13 at δ 8.81 ppm, and quinoxaline 13 has two more hydrogen than quinoxaline 12 
consistent with the extra –CH2- group on quinoxaline 13. The IR spectra of quinoxaline 12 gave 
a peak at vmax 3332 cm
-1 which is a strong indication of the presence of an –OH group, this was 
also observed in the IR spectrum of quinoxaline 13. Finally the EI mass spectrum gave the 
molecular ion peak of m/z 212 amu which is consistent with the calculated value of the desired 
product. From these results we concluded that the desired product was synthesized. 
In conclusion, it has been shown that the Sonogashira coupling of quinoxaline-benzenesulfonate 
proceeded readily with both aryl and alkyl acetylenes to give C-C bond coupled products in good 
to excellent yield under the normal coupling conditions. We now investigated the effects 
changing the temperature and leaving group will have on the reaction yields.   
 
2.2.1.1 Effect of temperature and mesylate leaving group 
We were interested in investigating the effect lowering the temperature of the reaction to room 
temperature under our Sonogashira coupling conditions. We began by subjecting sulfonate 7 and 
phenylacetylene to our Sonogashira coupling conditions but performing the reaction at room 
temperature. The yield of quinoxaline 8 dropped from 95% to 53% when doing the coupling 
reaction at room temperature and running the reaction for 90 minutes. TLC showed the presence 
of starting material after 90 minutes implying that the reaction is slow at room temperature. The 
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reaction still does not go to completion when left to stir overnight with starting material still 
visible on the TLC plate. Purification of the crude mixture gave 100 mg (when starting with 300 
mg) of recovered starting material giving the yield of 75% based on recovered starting material, 
a yield lower than that obtained at high temperature. 
Similar results were observed on the TMS-quinoxaline 9 where the yield dropped from 74% to 
35% when running the reaction for 90 minutes at room temperature. Increasing the reaction time 
to 24 hours gave no improvement on the yield, with starting material still visible on the TLC and 
120 mg of starting material (when starting with 300 mg), recovered upon purification on flash 
silica giving a yield of 56% based on recovered starting material. 
From these results it can be seen that lowering the temperature of the reaction results in reduced 
yield of products and full conversion of starting material to products is never achieved even after 
longer reaction times. Future work might involve adding more catalyst to the reaction mixture in 
an effort to drive the reaction to completion.  
With benzenesulfonate shown to be a good leaving group in Sonogashira coupling reactions, we 
turned our investigations into the cheaper sulfonate, methanesulfonate. The 2-
mesyloxyquinoxaline26 15 was prepared in 84% yield using the same conditions of making 
benzenesulfonate 7 but replacing benzenesulfonyl chloride with mesylchloride (Scheme 2.8). 
The 1H NMR spectrum integrated for 8H, with the downfield proton at δ 8.74 ppm, consistent 
with 3-H chemical shift of quinoxaline and finally the methyl protons were upfield at δ 3.49 
ppm.26  
Applying our Sonogashira coupling conditions to sulfonate 15 with phenylacetylene gave the 
quinoxaline 8 in 67% (a drop from 95% when using sulfonate 7) after running the reaction for 
two hours (Scheme 2.8, R = Ph). The TLC showed the presence of starting material to be present 
when the reaction was stopped. Complete conversion of starting material was only achieved 
when the reaction was allowed to run for 24 hours with an isolated yield of 75% obtained, 
suggesting that decomposition of starting material might be occurring. The NMR and MS spectra 
of the product were identical to these reported in the literature,24 and to those of quinoxaline 8 
prepared earlier. 
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Similarly the yield of TMS-quinoxaline 9 dropped from 70% to 54% and quinoxaline 10 dropped 
from 74% to 53% (Scheme 2.8). The presence of starting material was observed on TLC when 
the reactions were stopped after two hours, and full conversion of starting materials to respective 
products was only achieved when running the reactions for 24 hours or longer. The 1H NMR and 
mass spectra of both products were identical to previously reported data.24 
These results can be explained by comparing the relative acidity of the sulfonic acids. 
Benzenesulfonic acid has a Pka of -5.9 compared to methanesulfonic acid’s -1.9. Good leaving 
groups are conjugates of strong acids, therefore benzenesulfonate is a better leaving groups than 
mesylate as evidenced in our results. 
In conclusion, we had established that quinoxaline-benzenesulfonate 7 is a viable partner in 
Sonogashira coupling reactions with aryl and alkyl acetylenes. While it was not our initial stated 
goal, we decided to attempt the Sonogashira reactions with other heterocycles containing the 
benzenesulfonate leaving group.      
    
2.2.1.2 Sonogashira coupling on sulfonyloxy-heterocycles 
To investigate the scope of benzenesulfonyl substrates in Sonogashira coupling reactions, we 
attempted to prepare pyrimidine, pyridine and quinoline substrates bearing a benzenesulfonate 
leaving group. These nitrogen containing rings were to be prepared using the same method 
leading to sulfonate 7 and sulfonate 15 from their corresponding hydroxy derivatives.  
Treating quinoline-2-ol with benzenesulfonyl chloride in the presence of Et3N and DMAP with 
DCM as solvent, gave quinolin-2-yl benzenesulfonate 16 in 60% yield (Figure 2.2). The melting 
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point obtained from our results (m.p. 89oC) was in agreement with previously reported data of 
90oC.27 The 1H NMR spectra and mass spectra were consistent with that of the desired product. 
 Pyridin-2-yl benzenesulfonate 17 was prepared from pyridine-2-ol in 68% yield, following the 
same procedure for making 16 (Figure 2.2). The product was obtained as an oil as previous, and 
the 1H NMR and mass spectra of the product were in agreement with reported data.28  
Treating pyrimidin-2-ol with benzenesulfonyl chloride did not give the desired pyrimidin-2-yl 
benzenesulfonate 18 and no previous synthesis of the product has been reported. 
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Figure 2.2 
We then applied our Sonogashira coupling conditions (PdCl2(PPh3)2, CuI and Et3N) to the above 
substrate, choosing phenylacetylene as coupling partner. Treatment of the quinoline-sulfonate 16 
with phenylacetylene in refluxing THF and monitoring the reaction on TLC gave undesired 
results. TLC analysis of the crude showed the presence of starting material and a formation of 
one new product, however, 1H NMR and mass spectral analysis of the new product was not in 
agreement with that of the proposed structure. The EI mass spectrum gave a peak at m/z 202 
amu, while the 1H NMR spectrum integrated for 10H instead of the expected 11H. When 
increasing the reaction time from two to 24 hours, similar results were obtained. Increasing the 
temperature of the reaction by refluxing in DMF also proved to be unsuccessful. Changing the 
catalyst from PdCl2(PPh3)2 to the more reactive Pd(0) catalyst, Pd2(dba)3CHCl3, could yield the 
desired coupled product. 
Turning our attention to the pyridine-sulfonate 17, we attempted the Sonogashira coupling using 
our optimized conditions, choosing phenylacetylene as the coupling partner with DMF as solvent 
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and monitoring the reaction on TLC. Monitoring the reaction after 2 hours showed no conversion 
of starting material and the reaction was allowed to run for 24 hours. Purification of the crude 
mixture on flash silica gave three fractions which were analyzed by 1H NMR and mass 
spectroscopy.  
The first fraction was identical to the undesired product obtained in the quinoline-sulfonate 16 
coupling, where a peak at m/z 202 amu was obtained in the mass spectrum. The second fraction 
was an oil which had 1H NMR and mass spectra that were consistent with the desired coupled 
product 2-(2-phenylethynyl)pyridine29 19  (Scheme 2.9) where a peak at m/z 179 amu was 
obtained from the mass spectrum. The 1H NMR spectrum integrated for 9H, with a downfield 
singlet at δ 8.62 ppm in agreement with reported data.29 The product was obtained in 20% 
isolated yield and a yield of 66% based on recovered starting material . The third fraction had a 
NMR and mass spectra identical to those of starting material and was thus assigned to be the 
starting material Attempts to improve the yield by changing the catalyst to the more reactive 
Pd2(dba)3CHCl3 were unsuccessful. 
The 1H NMR and mass spectra of the undesired product obtained was consistent with the 
homocoupled product of two phenylacetylene molecules, i.e. 4-phenylbuta-1,3-diyn-1-
yl)benzene 20, previously reported to occur in a Cu catalyzed Sonogashira coupling reaction of 
two phenylacetylene substrates.29 Given these results, the earlier coupling using only palladium 
catalyst with no added CuI was attempted. 
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Scheme 2.9 
Treatment of the quinoxaline-sulfonate 7 with phenylacetylene under normal Sonogashira 
coupling conditions but omitting CuI, gave quinoxaline 8 in 96% yield after purification on flash 
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chromatography. These results show that CuI does not play an important role in this reaction and 
can thus be omitted.  
When using these modified conditions on quinoline-sulfonate 16 and phenylacetylene in DMF, 
running the reaction for 24 hours and monitoring the reaction on TLC. When analyzing the crude 
mixture by EI mass spectrometry, the peak at m/z 202 was no longer evident, but no peak 
corresponding to the desired product was observed. Instead the starting material peak was shown 
to be the dominant peak. Purification of the crude mixture gave recovered starting material in 
quantitative amounts. The lack of formation of bis-phenylacetylene 20 under Cu-free 
Sonogashira coupling strongly suggests that the homo-coupling is Cu catalyzed. 
Subjecting pyridine-sulfonate 17 to the Cu-free Sonogashira coupling with phenylacetylene in 
DMF for 24 hours and monitoring the reaction on TLC gave two fractions after purification on 
flash silica. The first fraction was assigned to be the desired coupled product, 2-(2-
phenylethynyl)pyridine 19 after its 1H NMR and mass spectra were identical to those previously 
reported29 and those obtained from our previous synthesis. The second fraction was identified to 
be the starting material following 1H NMR and mass spectroscopy characterization. The peak at 
m/z 202 amu was no longer evident, further supporting our claim that the homo-coupling is Cu 
catalyzed. 
An interesting observation was noted on the state of pyridine-sulfonate 17 where upon standing 
for a number of days, a phase change is observed. The sulfonate was obtained as an oil and this 
was in agreement with previously reported data.28 The mass spectrum of the isolated solid was 
identical to that of the oil and there were no notable differences in their 1H NMR spectrum. 
Heating the oil in ethanol afforded more of the solid which were collected and subjected to the 
Cu-free Sonogashira coupling conditions with phenylacetylene. When monitoring the reaction on 
TLC, no desired coupled product was observed but, a new spot with similar Rf value to the one 
observed from pyridine-sulfonate 17 (oil) was observed along with the solid starting material. 
Purification of the crude on flash chromatography gave fractions which confirmed the TLC 
observations. From these results we postulate that the crystals and the oil are isomers and are 
likely to be pyridine-o-benzenesulfonate 17a and pyridinone-N-benzenesulfonate 17b(Scheme 
2.10) 
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Scheme 2.10 
Previous work has shown that there exists an equilibrium between N-sulfonated and O-
sulfonated products at high temperatures for compounds having the 1,2 (N, O) relationship.30 
The N-sulfonyl isomer does not react under Sonogashira coupling conditions and its formation 
will result in low yields of the desired products. The same isomerization observed on pyridine-
sulfonate 17 could be happening on quinoline-sulfonate 16, hence explaining the lack of 
formation of coupled products. Due to high temperatures required for the Sonogashira coupling, 
and also high temperatures favoring isomerisation, the substrates 16 and 18 become generally 
unreactive.  
In recently reported Sonogashira coupling reactions quinoline- and pyridine-tosylates, the 
coupling was only reported to proceed at the 3-positions.31 The only reported Sonogashira 
coupling reactions at the 2-position of pyridine and quinoline were performed on substrates 
having the triflate leaving group.4 Triflates is a better leaving group than benzenesulfonate or 
tosylate, suggesting that the rate of coupling is much faster than the rate of isomerization when 
working with triflate bearing substrates. Further work needs to be done to substantiate these 
claims.  
 
2.2.1.3 Attempted Sonogashira coupling on sulfonyloxy-benzene substrates 
In previous publications, Sonogashira coupling reactions were reported on phenyl substrates 
possessing a triflate13 and more recently, substrates possessing a tosylate and mesylate leaving 
groups.5,6,32 In the latter publications, modified Sonogashira coupling conditions were employed 
where a strong base, Cs2CO3, was used
5,6 and bulky phosphine ligands were also employed.32 
We were interested in employing our simple Sonogashira coupling conditions on phenyl 
compounds possessing the benzenesulfonate leaving group. 
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The benzene substrates (benzenesulfonyloxy)benzene 21 and 1-(benzenesulfonyloxy)-3-
methoxybenzene 22 (Figure 2.3), were both prepared, according to the method of Choi et.al.33, 
by treating the corresponding phenols with Et3N and benzenesulfonyl chloride in tetrahydrofuran 
and stirring the mixture for 48 hours after which TLC showed no trace of starting material and a 
new product appeared to have formed. Both products were obtained as oils, following aqueous 
HCl workup and concentration of the crude organic layers, and the yields were 96% for 
[PhOSO2Ph] 21 and 99% for [3-MeO-PhOSO2Ph] 22. The NMR and mass spectra of both these 
products were in good agreement with literature data.33 
Treating the benzene-substrate 21 to our Sonogashira coupling conditions in the presence of 
phenylacetylene and monitoring the reaction on TLC gave the following observations.  Analysis 
of the crude by TLC showed the presence of starting material even when the reactions were run 
for 24 hours or longer. Purification of the reaction mixture gave only the unchanged starting 
material as judged by NMR and mass spectral analysis. Changing the temperature of the reaction 
from 80oC to 120oC gave no improvement. Changing the catalyst from PdCl2(PPh3)2 to 
Pd2(dba)3CHCl3 also gave no improvements. Similar observations were obtained when the 
methoxy-benzene substrate 22 was used. 
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Figure 2.3 
The lack of detectable Sonogashira coupled products under our conditions is in contrast to the 
success of the Sonogashira coupling with the quinoxaline sulfonates. The benzene substrates 
investigated can be classified as electron-rich while the quinoxaline and pyridine substrates can 
be considered to be electron-deficient. We then concluded that Sonogashira coupling reactions 
on benzenesulfonyl substrates proceeds smoothly on electron-deficient systems, while electron-
rich systems will require the presence of special phosphine ligands and a strong base. Possible 
future work might involve attempted synthetic coupling of pyridine-, quinoline- and benzene-
sulfonates, employing Cs2CO3 and bulky phosphine ligands conditions. 
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2.2.2 Sonogashira coupling of pteridine-O-sulfonates 
With conditions for the Sonogashira Coupling of heterocyclic substrates in hand, we turned to 
the challenge of extending the scope of this procedure to a pteridine system. Our chosen starting 
point was an O-sulfonate derived from the bis-protected pteridine 25 (Scheme 2.11). Previous 
investigations by Joule et.al.21 showed the substrate to undergo Stille coupling as described in 
Chapter 1, section 1.3.1. 
The pteridine ring was constructed, according to the method of Pfleiderer,34 from 
tetraaminopyrimidine (TAP) and glyoxylic acid in sulfuric acid (H2SO4) to give 2,4-
diaminopteridin-6-one 23 in 74% yield. The product was characterized by UV-vis spectrum 
which was consistent with that reported by Pfleiderer. The product was insoluble in common 
NMR solvents and no NMR data was obtained. The reaction was performed in an acidic medium 
so as to promote formation of the 6-oxo-pteridine over the 7-oxo-pteridine. The mechanistic 
explanation for the regioselectivity is that under acidic conditions, the N(1)- and N(5)- atoms are 
protonated, making the N(6)-atom more reactive towards electrophiles and thus reacts with the 
more reactive aldehyde of the glyoxylic acid (Scheme 2.11) 
There was no evidence of any detectable formation of the 7-oxo-pteridine during all our 
subsequent investigations, where all the products derived from the 6-oxo-pteridine were in 
agreement with those previously reported. Those results are explained below. 
Bredereck’s reagent [t-BuO(Me2N)2CH] 24, was chosen to introduce the dimethyl(formamidine) 
protecting and solubilising group, following previous work by Joule et.al.21 The Bredereck’s 
reagent was prepared by treating tetramethylformamidine chloride (TMFAC) with potassium 
tertiary-butoxide (KtBuO) in tetrahydrofuran. 
Dimethylcarbamoyl chloride (DMCC) and dimethylformamide (DMF) were heated at 120oC in a 
flask fitted with an air-bubbler until production of CO2 was no longer visible (3 days). The 
excess DMF was removed under high vacuum to give a brown solid with a 1H NMR and mass 
spectra similar to that of TMFAC.21 The product was obtained in 91% yield (Scheme 2.11).  
TMFAC and KtBuO were suspended in THF at room temperature until all solid has dissolved (4 
days). Following the removal of solvent and purification by distillation, a clear oil with NMR 
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and mass spectra similar to that of the Bredereck’s reagent was obtained in 79% yield (Scheme 
2.11). 
N
N
NH2
H2N
NH3
NH2
O
O
OH
N
NH2N
NH2
N
H
N O N
NN
N
N
H
N O
N
N
DMF, 60 oC
2M H2SO4
74%
90%
N
O
+ N
O
Cl N N
Cl
N
O
N
78%
68% THF, r.t
120oC
KOtBu
23
24
25
N
NH2N
NH2
NH2
NH2
H
12
3
4
5
6
80oC
 
Scheme 2.11 
Following the procedure reported by Joule et al,21 reacting pteridinone 23 and Bredereck’s 
reagent 24 in DMF at 60 oC afforded the more soluble pteridine, 2,4-di(N,N-
dimethylaminomethyleneamino)pteridine-6-one 25 in 90% yield (Scheme 2.11). The 1H NMR 
spectrum was in agreement to that reported by Joule, with a downfield singlet at δ 8.76 ppm 
corresponding to the 7(H) proton and the upfield singlets at δ 3.07, 3.08, 3.10 and 3.15 ppm 
corresponding to the four methyl groups on the amidine protecting groups. The difference in 
chemical shifts between the methyls shows hindered rotation and suggests a significant double 
bond character to the amidine bond, causing the methyl-C to be in different environments. The 
total number of protons was integrated to be 14, consistent with the proposed product. The mass 
spectral data gave a molecular ion peak at m/z 288 amu. The product was obtained as a pale 
yellow solid that displayed bright yellow fluorescence under long wave UV lamp, or in dilute 
solution when exposed to sunlight.  
The dimethylformamidine protecting groups have been used previously on the 2,4-
diaminopteridine ring. 21,35-36 On two occasions, the pteridine possessed a chlorine atom at the six 
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position35-36 and on one occasion it had an oxygen atom at the six position.21 These substrates 
were used to synthesize a number of six-substituted pteridines, some of which were tested for 
anti-cancer activity.35 
2,4-Di(N,N-dimethylaminomethyleneamino)-6-mesyloxopteridine 26 (Figure 2.4A) was 
prepared by treatment of pteridinone 25, mesylchloride and Et3N in DCM in a similar method for 
preparing quinoxaline 7. Following recrystallization from EtOH, the product was obtained as a 
yellow solid in 65 % yield. Spectroscopic data of the compound compared closely with the 
structurally related tosylate, previously prepared by Joule.21 There are down field singlets at 
around δ 8.76 ppm (1H) and δ 9.03 ppm (2H), corresponding to the 7(H) proton and the two 
formamidine protons, respectively (Figure 2.4 B). The APCI mass spectrum of the product gave 
a [M + H+] at m/z 367 amu that was in agreement with that calculated for C13H19N8O3
32S. 
2,4-Di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine 27 (Figure 2.4A) 
was prepared in 75% yield in a similar manner to the mesylate-pteridine 26. The 1H NMR 
spectrum of the product showed a downfield singlet at δ 8.56 ppm corresponding to the 7(H) and 
the four upfield singlets between δ 3.19 and 3.30 ppm. The EI mass spectrum gave a peak at m/z 
428 amu [M]+, consistent with that calculated for C18H20N8O3
32S.  
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Figure 2.4 B 
1
H NMR of the 6-mesyloxypteridine 26 
With a protected pteridine-6-sulfonate in hand, we were in a position to attempt the Sonogashira 
coupling reactions on these substrates. Subjecting the benzenesulfonate-pteridine 27 and 
phenylacetylene to our Cu-free Sonogashira coupling conditions previously found optimal for 
quinoxaline 7 (PdCl2(PPh3)2, Et3N, DMF, 80
oC) gave, after two hours, a mixture of two close 
running new products as judged by TLC, with no starting material observed. Both products had a 
blue fluorescence under long wave UV light, suggesting incorporation of a pteridine nucleus. 
Purification of the crude mixture on flash silica only partially separated these new products. 
Analysis of the close running products employing HPLC-UV-APCI-MS also showed the 
compounds to be close running. The APCI mass spectra of these two closely eluting fractions 
gave peaks at m/z 373 and 318 amu. The peak at m/z 373 amu was assigned to be that of the 
desired Sonogashira coupled product, 2,4-di(N,N-dimethylaminomethyleneamino)-6-(2-
phenylethynyl)pteridin-4-yl 28 (Scheme 2.12). The peak at m/z 318 amu, 55 less than molecular 
weight of the desired coupled product 28, corresponding to a loss of one protecting group was 
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tentatively assigned to be the mono-deprotected product 4-amino-2-( N,N-
dimethylaminomethyleneamino)-6-(2-phenylethynyl)pteridin-4-yl 29. A similar formation of a 
mono-deprotected pteridine was reported by Joule during the Stille coupling reaction of the 
tosylate derivative.21 
The 1H NMR spectrum of the combined fractions gave peaks that were consistent with the 
coupled products, however, overlapping of peaks was observed on both the upfield and 
downfield signals. Two downfield singlets δ 8.76 and 9.06 ppm, corresponding to the 7(H) and 
the formamidine (NCHN) respectively, from both compounds, were observed. The four 
downfield singlets between δ 3.01 and 3.12 ppm, were consistent with the amidine methyl 
groups from both molecules. Integration of the methyl peaks gave a product distribution of ~1:1 
but this ratio varied slightly when repeating the reaction and chromatographic purification. 
Further purification of the two close running fractions, by flash chromatography, gave a product 
distribution that favored the mono-deprotected product 29 in a 1:9 ratio, when integrating the 
methyl peaks. The ratio of the products can also be calculated by integrating the downfield 
protons at δ 8.76 and 9.06 ppm. 
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Scheme 2.12 
The general mass yield of these reactions were that, from one gram of sulfonate 27, 0.65 gram of 
mixed products were obtained and further purification lead to 0.55g of mainly mono-deprotected 
29 in an overall yield of 74%. Accurate mass measurements of the sample gave a peak at m/z 
317.13849 amu which is in good agreement to the calculated value for C17H15N7 of 317.13889 
amu. From these results we were confident that the Sonogashira coupled product from pteridine-
O-benzenesulfonate with phenylacetylene was achieved. The desired product however, loses one 
protecting group either during the reaction or during purification. This result shows the first 
Sonogashira coupling reaction involving pteridine-O-sulfonates. 
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We examined briefly, the effect of varying the catalyst by employing Pd2dba3.CHCl3 instead of 
PdCl2(PPh3)2. There was no apparent change in the rate of the reaction as judged by TLC 
analysis and purification of the crude on flash silica gave the two closely running fractions in 
similar mass yield (72%) to that obtained before. 1H NMR of the combined fractions gave a 
product distribution that favored the desired coupled pteridine 28 in 2:1 ratio, however, further 
purification of the fractions on flash silica gave product distribution that favored the mono-
deprotected pteridine 29 in a 1:9 ratio as observed before. HPLC-UV-APCI-MS confirmed the 
main component coming from the second purification to be the mono-deprotected pteridine 29. 
The APCI mass spectrum showed the peak at m/z 318 amu to be the dominant peak with minor 
peaks at 373 and 263, corresponding to fully protected coupled product 28 and fully deprotected 
product, 2,4-diamino-6-(phenylethynyl)pteridine 35 (Figure 2.5). In conclusion, it appears that 
the Pd source did not significantly affect the reaction yield in this case. 
 
Figure 2.5  HPLC-UV, TIC chromatograms and APCI-MS of the main component 
We then tried to understand how one protecting group is lost during either the reaction, or upon 
purification by flash chromatography. The removal of the protecting groups can be explained as 
follows; the protecting groups used are removed by acid hydrolysis and alkaline hydrolysis, thus 
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the presence of base or acid in the reaction mixture can result in the removal of the protecting 
groups with the more reactive site being easily displaced.  
The reactions are performed in the presence of Et3N, a hindered base, and the side product 
generated in the Sonogashira coupling is benzenesulfonic acid. Because the formation of the 
benzenesulfonyl-pteridine 27 is in the presence of Et3N, we eliminated the possibility of the Et3N 
to remove the protecting group. Benzenesulfonic acid on the contrary is a strong acid with 
similar strength to HCl and could explain the removal of the protecting group. However, with 
Et3N used in excess during the reaction, any benzenesulfonic acid formed will be neutralized by 
the base, thus making the sulfonic acid an unlikely candidate to deprotect the pteridine. 
During purification by chromatography, the solvent system used were MeOH/DCM, methanol 
can act as an acceptor while the silica gel can act as an acid leading to further hydrolysis. This 
could explain the observation of pteridine-29 becoming the more dominant product upon further 
purification. To further support our claims that MeOH/DCM in silica is responsible for the 
deprotection, we ran a 2-D TLC of the two close running fractions. A visible off-diagonal spot 
was apparent, clearly showing that deprotection of the di-protected 28 to give the mono-
protected pteridine 29 was occurring under these chromatographic conditions  
While it was likely that silica gel could provide an acidic surface capable of catalyzing the 
hydrolysis of the more labile PG, we also investigated the possibility that methanol itself would 
cause deprotection.  We prepared a solution of the starting material, benzenesulfonyl-O-pteridine 
27, in a MeOH/DCM mixture (9/1) and analyzing on HPLC-MS. The eluting solvent system 
chosen was water/methanol running a gradient for 12 minutes starting with 100% water, 
changing to 100% methanol over 6 minutes. The HPLC-UV-MS run gave a retention time (RT) 
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of 8.8 minutes, a peak of 429 [M+H]+ and λmax 253, 288 and 387nm (Figure 2.6). 
 
Figure 2.6 TIC and extracted UV and mass spectra, from HPLC analysis of the 
benzenesulfonate 27. 
When running the same sample after 24 hours, different results where the original peak at RT 
8.84 minutes was replaced by two new peaks at RT 8.43and 8.87 minutes, were observed. The 
two new peaks had m/z 374 and 319 amu, and were tentatively assigned to be the mono-
deprotected and fully deprotected benzenesulfonyl-pteridines 27 b and 27c, suggesting that 
methanol has the ability to deprotect (Figure 2.7). The isotopic distribution of the molecular ion 
peaks further supports our proposed structural assignments of these components. Both peaks 
have [M+1]+ and [M+2]+signals coming from the 13C isotope and 34S isotope.  In addition to the 
peak at m/z 374 amu, a peak at 375 amu which has 17% intensity relative to the 374 peak, and a 
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peak at 376 which has 6% intensity relative to the 374 peak are observed (Figure 2.7). These 
peaks correspond to a molecule having 17 carbon atoms and one sulfur atom as expected from 
our proposed structure. Similar isotopic distributions were observed on the m/z 319 amu peak, 
where peaks at m/z 320 (14%) and 321(6%) amu were observed. 
 
Figure 2.7 TIC resulting from HPLC analysis of the pteridine 27, in MeOH / DCM solution 
for 24 hours, and summed MS spectra over both eluting peaks. 
It is also likely that the residual moisture present in both MeOH and silica gel could be 
responsible for the deprotection. Evidence for this claim was observed on the 1H NMR spectra of 
the compounds obtained from the two reactions, where residual DMF peaks were visible. 
In conclusion, it appeared that while the Sonogashira coupling of the O-sulfonate 27 and 
phenylacetylene occurred readily, loss of the one amidine protecting group was also occurring 
either during the reaction itself, if an adventitious acceptor was present and during the 
chromatographic purification.  While this in itself did not affect the overall yield, it did 
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complicate analysis of both the crude and purified product.  This side reaction was found to 
accompany many of the reactions to be described below. 
Having shown that the pteridine-O-benzenesulfonate and phenylacetylene would undergo 
Sonogashira coupling, we investigated varying the acetylenes to those previously used in the 
coupling with quinoxaline-O-benzenesulfonate 7. Treating benzenesulfonate-pteridine 27 with 
ethynyltrimethylsilane under our previously optimized conditions, running the reaction for two 
hours and monitoring the reaction on TLC, showed consumption of starting material 27 and 
afforded a mixture of two new products, following flash purification on silica gel. Analysis of 
the close running products by HPLC-MS gave peaks at m/z 369 and 314 amu (both presumed 
[M+H]+). We tentatively assigned these peaks to come from the 6-TMS-ethynyl-pteridines 30 
and 31 (Figure 2.8) The 1H NMR of the mixture gave similar observations as with 
phenylethynyl-pteridine 28 and 29 (Scheme 2.12), where roughly equal amounts of products are 
present, and further purification on flash silica results in the formation of more TMS-pteridine 
31. General mass yield of these reactions were that, from one gram of sulfonate 27, 0.56 g of 
product mixture were obtained and further purification gave 0.46 gram of mainly 31 (1:9) in an 
overall yield of 63%. 
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Figure 2.8 
Treating benzenesulfonate-pteridine 27 with propargyl alcohol under the Sonogashira coupling 
conditions, running the reaction for two hours and monitoring the reaction on TLC, did not yield 
the desired coupled product, propargyl-pteridine 32 (Scheme 2.13). No starting materials were 
recovered suggesting a side reaction has taken place. Starting with one gram of sulfonate 27, 654 
mg of orange precipitates, with the fluorescent character of pteridines, were isolated from the 
reaction flask and their characterization by APCI mass spectroscopy gave a peak at m/z 319 amu 
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[M+H]+. The peak was assigned to be that of fully deprotected starting material, 
benzenesulfonyl-pteridine 27c (Figure 2.7), suggesting that deprotection had taken place. We 
postulated that the protecting groups on the pteridine ring were removed by the free hydroxyl 
group on the propargyl alcohol. This result is consistent with the observations above, which 
showed that benzenesulfonate-pteridine 27 can be fully deprotected in MeOH at room 
temperature over 24 hours (section 2.2.3.1). 
Since the free hydroxyl group appeared to be incompatible with the protecting groups under our 
optimized Sonogashira coupling conditions, we attempted to mask the free hydroxyl group on 
propargyl alcohol with a methyl group. 3-Methoxypropyne37 was obtained by treating propargyl 
alcohol with dimethyl sulfate in a 13M NaOH solution. The product was obtained as a clear oil, 
which boiled at 65 oC in keeping with the literature value. The 1H NMR spectrum of the product 
was identical to that reported previously.35 
Treating benzenesulfonate-pteridine 27 with 3-methoxypropyne under the optimized, Cu-free 
Sonogashira coupling conditions, running the reaction for two hours and monitoring the reaction 
on TLC, gave a mixture of two close running coupled products, after purification on flash silica. 
Partial separation employing HPLC-UV-MS showed two closely eluting components to be 
present which gave peaks at m/z 286 and 341amu, both presumed to be [M + H]+. The peaks 
were tentatively assigned to be the methoxypropynyl-pteridines 33 and 34 (Scheme 2.13). 1H 
NMR showed the product mixture to be roughly 80% fully protected pteridine 33 and 20% 
mono-deprotected pteridine 34. The mass yield for this reaction was that, from one gram of 
benzenesulfonate-pteridine 27, 0.5 gram of mixed products but with methoxypropynyl-pteridine 
33 as the dominant product, was obtained. Comparing this successful result to that obtained 
above clearly supports the suggestion that an adventitious acceptor (the OH of propargyl alcohol 
in this case) allows a fast deprotection of the O-sulfonate amidine groups, under the reaction 
conditions employed here. 
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Scheme 2.13 
We then turned our attention to the synthetic utility of the mesylate-pteridine 26 which offers the 
advantages of being relatively cheap to prepare and atom economic during the coupling 
reactions. Subjecting the mesylate-pteridine 26 to our optimized Cu-free Sonogashira coupling 
conditions with phenylacetylene, running the reaction for two hours and monitoring the reaction 
on TLC, showed two spots corresponding to the Sonogashira coupling products obtained above 
and unreacted O-mesylate 26.  Workup and purification by flash chromatography gave the 
coupled pteridine products 28 and 29 in 7% yield (84% based on recovered starting material). 
Increasing the reaction time to 24 hours did not improve the conversion. 
No reactions occurred when either 3-methoxypropyne or ethynyltrimethylsilane were used in an 
attempted Sonogashira coupling with mesylate 26. TLC showed the presence of starting material 
even when the reactions were run for longer than 24 hours. When purifying the crude mixture on 
flash silica, starting material was recovered in almost quantitative amounts and trace amounts of 
fully the deprotected starting material 27c were detected on the mass spectrum.  These results led 
to the conclusion that Sonogashira coupling reactions on the pteridine ring proceed smoothly 
with 6-O-benzenesulfonyl leaving group ability, while the 6-O-mesylate leaving group is 
unreactive under our Sonogashira coupling conditions. 
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In conclusion, we have demonstrated that a pteridine-O-benzenesulfonate 27 is a useful substrate 
for Sonogashira coupling reactions using simple Pd catalyzed conditions. 
 
2.2.3 Hydrolysis of protected pteridines  
2.2.3.1 Hydrolysis to 2,4-diaminopteridines 
With quantities of 6-acetylene-pteridines in hand, we turned to the issue of the hydrolysis. We 
intended that, under appropriate conditions, hydrolysis could be tuned to give initially the 2,4-
diaminopteridine, a much investigated motif in the area of medicinal chemistry, and under 
stronger hydrolytic conditions the corresponding 2-amino-4-oxo-pteridine (pterin) could be 
obtained. 
2,4-Diaminopteridines have previously been hydrolyzed into 2-amino-4-oxopteridines (pterin) 
under basic conditions17 or acidic conditions. A one molar sodium hydroxide (1M NaOH) and 
ethanol (EtOH) solutions are generally used for the basic hydrolysis while a six molar 
hydrochloric acid (6M HCl) solution is used in the acid hydrolysis.  
We anticipated, from both the behavior described above and previous literature, discussed in 
Chapter one, that removal of both the dimethylformamidine protecting groups would be facile. 
Treating the mixture of the phenylacetylene-pteridines 28 and 29 with ammonia solution (1M), 
gently refluxing the mixture for 16 hours and precipitation by addition of acetic acid, gave the 
expected 2,4-diamino-6-(phenylethynyl)pteridine 35 in 77% yield (Scheme 2.14). The product 
was obtained as a yellow solid and melting point, NMR and mass spectral data were consistent 
with both the proposed structure and data previously reported.17 The downfield singlet at δ 8.86 
ppm is consistent with the 7(H) from pteridine and a peak at m/z 263.1 amu [M+H]+, obtained as 
the sole peak from APCI-MS. HRESI gave a peak at m/z 263.10340 which is in agreement with 
that calculated for C14H11N6. 
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Scheme 2.14 
Similarly the mixture of the TMS-acetylene-pteridines 30 and 31 gave 2,4-diamino-6-
(ethynyl)pteridine 36 as a yellow solid in 76% yield, with the 1H NMR and mass spectral data 
identical to literature data (Scheme 2.14).17  A peak at m/z 187 [M+H]+ was obtained from the 
APCI mass spectrum, confirming the formation of product (Figure 2.9, a small [2M+H]+ is also 
evident). 
 
Figure 2.9 TIC chromatogram and APCI mass spectrum of 2,4-diamino-6-
(ethynyl)pteridine. 
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Finally, 2,4-Diamino-6-[(methoxymethyl)ethynyl)pteridine 37 was prepared, as a yellow solid in 
74% yield from the mixture of 33 and 34 (Scheme 2.14). The NMR and mass spectra were 
identical to that reported previously.17 No deprotection of the methoxy group was noted as 
judged by the 1H NMR spectrum which gave a singlet at δ 3.35 ppm (3H) and a singlet at δ 4.40 
ppm (2H) corresponding the the -CH3
 and -CH2 groups respectively. The APCI mass spectrum 
gave a molecular ion peak at m/z 231amu [M+H]+ in agreement with that calculated for 
C10H11N6O. 
In conclusion, the ammoniolysis proceeded smoothly as judged by the chromatographic 
homogeneity of the three diaminopteridines described above. We then addressed the hydrolysis 
to the corresponding pterin derivatives. 
 
2.2.3.2 Hydrolysis to 2-amino-4-oxo-pteridines (pterins) 
Hydrolysis of 2,4-diaminopteridines to their corresponding pterin derivatives have been 
previously reported to proceed smoothly in a 1M NaOH/Ethanol solution under reflux, and 
obtaining the products by precipitation with AcOH.17 Treating the mixture of the phenylethynyl-
pteridines 28 and 29  with 1M NaOH/ EtOH solution and refluxing for 18 hours and precipitation 
by acidifying the solution with AcOH, gave the desired 6-(phenylethynyl)pterin 38  in 73% yield 
(Scheme 2.15). The product was isolated as a yellow solid and its 1H NMR spectrum was 
identical to the one reported by Taylor.17 Accurate mass measurement of the sample gave a 
molecular ion at 263.08092 amu, in good agreement with that of C14H9N5O calculated to be 
263.08071 amu.       
HN
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Applying the same alkaline hydrolytic conditions to the TMS-ethynyl-pteridines 30 and 31 
resulted in the solution turning from yellow to black. Attempts to precipitate the product by 
addition of AcOH resulted in black precipitates forming, however, these precipitates were not 
soluble in any organic solvent and could not be characterized by 1H NMR. An APCI mass 
spectrum of the crude dark solution did not have the desired molecular ion peak of 187 amu (or 
188 if [M+H]+), instead a peak at m/z 178 amu was dominant.  
Similarly, treatment of the mixtures of methoxypropynyl-pteridines 33 and 34 with the alkaline 
hydrolytic conditions, resulted in the solution changing color from yellow to black upon 
refluxing and the reaction mixtures could not be analyzed by 1H NMR. A peak at m/z 177 amu 
was obtained as the dominant peak from the APCI spectrum. The retention time of this peak was 
very similar to the one obtained in the attempted TMS-acetylene hydrolysis, suggesting that it 
could be the same product.  
We then turned our attention into monitoring these unsuccessful reactions by partial separation 
with HPLC and characterization with APCI mass spectroscopy. In addition, HPLC-MS was used 
to analyze the purity of the products and respective starting material, and also the relative rates of 
the hydrolysis reactions. The results are discussed below. 
 
2.2.3.3 Use of HPLC-MS in monitoring the hydrolysis of 6-ethynyl-pteridine to 6-
ethynylpterin.  
In investigating the deprotection and hydrolysis of TMS-ethynylpteridine 30 and 31 in the 
presence of NaOH, we prepared a solution of the two acetylenes in DCM/MeOH (1:9). Before 
treating the solution with base, HPLC-MS analysis was run to confirm the presence of the two 
products where two close RT values of 7.34 and 7.49 minutes were obtained (Figure 2.10). The 
mass spectra of the samples however, were not in agreement with the molecular ion peak of 
[M+H]+ 369 and 314 amu, instead m/z 241 and 296 amu were observed (Figure 2.10), 
corresponding to the loss of the trimethylsilyl (TMS) group. These results suggest that the TMS 
group is labile and does not require the presence of acid, as in many cases, to be removed.  
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 Figure 2.10 HPLC-UV and TIC chromatograms, along with the APCI-MS spectra of the 
ethynyl-pteridines 30 and 31. 
Treating the mixture of 30 and 31 with NaOH/EtOH at reflux temperature and monitoring the 
reaction at different time intervals gave the following results; an HPLC-MS run of the reaction 
mixture after one hour showed one compound to be present in solution, which was tentatively 
assigned to be 6-ethynylpteridine 36 (RT 4.60 min, m/z 187 [M+H]+ , Scheme 2.16), suggesting 
that the deprotection step is relatively fast.   
When sampling the reaction mixture after three hours we observed two new peaks with RT 5.93, 
5.99 minutes and m/z 188,  233 amu (both presumed to be [M+H]+), respectively, along with the 
6-ethynylpteridine 36. The species with m/z 188 amu was tentatively assigned to be the desired 
6-(ethynyl)pterin 36b. The peak at m/z 233 amu, 46 amu up on ethyne 36, was tentatively 
assigned to the ethoxyene-pteridine 38. It is likely that this results from the addition of an ethanol 
molecule across the triple bond of pteridine 36.  In support of our structural assignment of the 
ethoxyene-pteridine 38, the 13C isotope peak at m/z 234 amu had an intensity of ~11% that of the 
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peak at 233 which was is in agreement with a molecule having ten C atoms, as is the case with 
our proposed structure (Scheme 2.16). 
Similar additions of an ethanol group across a triple bond were observed on pterin 36b after four 
hours to give 6-ethoxyene-pterin 39 (RT 7.38 min, m/z 234 amu [M+H]+). A peak at m/z 235 
amu, with ~11% intensity to that of peak at 234, was observed. At this point the species present 
in solution had m/z 188, 233 and 234 amu.  
Further addition of ethanol groups on pteridine 38 and pterin 39 were observed after six hours, 
where the only peaks observed were at m/z 278 and 279 amu and were tentatively assigned to be 
6-[(diethoxy)ethyl]pteridine 38 and 6-[(diethoxy)ethyl]pterin 39, respectively . The latter two 
peaks gradually disappear over ten hours to give a new peak with RT 5.08 min and m/z 178 amu, 
which we tentatively assigned to be 6-(methyl)pterin 42. These results are summarized in 
Scheme 2.16. 
 
Scheme 2.16 Proposed scheme for the alkaline hydrolysis of the ethynyl-pteridines 30 and 
31. All mass peaks are assumed to be [M+H
+
]. 
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To investigate further that ethanol was adding twice to the triple bond, the solvent was changed 
from ethanol to methanol, while following the same reaction procedure and sampling the 
reaction mixture at same intervals. The peaks at RT 5.99 min., m/z 233 and  RT 7.38 min., m/z 
234 amu were replaced by RT 6.21 min., m/z 218 and RT 7.45 min., m/z 219 amu, respectively, 
while peaks at m/z 278 and 279 amu were replaced by m/z 263 and 264 amu, respectively. All the 
new masses are 15 amu less, which corresponds to the mass difference expected when changing 
from ethanol to methanol. This strongly supported the mechanism proposed in Scheme 2.16.  
While the structural assignments are tentative, we could not think of any other likely mechanism.   
These results suggest that the ethynyl group is reactive towards nucleophiles, in our case 
ethoxide or methoxide, in a Michael addition-type reaction. Upon heating the acetal group 
cleaves off in a mechanism unknown to us but that most likely involves breaking of the required 
C-C bond through anomeric assistance of an acetal group, as illustrated in Scheme 2.17. The 
leaving group is then the tautomer of the 6-methylpterin. We found little precedent for this 
mechanism. In a possible related report, a methoxide nucleophile adds to a 6-ethynylpurine.38 
The intermediate acetal, which was not isolated, then cleaves to give a 6-methylpurine.  
It is also possible that, given the rich radical chemistry that pterin systems are known to undergo, 
a single electron mechanism can also account for our observations. Future work might involve an 
exploration of the mechanism by which this process occurs and an unequivocal synthesis of 6-
methylpterin in order to confirm the structure of the final hydrolysis product. 
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Scheme 2.17 
To prove that we did not have 3-N-(methyl)pterin as product, we obtained a sample of [2-(N,N-
dimethylaminomethyleneamino)]-3-N-(methyl)pterin 43 and subjecting it to the alkaline 
hydrolysis conditions, mentioned above, gave N-(methyl)pterin 44 which have m/z 178 amu 
[M+H]+,  but different Uv-vis spectra to 42 (Scheme 2.18 and Figure 2.11).  
                                            
N
N
Scheme 2.18 
 
Figure 2.11 
After obtaining an insight into the alkaline hydrolysis of the ethynylpteridines, we attempted to 
hydrolyze the ethynylpteridines 
6M HCl to hydrolyze 2,4-diaminopteridin
reported to proceed smoothly under reflux.
with 6M HCl/EtOH at room temperature
MS suggested that one principal species was present. This 
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diamino-6-(ethynyl)pteridine 36 detected during the attempted alkaline hydrolysis, and a 
molecular ion at m/z 187 amu. No further changes were observed when the reaction was 
analyzed after 24 hours. 
When repeating the above reaction, but increasing the temperature to reflux and monitoring the 
progression after six hours on HPLC-MS, a peak eluting with RT 4.55 min and m/z 223 amu was 
obtained along with a peak at m/z 187 amu, previously assigned to be 6-ethynylpteridine 36. We 
tentatively assigned the peak at m/z 223 amu to be 6-(1-chloroethenyl)-2,4-(diamino)pteridine 
45, corresponding to the addition of HCl across the triple bond to give presumably, the 
Markovnikov product (Figure 2.12). The isotopic distribution of the molecular ion peak was 
consistent with the addition of one chlorine atom which has two isotopes, 35Cl (76%) and 37Cl 
(24%). In addition to m/z 223 amu, a peak at m/z 225 amu, with 24% relative intensity to the 
peak at 223, was observed confirming the presence of chlorine atom in the molecule. 
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Figure 2.12 
We then replaced HCl with a strong organic acid, CF3COOH, hoping to avoid the side reaction 
of HCl adding across the triple bond. Treatment of the ethynylpteridines 30 and 31 with 
CF3COOH and refluxing the reaction for 18 hours while monitoring the reaction by HPLC-MS, 
only afforded the diamino-6-ethynylpteridine 36. The deprotection was observed in the first 
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hour, however, full deprotection was only achieved after 18 hours, indicating the relative 
slowness of the reaction. 
When using a strong non-chlorinated inorganic acid, 2 M sulfuric acid (H2SO4), on a small scale 
we did manage to get the desired 6-(ethynyl)pterin 36b as observed from HPLC-MS analysis 
where  peaks at RT 5.99 minutes and m/z 188 were obtained. However, when scaling up the 
reaction, the desired product could not be isolated in a pure form. Attempts to precipitate the 
product out of solution gave a dark solid which appeared to contain mainly the desired pterin 
36b, but substantial amounts of impurities were noted on the HPLC chromatogram.  
In conclusion, the selective hydrolysis to give the natural pterin substituents occurs cleanly when 
the phenylacetylene Sonogashira coupling products 28 and 29 were exposed to alkaline 
hydrolysis conditions. When the TMS-ethynylpteridines 30 and 31, and the methoxymethyl-
ethynylpteridines 33 and 34, were subjected to the alkaline hydrolysis conditions, side reactions 
occurred. The resultant by-products appear to result from Michael-type addition of the alkoxide 
solvent and ultimate C-C bond cleavage to give 6-methylpterin. With these substrates, selective 
hydrolysis to the corresponding pterin derivatives requires careful monitoring under alkaline 
conditions and acid hydrolysis employing a non-nucleophilic anion for which sulfuric acid 
appears appropriate. 
 
2.3 Total Synthesis of Sepiapterin-C 
In order to find useful applications for our Sonogashira coupling methodology, we looked for a 
natural product which might constitute a target. Sepiapterin-C 46, a natural pterin, has been 
isolated from the eye pigments of the mutant wild type Drosophila melanogaster as a minor 
component along with sepiapterin and isosepiapterin.39 The three pterin molecules were isolated 
as yellow compounds and are believed to be responsible for the yellow eye color pigments, no 
other information is known about the biological role of sepiapterin-C. The total synthesis of 
sepiapterin-C has been reported by Murata et al.40 where a classical ring synthesis approach was 
employed (Scheme 2.19).  
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Scheme 2.19 
Our initial proposed synthesis of sepiapterin-C was to start with the mixed protected 6-
(ethynyl)pteridine 30 and 31, deprotection and hydrolysis with NaOH, addition of water across 
the triple bond, which we intended be facilitated by silver oxide (HgO), to give 6-methylketone-
pteridine, and a dissolving metal/amalgam reduction of the 7-8 imine employing the conditions 
described by Murata.40 However, this route was abandoned due to the side reactions associated 
with the deprotection/hydrolysis step, described in scheme 2.16.  
Having shown that sulfuric acid can be used in the hydrolysis of protected 6-ethynylpteridines 30 
and 31 to 6-ethynylpterin, we turned to hydrolysis of ethyne to a methyl ketone. Hydrolysis of a 
heterocyclic ethyne to a methyl ketone has previously been achieved using the combination 
CF3COOH and HgO.
41 We investigated conditions where we might achieve the hydrolysis of the 
protected ethynylpteridines 30 and 31 to give the methylketone derivative. To this end, the 
readily available model system, consisting of the quinoxaline 9 was initially employed. 
The addition of water across the triple bond was first investigated on the 2-[2-
(trimethylsilyl)ethynyl]quinoxaline 9 which was treated with CF3COOH, HgO and water, and 
stirred at 50 oC for 18 hours to give 1-(quinoxalin-2-yl)ethan-1-one 47 in 55% yield (Scheme 
2.20). The melting point of the product was found to be 78o C, in agreement with the literature 
value of 77.5oC.42 The IR spectra gave a sharp peak at 1688 cm-1 which is consistent with a C=O 
stretch. The NMR and mass spectra were in good agreement with those reported previously.42  
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We then attempted to combine the deprotection/hydrolysis step with H2SO4, coupling the 
reaction with the addition of water on the triple bond by the addition of HgO. We then treated the 
mixed ethynylpteridines 30 and 31 with 2M H2SO4 and HgO, warming the reaction to 80
oC for 
18 hours while monitoring by HPLC-MS. Two principal peaks at RT 4.69 min, m/z 205 amu and 
RT 6.15 min, m/z 206 amu, were obtained with the latter peak more dominant. We tentatively 
assigned the peak at RT 6.15 min, m/z 206 amu to be the desired 6-acetyl-2-amino-3,4-
dihydropteridin-4-one 48 and the peak at RT 4.69 min, m/z 205 amu to be the 6-acetyl-pteridine 
48a.The reaction was allowed to run for another two hours at 80oC, after which HPLC-MS 
analysis of the crude showed only one peak at RT 6.15 min, m/z 206 to be present.(Scheme 
2.21).  
Neutralization of the solution with 1M NaOH resulted in precipitates forming, and after 
collection by centrifugation, the product was obtained as yellow solid in 66% yield. The 1H 
NMR spectrum gave a downfield singlet at δ 9.13 ppm, which we tentatively assigned to be 
7(H), and an upfield singlet at δ 2.46 ppm tentatively assigned to be the methyl singlet.  
The reduction of the 7,8 C=N to form the desired natural pterin has been previously reported by 
Murata to proceed smoothly by a dissolving  aluminium (Al) reduction in aqueous ammonia.40 
We subjected our 6-acetyl-pterin 48 to the conditions of  dissolving Al in NH3, warming the 
reaction to 55oC for 16 hours, followed by purification on a florisil column to give a yellow 
solid. The 1H NMR, mass and UV spectra of the compound was in agreement with data 
previously reported by Murata for Sepiapterin-C 46 (Scheme 2.21 and Figure 2.13). The product 
was isolated in 57% yield, with an overall yield of 24% when starting from benzenesulfonate-
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pteridine 27 over three steps. 
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Scheme 2.21 
 
Figure 2.13 HPLC-UV and TIC chromatogram of Sepiapterin-C, with extracted UV-vis 
and mass spectra. 
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The synthesis of Sepiapterin-C 46 can be achieved in a one-pot reaction starting from the 
mixture of ethynyl-pteridines 30 and 31 where the crude product of 48 was treated, without 
purification, with Al/aq. NH3 to give the desired product in overall yield of 14% over two steps 
when starting from benzenesulfonate-pteridine 27. The characterization spectra of the product 
were in agreement with those found earlier and reported in the literature.39,40  
In conclusion, we have successfully achieved the total synthesis of Sepiapterin-C from a 
precursor obtained from a Sonogashira coupling reaction. These results further demonstrate the 
wide range of transformations that can be accomplished on Sonogashira coupled products.  
 
2.4 Experimental  
2.4.1 General 
a) Purification of reagents and solvents 
 
• THF was distilled from sodium/benzophenone 
• Dichloromethane and triethylamine were distilled from calcium hydride 
• DMF and ethanol were stored over molecular sieves (3Å) 
 
b) Spectroscopic and physical data 
 
• Melting points were obtained using a Stuart melting point apparatus, and are 
uncorrected. 
• 1H and 13C spectra were reported on Bruker Avance-300 spectrometer at 300 
MHz. Chemical shifts are reported in parts per million (ppm) relative to 
tetramethylsilane as internal standard (in the case of the 1H NMR at 7.27 ppm for 
CDCl3 and 2.45 ppm for DMSO, and in the case of 
13C NMR spectra at 77 ppm). 
The 1H NMR chemical shifts are reported: value (number of hydrogens, 
description of signal, coupling constant(s) in hertz (Hz) where applicable). 
Abbreviations used: s = singlet, d = doublet, t = triplet, q = quartet and m = 
multiplet. 
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• Infrared spectra were obtained on a Bruker Tensor 27 spectrometer. Samples were 
placed on a diamond thin film. The absorptions are reported on the wave number 
(cm-1) scale, in the range 400 – 4000 cm-1. 
• High resolution mass spectra were recorded on a Thermo-Finigan DFS 
instrument. Data are quoted : m/z value (relative abundance). 
• Low resolution mass spectra were recorded on Thermo-Finigan LXQ instrument 
using either atmospheric pressure chemical ionization (APCI) or electro spray 
ionization (ESI) techniques. 
• HPLC was run on a Thermo-Finigan instrument using a C18 (2) Phenomenex 
column with 150 x 4.60 mm dimensions. The samples were eluted with a water-
methanol solvent system over 10 minutes using a gradient program: starting with 
95% water for 2 minutes, changing to 100% methanol over the next 4 minutes and 
running for 4 minutes with 100% methanol. Detection of eluting components was 
achieved by a photodiode array and APCI-MS detector. 
 
         c) Nomenclature and numbering of compounds 
The compounds prepared during the course of this project are named in the following 
experimental sections according to systematic nomenclature. However, the numbering 
system used to illustrate the diagrams of these compounds is one adopted for 
convenience and is not meant to reflect systematic numbering of these compounds. 
 
2.4.2 Synthetic Procedures on quinoxaline 
Synthesis of 2-quinoxalinone (6)23 
o-Phenylenediamine (10.01g, 0.092 mol) was dissolved in acetic acid (10 ml) and methanol (10 
ml), and the solution cooled to -15oC with stirring. Glyoxylic acid (8.50g, 0.092 mol) in water 
(20 ml )was added drop-wise over 30 minutes to the solution, maintaining the temperature at -
15oC. The final solution was allowed to warm up to 0 oC over 90 minutes, filtered, the filtrate 
washed with water (15 ml) then methanol (15 ml), and air dried to give a dark grey solid. 
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Recrystallization from DMF gave the 2-quinoxalinone as a tan solid (9.40 g, 70%); m.p 267oC 
(Lit. 266-267oC)40;δH (300 MHz, DMSO)  7.25–7.34 (2 H, m), 7.54 (1 H, m), 7.77 (1 H, m) and 
8.16 (1 H, s). Spectroscopic data agree with those reported elsewhere.23,40 
 
Synthesis of 2-benzenesulfonyloxyquinoxaline (7) 
In a round bottom flask, quinoxalinone 6 (1.25 g, 8.5 mmol), DMAP (0.104 g, 0.85 mmol) and 
benzenesulfonyl chloride (2.18 ml, 17 mmol) were dissolved in dry DCM (20 ml), cooled to 0 oC 
and stirred for 5 minutes. Et3N (3 ml, 22 mmol) was added drop-wise over 5 minutes, the 
solution allowed to stir at room temperature for 1 hour, reaction quenched with sat. NaHCO3 (20 
ml), the two layers separated and the aqueous layer washed with DCM (2 x 15 ml). The 
combined organic layers were dried over Na2SO4, concentrated and purified on flash silica 
eluting with DCM to give 2-benzenesulfonyloxyquinoxaline as a brown solid (2.3g, 95%); m.p. 
91oC; Rf  0.4; δH (CDCl3, 300 MHz) 7.58 - 7.63 (2H, m), 7.69 – 7.77 (3H, m), 7.87 – 7.90 (1H, 
m), 8.09 – 8.17 (3H, m) and 8.67 ppm (1H, s); δC (CDCl3, 100 MHz) 128.5, 128.8, 129.0, 129.2, 
129.5, 131.2, 134.7, 136.4, 139.1, 139.7, 141.3 and 150.9 ppm, we expected 14C environments 
but only 12 were observed on the spectrum. It is likely that the symmetry on the phenyl ring 
could be responsible for few C signals; m/z (APCI +ve) 287 amu [M+H+, 100] 
 
Synthesis of 2-mesyloxyquinoxaline (15)26 
In a round bottom flask, quinoxalinone (1.25 g, 8.5 mmol), DMAP (0.104 g,0.85 mmol) and 
methanesulfonyl chloride (1.32 ml, 17 mmol) were dissolved in dry DCM (20 ml), cooled to 0 
oC and stirred for 5 minutes. Et3N (3 ml, 22 mmol) was added drop-wise over 5 minutes, the 
solution allowed to stir at room temperature for 1 hour, and the reaction quenched with sat. 
NaHCO3 (20 ml), the two layers separated and the aqueous layer washed with DCM (2 x 15 ml). 
The combined organic layers were dried over Na2SO4, concentrated and purified on flash silica 
eluting with DCM to give 2-mesyloxyquinoxaline as a grey solid (1.581 g, 82%); Rf  0.38; m.p. 
91oC (Lit. 92-93oC)26 ;δH (300 MHz, CDCl3) 3.49 (3H, s), 7.78 – 7.87 (2H, m), 7.91 – 8.08 (1H, 
m), 8.11 – 8.22 (1H, m) and 8.74 ppm (1H, s); δC (CDCl3, 100 MHz) 41.3, 128.4, 129.4, 130.0, 
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131.4, 139.3, 139.5, 141.5 and 151.2 ppm. Spectroscopic data agree with those reported 
elsewhere.26 
 
Synthesis of Pyridin-2-yl benzenesulfonate (17)
28 
In a round bottom flask, pyridin-2-ol (2 g, 21 mmol), DMAP (0.132 g, 2.1 mmol) and 
benzenesulfonyl chloride (3.23 ml, 25.2 mmol) were dissolved in dry DCM (20 ml), cooled to 0 
oC and stirred for 5 minutes. Et3N (3 ml, 25.2 mmol) was added drop-wise over 5 minutes, the 
solution allowed to stir at room temperature for 1 hour, and the reaction quenched with sat. 
NaHCO3 (20 ml), the two layers separated and the aqueous layer washed with DCM (2 x 15 ml). 
The combined organic layers were dried over Na2SO4, concentrated and purified on flash silica 
eluting with 20% EtOAc/ hexane to give pyridin-2-yl benzenesulfonate as a clear oil (3.313 g, 
68%); Rf 0.31; δH  (CDCl3, 300 MHz) 7.11 – 7.14 (1H, dd, J = 7.8, 0.8 Hz), 7.20 – 7.27 (1H, m), 
7.53 – 7.58 (2H, m), 7.65 – 7.70 (1H, m), 7.75 – 7.81 (1H, dt, J = 0.8, 8 Hz), 8.02 (2H, m) and 
8.25 ppm (1H, dd, 7.8, 0.8 Hz); m/z (APCI) 236.1 [M+H+, 100]. Spectroscopic data agree with 
those reported elsewhere.28 
 
General procedure for the Sonogashira coupling on 2-benzenesulfonyloxyquinoxaline 
(method 1) 
In a 50 ml 3 neck round bottom flask, equipped with a stirrer bar and under Ar, 2-
benzenesulfonyloxyquinoxaline (0.301 g, 1.05 mmol), PdCl2(PPh3)2 (38. 0 mg, 0.052 mmol, 5 
mol%), Et3N (0.2 ml, 2.1 mmol, 2 eq.) and the ethynyl substrate (1.26 mmol, 1.2 eq.) were 
dissolved in dry THF (10 ml). The solution was heated at reflux for 90 minutes, partitioned 
between EtOAc/water (20 ml, 3:2), filtered through celite, the layers separated and aqueous layer 
washed with EtOAc (15 ml). The combined organic layers were dried over Na2SO4, concentrated 
and purified on flash silica. 
 
Synthesis of 2(2-phenylethynyl)quinoxaline (8)
24 
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According to method 1, 2-benzenesulfonylquinoxaline (0.30 g) was treated with phenylacetylene 
(154 µl, 1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with DCM gave 2(2-
phenylethynyl)quinoxaline as tan crystals (0.234 g, 95%); m.p. 64-65oC (Lit. 65-66.5oC)24; Rf  
0.35; δH (CDCl3, 300 MHz) 7.43 – 7.44 (3H, m), 7.68 – 7.71 (2H, m), 7.77 – 7.81 (2H, m), 8.10 
– 8.13 (2H, m) and 8.99 ppm (1H, s); δC (CDCl3, 100 MHz) 86.9, 93.7, 121.4, 128.6, 129.2, 
129.3, 129.8, 130.4, 130.7, 132.4, 139.6, 140.9, 142.2, and 147.4 ppm; m/z (EI) 230.03 (M+, 
100%), 204.0 (40), 202.99 (100), 201.98 (30), 175.94 (15), 126.90 (42), 114.89 (35) and 102.85 
(32)  (HREI found: 230.08445. C16H10N2 requires 230.08440). Physical and spectroscopic data 
agree with those reported elsewhere.24 
 
Synthesis of 2-[2-(trimethylsilyl)ethynyl]quinoxaline (9)24 
According to method 1, 2-benzenesulfonylquinoxaline (0.301 g) was treated with 
ethynyltrimethylsilane (178 µl, 1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with 
DCM gave 2-[2-(trimethylsilyl)ethynyl]quinoxaline as a brown oil (177 mg, 74%); Rf 0.45; δH 
CDCl3) 0.34 (9H, s), 7.74 – 7.82 (2H, m), 8.07 – 8.11 (2H, m) and 8.90 ppm(1H, s); δC (CDCl3, 
100 MHz) 0.01, 100.8, 102.0, 129.6, 129.7, 130.9, 131.1, 139.6, 141.4, 142.4 and 147.8 ppm; 
m/z (EI) 226.14 (M+, 23%), 211.09 (100) (HREI found:  226.09185. C13H14N2
28Si requires 
226.09262). Spectroscopic data agree with those reported elsewhere.24 
 
Synthesis of 3-(quinoxalin-2-yl)prop-2-yl-1-ol (10)24 
According to method 1, 2-benzenesulfonylquinoxaline (0.300 g) was treated with propargyl 
alcohol (73.3 µl, 1.26 mmol, 1.2 eq.). Crystallization of the crude product from acetone gave 3-
(quinoxalin-2-yl)prop-2-yl-1-ol as a light brown solid (131 mg, 70%); M.p. 139oC (Lit. 141-
142oC); vmax/ cm
-1 3271 (O-H)  δH (300 MHz, CDCl3) 2.96 (1H, s), 4.64 (2H, s), 7.75 – 7.83 (2H, 
m), 8.06 – 8.11 (2H, m) and 8.90 ppm (1H, s); δC (100 MHz, CDCl3) 51.3, 82.9, 92.2, 128.6, 
129.1, 130.8, 132.2, 138.8, 141.1, 142.0 and 146.9 ppm; m/z (EI) 184.05 (M+, 94%), 155.01 
(100) and 128.96 (32) (HREI found: 184.06313. C11H8N2O requires 184.06366). Spectroscopic 
data agree with those reported elsewhere.24 
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Synthesis of 2-(3-methoxyprop-1-yn-1-yl)quinoxaline (11) 
 According to method 1, 2-benzenesulfonylquinoxaline (0.301 g) was treated with 3-
methoxyprop-1-yne (88.2 mg, 1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with 
DCM gave 2-(3-methoxyprop-1-yn-1-yl)quinoxaline as a light brown solid (180 mg, 95%); m.p. 
61oC ; Rf 0.24; δH (300 MHz, CDCl3) 3.45 (3H, s), 4.37 (2H, s), 7.70 – 7.80 (2H, m), 7.99- 8.04 
(2H, m) and 8.83 ppm (1H, s); δC (100 MHz, CDCl3) 58.2, 60.2, 83.9, 89.7, 129.3, 130.6, 130.7, 
130.8, 138.9, 141.1, 142.1 and 147.1 ppm; m/z (EI) 198.21 (M+, 25%), 183.18 (30), 168.19 
(100), 155.19 (30) and 129.17 (32) (HREI found: 198.07978. C12H10N2O requires 198.07930). 
 
 
Synthesis of 5-(quinoxalin-2-yl)pent-4-yn-1-ol (12) 
According to method 1, 2-benzenesulfonylquinoxaline was treated with 4-pentyn-1-ol (117 µl, 
1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with 5% MeOH/DCM gave 5-
(quinoxalin-2-yl)pent-4-yn-1-ol as a brown oil (175 mg, 83%); Rf 0.23; vmax/ cm
-1 3332 (O-H); δH 
(300 MHz, CDCl3) 1.97 (2H, quintet, J = 6.9 Hz), 2.70 (2H, t, J = 6.9 Hz), 3.89 (2H, t, J = 6 Hz), 
7.75 – 7.78 (2H, m), 8.04 – 8.09 (2H, m) and 8.84 ppm (1H, s); δC (100 MHz, CDCl3) 16.1, 30.9, 
61.4, 79.2, 95.2, 129.1, 129.2, 130.2, 130.6, 139.8, 140.8, 142.0 and 147.3; m/z (EI) 212 (M+, 
100), 181 (70), 171 (25) and 147 (70) (HRESI found 213.10281, C13H13N2O requires 
212.10224). 
 
Synthesis of 6-(quinoxalin-2-yl)hex-5-yn-1-ol (13)
25 
According to method 1, 2-benzenesulfonylquinoxaline (0.302 g) was treated with 5-hexyn-1-ol 
(138 µl, 1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with 5% MeOH/DCM gave 6-
(quinoxalin-2-yl)hex-5-yn-1-ol as a brown solid (176 mg, 79%); m.p. 65oC; Rf 0.25; vmax/ cm
-1 
3335 (O-H); δH (CDCl3, 300 MHz) 1.80 (4H, quintet, J = 2.7Hz), 2.59 (2H, t, J = 6.3 Hz), 3.75 
(2H, t, 6.3 J = 6.3 Hz), 7.71 – 7.78 (2H, m), 8.02 – 8.07 (2H, m) and 8.81 ppm (1H, s); δC 
(CDCl3, 100 MHz) 19.4, 24.5, 31.7, 62.0, 79.1, 95.9, 128.9, 129.0, 130.1, 130.5, 138.9, 140.7, 
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141.9 and 147.2 ppm; m/z (EI) 226 (M+, 70%), 221 (35), 197 (65), 184 (90), 181 (100), 169 (70) 
and 144 (50) (HREI found: 226.11028. C14H14N2O requires 226.11060). Spectroscopic data 
agree with those reported elsewhere.25 
 
Synthesis of 4-[2-(quinoxalin-2-yl)ethynyl]aniline (14)
24 
According to method 1, 2-benzenesulfonylquinoxaline (0.299 g) was treated with 4-
ethynylanaline (143 µl, 1.26 mmol, 1.2 eq.). Purification on flash silica, eluting with DCM gave 
4-[2-(quinoxalin-2-yl)ethynyl]aniline as a yellow solid (190 mg, 74%); m.p. 179oC (Lit. 180oC); 
Rf 0.20; δH (DMSO, 300 MHz) 5.63 (2H,  broad s, -NH2), 6.52 (2H, t, J = 7.5 Hz), 6.72 (2H, d, J 
= 8.1 Hz), 7.11 (2H, t, J = 7.2 Hz), 7.23 (2H, d, J = 7.5 Hz) and 7.8 ppm (1H, s); δC (DMSO, 100 
MHz) 78.7, 80.5, 114.1, 114.3, 115.9, 116.8, 125.6, 128.9, 130.5, 132.1, 132.5, 134.7, 142.8, 
150.9, 151.4 and 188.5 ppm; m/z (APCI) 246 [M+H+, 100]. Physical and spectroscopic data 
agree with those reported elsewhere.24 
 
Synthesis of 2-(2-phenylethynyl)pyridine (19)
29 
Pyridin-2-yl benzenesulfonate (0.3 g, 1.27 mmol), PdCl2(PPh3)2 (46.5 mg, 0.064 mmol, 5 
mol%), Et3N (0.24 ml, 2.54 mmol, 2 eq) and the phenylacetylene (186 µ, 1.52 mmol, 1.2 eq.) 
were dissolved in dry DMF (10 ml). The solution was refluxed under argon for 4 hours, filtered 
through celite, concentrated and purified on flash silica eluting with 20% EtOAc/hexane to give 
2-(2-phenylethynyl)pyridine as a yellow oil (55 mg, 25%); Rf 0.35; δH (CDCl3, 300 MHz) 7.21 – 
7.25 (1H, m), 7.36 – 7.38 (3H, m), 7.52 – 7.54 (1H, dd, J = 7.8, 0.8 Hz), 7.60 – 7.62 (2H, m), 
7.68 – 7.71 (1H, dt, J = 7.7, 1.8 Hz) and 8.61 - 8.63 ppm (1H, d, J = 4.8 Hz); δC (CDCl3, 100 
MHz) 88.6, 89.3, 122.8, 127.2, 128.6, 129.0, 129.1, 132.1, 136.2, 143.4 and 150.0 ppm; m/z (EI) 
179.05 (M+, 100), 151.0 (10) (HREI found: 179.07327. C13H9N requires 179.07350). 
Spectroscopic data agree with those reported elsewhere.29 
 
Synthesis of 1-(quinoxalin-2-yl)ethan-1-one (47)39 
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2-[2-(trimethylsilyl)ethynyl]quinoxaline (205 mg, 0.895 mmol) in CF3COOH (10 ml) was 
treated with HgO (64 mg, 0.295 mmol), the solution warmed to 50 oC and stirred for 18 hours, 
concentrated  and diluted with water (10 ml). The solution was neutralized with 1M NH4OH, 
extracted with chloroform (3 x 15 ml), the combined organic layers dried over Na2SO4, 
concentrated and purified on flash silica eluting with 5% EtOAc/hexane to give 1-(quinoxalin-2-
yl)ethan-1-one as a brown solid (87 mg, 55%); m.p. 78oC (Lit. 77.5oC)39; Rf 0.18; vmax/ cm
-1 
1688 (C=O); δH (300 MHz, CDCl3) 2.87 (3H, s), 7.84 – 7.93 (2H, m), 8.15 – 8.22 (2H, dd, 7.8, 
0.8 Hz) and 9.51 ppm (1H, s); δC (CDCl3, 100 MHz) 25.6, 129.4, 130.5, 130.7, 132.2, 141.1, 
143.1, 143.9, 146.6 and 199.8 ppm; m/z (EI) 172.02 (M+, 95%), 144.0 (46), 129.97 (100), 102.91 
(45) (HREI found: 172.06312. C10H8N2O requires 172.06366). Physical and spectroscopic data 
agree with those reported elsewhere.39 
 
2.4.3 Synthetic procedures on pteridines 
Synthesis of tetramethylformamidine chloride (TMFAC) 
To a 500 ml pre-weighed round bottom flask, connected to a condenser and a bubbler, was added 
DMF (100 ml, 1.292 mol) and dimethylcarbamoyl chloride (48 ml, 0.522 mol). The flask was 
heated in an oil bath maintained at 120oC and stirred for 44 hours. The initial rate of 
effervescence produced ~1-2 bubbles per second. This rate slowly dropped as the reaction 
proceeded and no gas evolution was detectable after ~40 hours. The condenser and bubbler were 
replaced by a short distillation head, attached to a water condenser and receiver flask. The 
apparatus was slowly evacuated (to high vacuum) at such a rate as to avoid bumping and the 
remaining DMF was distilled. After condensation of DMF was no longer visible in the water 
condenser, heating at 120oC was maintained for a further two hours, to give the 
tetramethylformamidine chloride (71.25 g, 91%) as a tan crystalline solid; δH (D2O, 300 MHz) 
3.24 (6H, s), 3.36 (6H, s) and 7.65 ppm (1H, s) 
 
Synthesis of the Bredereck’s reagent [t-BuO(Me2N)2CH] (24) 
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In a 500 ml 2-neck round bottom flask, equipped with a stirrer bar and under positive pressure of 
Ar, TMFAC (40 g, 0.3 mol) and KtOBu (36 g, 0.32 mol) were suspended in dry THF (400 ml), 
stirred at room temperature for 4 days. The solution was filtered, cautiously concentrated in 
vacuo and purified by distillation (water pump) to give Bredereck’s reagent (41.9 g, 79%) as a 
clear oil; b.p. 52oC at 20 mmHg; δH (C6D6, 300 MHz) 1.26 (9H, s), 2.41 (12H, s) and  4.15 ppm 
(1H, s); δC (C6D6, 100 MHz) 29.1, 36.8, 72.0 and 100.8 ppm. 
 
Synthesis of 2,4-diaminopteridin-6-one (23)
34 
In a 1L flask fitted with a stirrer bar, was added 2M H2SO4 (550 ml) and the flask warmed to 
80oC. To the flask was added tetraaminopyrimidine (21.17 g, 0.136 mol) and stirring continued 
for 10 minutes. Glyoxylic acid (16.35 g, 0.272 mol, 2 eq.) was added, the solution stirred  for a 
further 15 min then allowed to cool to room temperature and left to stir for 2 hours. The resultant 
suspension was filtered, and the mustard solid washed with water (3 x 50 ml). The solid was 
suspended in water (150 ml) and neutralized with sat. NaHCO3 (cautiously added in 10 ml 
portions until effervescence stopped, ca. ~150 ml was required), the solid filtered and washed 
with water (5 x 60 ml) then MeOH (3 x 50 ml), air dried, and then dried under reduced pressure 
over P2O5 to give 2,4-diaminopteridin-6-one (17.952 g, 74%) as a mustard solid. m.p. (dec.) 
>300oC; m/z (ESI) 179 (M+H+, 100); λmax (1M NaOH) 410 and 265 nm. Physical and 
spectroscopic data agree with those reported elsewhere.34 
 
Synthesis of 2,4-Di(N,N-dimethylaminomethyleneamino)pteridine-6-one  (25)21 
2,4-Diaminopteridin-6-one (4.02 g, 0.0225 mol) and Bredereck’s reagent (14 ml, 0.0675 mol, 3 
eq.) were stirred together in DMF (50 ml), under an Ar atmosphere and warmed to 65oC for 3 
hours, and allowed to cool to room temperature. The yellow precipitates were filtered, washed 
with little cold DMF then Et2O, air dried and finally dried under reduced pressure over P2O5 to 
give 2,4-di(N,N-dimethylaminomethyleneamino)pteridine-6-one (6.20 g, 91%); m.p. (dec.) 
270oC; δH (300 MHz, CDCl3) 3.07 (3H, s), 3.08 (3H, s), 3.10 (3H, s), 3.15 (3H, s), 8.15 (1H, s), 
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8.48 (1H, s) and 8.76 ppm (1H, s); m/z (EI) 288 (M+, 100), 273 (45), 244 (19) and 232 (45). 
Spectroscopic data agree with those reported elsewhere.21 
 
Synthesis of 2,4-Di(N,N-dimethylaminomethyleneamino)-6-mesyloxopteridine (26) 
2,4-Di(N,N-dimethylaminomethyleneamino)pteridine-6-one (2.0 g, 7 mmol), DMAP (0.09 g, 0.7 
mmol) and mesyl chloride (1.08 ml, 14 mmol, 2eq.) were dissolved in DCM (25 ml )and cooled 
to 0oC. Et3N (2.5 ml,18 mmol, 2.5 eq.) was added drop-wise into the mixture, and the final 
solution was allowed to warm to room temperature and stirred for 1 hour. The reaction was 
quenched with sat. NaHCO3 (10 ml), the organic layer separated and the aqueous layer washed 
with DCM (2 x 15 ml). The combined organic layers were dried over MgSO4, and the solvent 
evaporated to dryness to give a dark yellow solid which was recrystalized from EtOH to give 
2,4-Di(N,N-dimethylaminomethyleneamino)-6-mesyloxopteridine (1.65 g, 62%) as a yellow 
solid; m.p. (dec) 270oC; δH (CDCl3, 300 MHz) 3.21 (3H, s), 3.24 (6H, overlapping s), 3.27 (3H, 
s), 3.69 (3H, s), 8.76 (1H, s), 9.01 (1H, s) and 9.04 ppm (1H, s); m/z (FAB) 367 [M + H+, 100%], 
289.1 (15) and 136 (30).(HREI found: 366.1236, C13H18N8O3
32S requires 366.1223). 
 
Synthesis of 2,4-Di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine 
(27) 
2,4-Di(N,N-dimethylaminomethyleneamino)pteridine-6-one (4.160 g, 14.5 mmol), DMAP (0.2 
g, 1.45 mmol) and benzenesulfonyl chloride (3.8 ml, 29 mmol, 2eq.) were dissolved in DCM (40 
ml) and cooled to 0oC. Et3N (3.7 ml, 29 mmol, 2 eq.) was added drop-wise into the mixture, and 
the final solution was allowed to warm to room temperature and stirred for 1 hour. The reaction 
was quenched with sat. NaHCO3 (15 ml), the organic layer separated and the aqueous layer 
washed with DCM (2 x 20 ml). The combined organic layers were dried over MgSO4, and the 
solvent evaporated to dryness to give a dark yellow solid which was recrystalized from EtOH to 
give 2,4-Di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine (4.62 g, 75%) 
as a yellow solid; m.p. (dec) 203 – 205oC; δH (CDCl3, 300 MHz) 3.19 (3H, s), 3.22 (3H, s), 3.23 
(3H, s), 3.30 (3H, s), 7.53 – 7.79 (3H, m), 8.25 – 8.28 (2H, dd, J = 7.8, 0.8 Hz), 8.56 (1H, s) and 
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8.95 – 8.97 ppm (2H, overlapping singlet); δC (CDCl3, 100 MHz) 35.4, 41.4, 125.2, 129.0, 129.4, 
134.4, 136.3, 144.4, 148.6, 155.6, 158.3, 159.8, 166.5 and 168.5 ppm, we expected 18C 
environments but only observed 14 on the spectrum, it is likely that the symmetry on the phenyl 
ring and the dimethylamine could be responsible for the few C signals observed; m/z (EI) 428 
(M+, 21%), 413 (40), 288.2 (100), 273.1(45), 232 (40), 217 (80) and 162.9 (35) (HREI found: 
428.13775. C18H20N8O3
32S requires 428.13791). 
 
Synthesis of 4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(2-phenylethynyl)pterin-4-
yl (29) 
In a 2-neck 50 ml round bottom flask, equipped with a magnetic stirrer bar and positive pressure 
of argon, 2,4-di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine (1.0 g, 
2.34 mmol), PdCl2(PPh3)2 (80 mg, 0.11 mmol), phenylacetylene (350 µl, 2.808 mmol) and Et3N 
(0.5 ml, 4.68 mmol, 2eq.) were dissolved in DMF (15 ml), warmed to 80oC and stirred for 2 
hours. The flask was cooled to room temperature, filtered through celite, concentrated in vacuo 
and purified on flash silica (eluting with 5% MeOH/DCM) to give two close running fractions 
(650 mg); m/z (APCI) 373 [M+H+, 60%], 318 [M-55, 70%]+; LCRT 7.01 and 7.05 minutes. 
Further purification of the close running fractions by flash chromatography on flash silica gave 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(2-phenylethynyl)pterin-4-yl (550 mg, 74%) 
as a yellow solid; m.p. (dec) 201 – 203oC; Rf 0.25; δH (d6-DMSO, 300 MHz) 3.01 (3H, s), 3.12 
(3H, s), 7.46 – 7.51 (3H, m), 7.58 – 7.69 (2H, m), 8.03 (2H, broad s), 8.76 (1H, s) and 9.06 ppm 
(1H, s); m/z (EI) 317 (M+, 30%), 302 (50) and 262 (100) (HREI found: 317.13849. C17H15N7 
requires 317.13889). 
 
Synthesis of 4-amino-2-(N,N-dimethylaminomethyleneamino)-6-[2-(trimethylsilyl)ethynyl]-
pteridin-4-yl (31) 
In a 2-neck 50 ml round bottom flask, equipped with a magnetic stirrer bar and positive pressure 
of argon, 2,4-di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine (1.0 g, 
2.34 mmol), PdCl2(PPh3)2 (80 mg, 0.11 mmol), TMS-Cl (395 µl, 2.808 mmol) and Et3N (0.5 ml, 
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4.68 mmol, 2eq.) were dissolved in DMF (15 ml), warmed to 80oC and stirred for 2 hours. The 
flask was cooled to room temperature, filtered through celite, concentrated in vacuo and purified 
on flash silica (eluting with 5% MeOH/DCM) to give two close running fractions (650 mg) as 
dark yellow solid; m/z (APCI) 369 [M+H+, 45%], 314 [M-55]+; LCRT 7.34 and 7.45 minutes. 
Further purification by flash chromatography on flash silica gave 4-amino-2-(N,N-
dimethylaminomethyleneamino)-6-[2-(trimethylsilyl)ethynyl]-pteridin-4-yl (460 mg, 63%) as a 
yellow solid; m.p. (dec) 253oC; Rf 0.29;  δH (d6-DMSO, 300 MHz) 0.29 (9H, s), 3.23 (3H, s), 3.29 
(3H, s), 8.88 (1H, s) and 9.03 ppm (1H, s); m/z (EI) 313 (M+, 90%), 298 (30), 269 (70), 258 (94), 
243 (100) and 201 (40) (HREI Found: 313.14542. C14H19N7
28Si requires 313.14712). 
 
Synthesis of 2,4-Di(N,N-dimethylaminomethyleneamino)-6-(3-methoxyprop-1-yn-1-
yl)pteridine-4-yl (33)   
In a 2-neck 50 ml round bottom flask, equipped with a magnetic stirrer bar and positive pressure 
of argon, 2,4-di(N,N-dimethylaminomethyleneamino)-6-benzenesulfonyloxopteridine (1.0 g, 
2.34 mmol), PdCl2(PPh3)2 (80 mg, 0.11 mmol), propargyl alcohol (198 mg, 2.808 mmol) and 
Et3N (0.5 ml, 4.68 mmol, 2eq.) were dissolved in 15 ml DMF, warmed to 80
oC and stirred for 2 
hours. The flask was cooled to room temperature, filtered through celite, concentrated and 
purified on flash silica (eluting with 5% MeOH/DCM) to give 2,4-di(N,N-
dimethylaminomethyleneamino)-6-(3-methoxyprop-1-yn-1-yl)pteridine-4-yl (500 mg, 63%) as a 
yellow solid; m.p. (dec) 196oC; Rf 0.20; δH (CDCl3, 300 MHz) 3.19– 3.22 (12H, overlapping s), 
3.50 (3H, s), 4.40 (2H, s), 8.88 (1H, s) and 9.01– 9.03 ppm (2H, overlapping s); δC (CDCl3, 100 
MHz) 35.4, 35.8, 41,4, 41.6, 58.0, 60.2, 84.2, 88.8, 123.5, 128.8, 135.1, 153.6, 158.5, 162.5, 
167.1 and 168.6 ppm; m/z (APCI) 341.2 [M + H+, 100%];(HRESI found: 341.18460, C16H21N8O 
requires 341.1833) 
 
Synthesis of 2,4-diamino-6-(phenylethynyl)pteridine (35)17 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(2-phenylethynyl)pterin-4-yl (150 mg, 
0.473 mmol) was treated with 10 ml EtOH/1M NH3 (1:1) mixture, gently refluxed for 16 hours, 
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filtered, the solid washed sequentially with water (5 ml), EtOH (5 ml) and Et2O (5 ml), and dried 
under Hi-vac. at 70oC to give 2,4-diamino-6-(phenylethynyl)pteridine (95 mg, 77%) as a yellow 
solid; m.p. (dec) >300oC; δH (d6-DMSO, 300 MHz) 6.91 – 7.01 (2H, broad s), 7.46 – 7.48 (3H, 
m), 7.61 – 7.62 (2H, m), 7.84 – 7.87 (2H, broad s) and 8.86 ppm (1H, s); m/z (APCI) 263.1 [M + 
H+, 100](HRESI found: 263.10340, C14H10N6 requires 263.10397). Spectroscopic data agree 
with those reported elsewhere.17 
 
Synthesis of 2,4-diamino-(ethynyl)pteridine (36) 
4-Amino-2-(N,N-dimethylaminomethyleneamino)-6-[2-(trimethylsilyl)ethynyl]-pteridin-4-yl 
(200 mg, 0.64 mmol) was suspended in 25% NH3 solution (10 ml) and gently refluxed for 18 
hours, filtered through celite, concentrated to a small volume (ca.~3 ml), acidified with glacial 
AcOH (~1 ml) and stored at 2oC for 24 hours. The precipitates were collected by centrifugation, 
washed sequentially with water (5 ml), acetone (5 ml) and Et2O (5 ml) to give 2,4-diamino-
(ethynyl)pteridine (70 mg, 76%) as yellow solid; m.p. (dec) >300oC; vmax /cm
-1 3410 (-NH), 3310 
(-NH2), 3016, 2926; δH (d6-DMSO, 300 MHz) 7.09 – 7.11 (2H, broad s), 7.95 – 8.17 (2H, broad 
s) and 9.16 ppm (1H, s); m/z (APCI) 186 [M + H+, 100]. Attempts to get high resolution mass 
were unsuccessful in both HREI and HRESI instruments. 
 
Synthesis of 2,4-Diamino-6-[(methoxymethyl)ethynyl)pteridine (37)17 
2,4-Di(N,N-dimethylaminomethyleneamino)-6-(3-methoxyprop-1-yn-1-yl)pteridine-4-yl (130 
mg, 0.381 mmol) was dissolved in 8 ml EtOH/1M NH3 (1:1) mixture, gently refluxed for 8 
hours, allowed to cool to room temperature, acidified with AcOH and stored at 2oC for 24 hours. 
The precipitates were filtered, washed sequentially with water (5 ml), EtOH (5 ml) and Et2O (5 
ml), and dried under High vac. at 60oC to give 2,4-Diamino-6-[(methoxymethyl)ethynyl)pteridine 
(65 mg, 74%) as a yellow solid; m.p. (dec) >300oC; δH (d6- DMSO, 300 MHz) 3.35 (3H, s), 4.40 
(2H, s), 6.87 – 6.99 (2H, broad s), 7.83 (2H, broad s) and 8.74 ppm (1H, s); δC (d6-DMSO, 100 
MHz) 57.2, 59.3, 83.4, 87.9, 122.5, 129.5, 152.6, 154.8, 163.4 and 172.3 ppm; m/z (APCI) 
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231[M + H+, 100](HRESI found: 231.0995, C10H10N6O requires 231.09888). Spectroscopic data 
agree with those reported elsewhere.17 
 
Synthesis of 6-(phenylethynyl)pterin (38)17 
According to the method of Taylor,17 4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(2-
phenylethynyl)pterin-4-yl (200 mg, 0.631 mmol) was treated with 10 ml EtOH/1M NaOH (1:1) 
mixture, gently refluxed for 16 hours, filtered through celite, concentrated to small volume (~3 
ml), acidified with AcOH (~1.5 ml), and stored at 2oC for 18 hours. The yellow precipitates were 
collected by centrifugation, washed sequentially with water (5 ml), acetone (5 ml) and Et2O (5 
ml), and dried under reduced pressure at 60oC to give 6-(phenylethynyl)pterin (120 mg, 73%) as 
a yellow solid; m.p. (dec) >300oC; vmax /cm
-1 1737 (C=O);  δH (d6-DMSO, 300 MHz) 7.34 – 7.48 
(3H, m), 7.63 (2H, m) and 8.72 ppm (1H, s); m/z (APCI) 264 [M + H+, 100] (HREI Found: 
263.08092. C14H9N5O requires 263.08071). Spectroscopic data agree with those reported 
elsewhere.17 
 
Synthesis of 6-acetyl-2-amino-3,4-dihydropteridin-4-one (6-acetylpterin) (48) 
4-Amino-2-(N,N-dimethylaminomethyleneamino)-6-[2-(trimethylsilyl)ethynyl]-pteridin-4-yl 
(300 mg, 0.958 mmol) was dissolved in 2M H2SO4 (3 ml) and treated with HgO (100 mg, 0.461 
mmol), heated to 60oC and stirred at this temperature for 16 hours. 1M NaOH (3 ml) was added 
and the final solution stirred for 3 hours at 60oC, allowed to cool to room temperature, filtered 
through celite, concentrated and neutralized by drop-wise addition of 1M NaOH until the pH, as 
measured by universal indicator strips, was ~7.0. The yellow precipitates that formed, were 
isolated by centrifugation, washed with 50% MeOH/water (10 ml), dried under reduced pressure 
at 60oC to give 203 mg of yellow residue. Extraction of the yellow residue with hot MeOH (3 x 
15 ml), followed by evaporation,  gave 6-acetyl-2-amino-3,4-dihydropteridin-4-one (130 mg, 
66%) as a yellow solid; m.p. (dec) >300oC; δH (CF3COOD, 300 MHz) 2.46 (3H, s) and 9.13 ppm 
(1H, s); m/z (APCI) 206 [M + H+, 100%]; LCRT 6.10 minutes. Attempts to get high resolution 
mass were unsuccessful in both HREI and HRESI instruments. 
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Synthesis of Sepiapterin-C (46)
40 
According to the method of Murata,40 6-acetyl-2-amino-3,4-dihydropteridin-4-one (90 mg, 0.439 
mmol) was dissolved in 1M NH3 (150 ml) and treated with aluminium tunings (200 mg, 7.41 
mmol) [pre-treated by immersing in HgCl2 solution (50 mg in 10 ml water) for 10 minutes and 
washed with water (3 x 5 ml)], warmed to 55oC, and stirred under Ar for 16 hours, filtered, 
concentrated to ca. 40 ml, charged through florisil column, washed with water (500 ml) and 
eluted with 10% aq. Acetone, collecting the yellow eluting fraction. The collected fraction was 
evaporated to dryness and the residue extracted with hot methanol (3 x 15 ml) to give 
sepiapterin-C (52 mg, 57%) as yellow solid; m.p. (dec) 252oC; δH (CF3COOD, 300 MHz) 2.28 
(3H, s) and 4.09 ppm (2H, s); vmax /cm
-1 3183 (broad), 1738; m/z (APCI) 207 (M+, 100) 
Spectroscopic data agree with those reported elsewhere.40 
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Chapter 3    Negishi coupling of quinoxaline and pteridine-O-
sulfonates 
 
3.1 Introduction 
The Negishi coupling chemistry was first reported in 1977 by Negishi et.al.1 where a cross-
coupling reaction between an organozinc compound (R-ZnX) and organic halide (R1-X) 
catalyzed by palladium was observed (Scheme 3.1). Over the past three decades, the chemistry 
has received much attention and many variations and improvements to suit a particular group of 
compounds. The variations include the replacement of palladium with a nickel catalyst, the 
replacement of the halogen leaving group with oxygen containing groups such as triflates and 
phosphor-ester groups, and also replacing the triphenylphosphine ligands with more bulky 
electron-rich ligands.   A recent search on Reaxys database (Nov 2010) has revealed over 100 
000 hits of reactions involving Negishi coupling. The chemistry has been used in key steps 
toward the total synthesis of various natural products such as vitamin-A, carotenes, reveromycin-
B and many more.2 The pioneer of this chemistry, Professor Ei-ichi Negishi, was awarded the 
Nobel prize in chemistry in 2010 along with R.F Heck and A. Suzuki for their contribution in C-
C bond forming reactions. The Negishi coupling has also led to the development of other 
coupling reactions such as Suzuki and Stille coupling, where the zinc is replaced by boron (B) 
and tin (Sn) respectively.2 
                                
R ZnX R1 X' R R1+
Pd or Ni
X = Cl, Br
X' = Cl, Br, I, OTf, OPO(OR)2  
Scheme 3.1 
The advantages of using Negishi cross-coupling reactions over other C-C bond formation 
reactions like the Suzuki and Stille are; (i) the reactions are usually performed at room 
temperature due to the ease in the transmetallation reaction between Zn and Pd while Suzuki and 
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Stille couplings generally require high temperature, (ii)  the reactions do not require hydrolytic 
base to proceed, as required in the Suzuki coupling reactions, and (iii) the zinc reagents are 
known to tolerate a wide range of functional groups and in some cases the reactions can be 
performed in water, an example being  the Reformatsky reaction.3  
Zinc reagents were the first organometallic reagents used in C-C bond forming reactions, dating 
back to the 19th century. However, these reactions were generally slow, leading to the 
development of more reactive organometallic reagents having magnesium (Grignard reagents) 
and lithium metal ions. The use of Grignard and Li-reagents in C-C bond forming reactions has 
reduced the use of Zn-reagents to largely Negishi coupling reactions. 
The drawback with the Negishi coupling, like other C-C bond coupling reactions, is the need to 
prepare the Zn-reagent. Zn reagents are usually prepared by one of three general methods, the 
first of which involves transmetallation reactions between ZnCl2 and a Li-reagent or Mg-reagent 
(Scheme 3.2 number 1). The Li- and Mg-reagents are known to be highly reactive and not 
compatible with many functional groups, thus preparing Zn-reagents from Li- or Mg-reagents 
might result in functional group incompatibility.  
A second method for preparing Zn-reagents is by metal-halogen exchange reaction, where 
diethyl-zinc (Et2Zn) is reacted with a halogenated compound leading to the desired Zn-reagent 
(Scheme 3.2 number 2).  
                             
R ZnX
R ZnX
R Li
or
R MgX
ZnCl2
R X Et2Zn
R ZnXR X Zn
1.
2.
3.
 
Scheme 3.2 
A third method for preparing Zn-reagents is by inserting an activated Zn metal into a C-halogen 
bond (Scheme 3.2 number 3). This is perhaps the most functional group tolerant method 
available for preparing Zn-reagents but, the need for a halogen atom in the molecule is the 
89 
 
drawback. Reagents for the Reformatsky and Barbier reactions are prepared via this method, and 
more recently Zn-reagents for ‘Negishi like coupling’ reactions has been reported to be prepared 
in situ in water.4 
Unlike the Suzuki coupling reactions, Negishi coupling reactions allow for coupling between a 
wide range groups, including aryl, heteroaryl, alkenyl and alky substituents. 1, 3-10 Coupling 
between two electron-rich groups, two electron-deficient groups, and electron-rich-electron-
deficient groups have been reported to proceed in high yields. Highly stereospecific reactions 
Csp3-Csp2  Negishi coupling reactions with a wide range of substituted alky- and alkenyl-zinc 
compounds have been reported recently (Scheme 3.3).4,5  
            
ZnCl
O
CO2Et
O
CO2Et
Br
81%
98:2 d.r.OMe
Br
MeO
78%
99:1 d.r.
TMS
ZnBr
I CO2Et
+ TMS CO2Et
84% 96/4 (E/Z)
ZnBr
Br
O
O
+
93%
98/2 (Z/E)
1.
2.
3.
 
Scheme 3.3       
The most common leaving groups in Negishi coupling are the halogens (Cl, Br and I) with iodine 
containing electrophiles being the most reactive and chlorine containing electrophiles being less 
reactive.2 Oxygen containing leaving groups are mainly the sulfonyl groups (triflates, tosylate 
etc..) with triflates being the more reactive and widely used.2,11,12 The various methods usually 
employed to prepare these coupling partners have already been described in Chapter 2.   
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Recently the less expensive tosylate group has received much attention and has been shown to 
undergo Negishi coupling when attached to an electron-deficient system.13 However, only three 
examples of heteroaryl-O-arylsulfonate undergoing Negishi coupling were found (Sci-finder 
search December 2010).13,14 The ring system in which these Negishi coupling were reported are 
the cumarin and quinolinone ring system bearing an arylsulphonate leaving group (Scheme 3.4). 
No mention of a mesylate leaving group undergoing Negishi coupling was found (Reaxys and 
Sci-finder database, December 2010).  
                                     
N NO
OTs
O
R
O O
OTs
O O
R
Pd, RZnX
Pd, RZnX
 
Scheme 3.4 
To our knowledge, no Negishi coupling reactions have been reported on pteridine or pterin ring 
systems but, two reactions have been reported on the quinoxaline ring system. Joule et. al. 
reported coupling between 2-chloroquinoxaline and diethyl zinc in 94% yield,15 while Hocek 
reported coupling between 2-chloroquinoxaline and (benzoyloxymethyl)zinc iodide in 65% yield 
(Scheme 3.5).16 
                  
N
N Cl
N
N
O
N
N
O
94% 65%
 
Scheme 3.5 
The mechanism involved in the Negishi coupling reaction is not fully understood but, it is 
believed to be similar to that of Stille coupling reaction. The oxidative addition of the 
halogenated or sulfonated compound is believed to be the first step, followed by transmetallation 
between Zn and Pd, and finally the reductive elimination giving the desired coupled product 
(Scheme 3.6).  
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PdIIX2L2
Pd0Ln
Reduction
oxidative
additionreductive
elimination
transmetalation
R2-ZnXZnX2
R1-XR1-R2
X
PdIILn
R1
R2
PdIILn
R1
 
Scheme 3.6 
The oxidative addition step is believed to be the rate determining step (RDS) while the 
transmetallation is relatively fast due to similar electronic properties between Pd and Zn. Recent 
studies have shown that electron withdrawing groups attached to the halogenated compound, 
increases the rate of the oxidative addition step. Electron donating groups attached to the Zn-
reagent, on the contrary, increases the rate of the transmetallation step.6 
In this chapter, we report Negishi coupling of both quinoxaline and pteridine ring systems 
possessing benzenesulfonyl and mesylate leaving groups. Hydrolysis of the product pteridine to 
give various 6-substituted pterin is also reported.  
 
 
3.2 Results and Discussion 
3.2.1 Negishi coupling of quinoxaline-O-sulfonates with alkyl- and aryl-Zn substrates 
With recent results showing Negishi coupling of heterocycles bearing a tosylate leaving group,13-
15 we were interested in investigating if the quinoxaline and pteridine-O-sulfonate substrates 
prepared in our laboratory, would participate in Negishi coupling reactions. 
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We started our investigations by treating benzenesulfonyl quinoxaline 7 with diethyl zinc (Et2Zn) 
in THF, with 5 mol % of PdCl2(PPh3)2 catalyst and stirring the reaction at room temperature for 
six hours, when no trace of starting material was detected on TLC. Quenching the reaction with 
sat. NaHCO3 and purification on flash silica gave the desired 2-ethylquinoxaline 49 in a 15% 
yield (Scheme 3.7). The product was isolated as an oil as previously reported and the 1H NMR 
and mass spectra were identical to those reported.15 No other fractions were obtained from the 
column suggesting that decomposition or unidentified side reactions, giving polar products could 
be responsible for the low yield and unaccounted mass balance. 
Recent mechanistic investigation of Negishi coupling of aryl-halogens, described in section 3.1, 
suggest that the RDS may be the insertion of a Pd-species into the C-Hal bond.6 It appeared that 
the insertion of Pd may have been limiting the rate at which our sulfonate system could also 
undergo Negishi coupling.    
In an effort to improve the yield and possibly increase the rate of the oxidative addition step, the 
reaction was performed at reflux temperature for six hours with TLC showing no trace of starting 
material. Normal work-up and purification gave an improved yield of 35%. When increasing the 
reaction time to 18 hours with reflux, the yield improved to 60% with the 1H NMR and mass 
spectra identical to those obtained by Joule.15 The yields were lower compared to the reaction 
starting with 2-chloroquinoxaline, where 94%yield at room temperature was reported by Joule 
et.al.
15 suggesting that chlorine is a better leaving group than benzenesulfonate, under these 
conditions. 
This successful Negishi coupling reaction was very encouraging. However, it appeared as though 
alkyl zinc reagents would be sluggish substrates in Negishi coupling reactions with 
heteroarylsulfonates, so we turned to the zinc-aryls as possible coupling partners. The Zn-aryls 
are relatively electron rich substrates when compared to Zn-alkyls and should, according to 
recent studies,6 be able to undergo relatively faster transmetallation with Pd. 
Shifting the focus to aromatic-zinc substrates, we began by preparing a solution containing a 
phenyl-Zn species. For this, we prepared a stock solution of PhMgBr, calculated to be ~ 1.1 M, 
by standard Grignard methodology. Aliquots of this were used to form the zinc phenyl, by 
simple addition of a molar equivalent of ZnCl2, either as a pre-prepared stock solution in THF or 
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as a solid, under a dry argon atmosphere. No precipitation was observed, and the resultant 
solution was assumed to be ~1.1M in PhZn+, Mg2+ and bromide, and ~ 2.2M in chloride. 
The bromobenzene was employed in slight excess (1.1 equivalent) during the preparation of the 
Grignard and it was likely that some remained in this solution. During the subsequent work 
employing this solution, we did not detect any bi-phenyl products, which might have resulted 
from Pd-catalyzed reactions of PhZn with residual PhBr 
Subjecting phenyl-ZnCl and  benzenesulfonyl quinoxaline 7  to our optimized Negishi coupling 
conditions, i.e. reflux in THF for 18 hours, quenching with sat.NaHCO3 and purification on flash 
silica, gave 2-phenylquinoxaline 50 in 95%. The NMR and mass spectra of the product were 
consistent with the desired product and were in good agreement with previously reported data 
(Scheme 3.7).17  
When the same reaction was performed at room temperature, the reaction yield dropped to 50% 
with starting material observed on TLC. Refluxing the reaction for 6 hours gave a reduced yield 
of 60% (76% based on recovered starting material). 
                 
N
N OSO2Ph
N
N
PdCl2(PPh3)2
95%
THF, reflux, 18 hrs
80%N
N
OMe
OMe
OMe
N
N
N
N
55%60%49
50
51
52
7
 
Scheme 3.7 
Toluene-2-zinc species have been previously prepared by lithiation of 2-bromotoluene with n-
BuLi, followed by transmetallation with ZnCl2 and been used in Negishi coupling reactions.
18 
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We prepared the 2-toluenyl-ZnBr according to literature procedure and attempted Negishi 
coupling with our quinoxaline 7.  
Subjecting 2-toluenyl-ZnBr and quinoxaline 7 to our Negishi coupling conditions, followed by 
quenching with sat.NaHCO3, workup and after purification on flash silica, two fractions were 
collected. The first eluting fraction had a 1H NMR consistent with that of proposed structure and 
reported literature19 of 2-toluenequinoxaline 51. The mass spectrum gave a molecular ion peak at 
m/z 221 amu further supporting our proposed structure. 
The second eluting fraction was unreacted quinoxaline 7, as judged by the NMR and mass 
spectra. The isolated yield was 55% (or 73% based on recovered quinoxaline 7). When the 
reaction was allowed to run for longer than 24 hours, no full conversion of starting material was 
observed as judged on TLC and no improvement on the yield was achieved.  The low yield of 
tolylquinoxaline 51 could be attributed to the steric crowding around the reactive site, which 
might slow the transmetallation step between Pd and Zn. 
The substituted 3,4,5-trimethoxybenzene motif occurs extensively in natural products derived via 
the Shikimic acid route, examples being mescaline and reserpine, and it has also found extensive 
use in the field of medicinal chemistry.20 Almost all synthetic approaches to this system have 
made use of Suzuki coupling conditions where, most commonly a halogenated 
trimethoxybenzene acts as precursor to a boronic acid, or is a coupling partner with an 
arylboronic acid. To our knowledge, the zincyl-trimethoxybenzene has never been reported. 
We prepared the zincyl-trimethoxybenzene, following the same procedure used to prepare 2-
toluenyl-ZnBr, where we started by the lithiation of 3,4,5-trimethoxy-bromobenzene with n-
BuLi, followed by transmetallation with ZnCl2. Subjecting the Zn-substrate and quinoxaline 7 to 
our Negishi coupling conditions, a normal work-up and following purification on flash silica, 
one fraction was isolated. The compound was isolated as a yellow solid and had a melting point 
in the range 82 – 83oC, a molecular ion peak at m/z 296 amu was obtained, while the 1H NMR 
spectrum gave peaks that were consistent with the proposed structure. A downfield singlet at δ 
9.30 ppm (tentatively assigned to the 3-H proton), a singlet at δ 7.44 ppm (tentatively assigned to 
be the trimethoxyphenyl protons) and two upfield singlets at δ 3.90  and 4.03 ppm (tentatively 
assigned to be the methoxy protons), led us to conclude that we had prepared 2-(3,4,5-
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trimethoxybenzene)quinoxaline 52 (Scheme 3.7). The product was obtained in 80% yield and its 
synthesis has never been reported. 
In conclusion, we have demonstrated Negishi coupling reactions involving benzenesulfonyloxy-
2-quinoxaline with various phenyl-Zn substrates in moderate to excellent yields. The phenyl-Zn 
substrates were shown to be better coupling partners when compared to the alky-Zn substrate. 
We then turned our attention in investigating heteroaryl-Zn substrates as coupling partners in 
Negishi coupling reactions. 
3.2.2 Negishi coupling of quinoxaline-O-sulfonates with hetero-aryl substrates 
We started our investigation of heteroaryl-Zn substrates with 3-zincyl-thiophene.  The thiophene 
occurs extensively in natural products, examples being tiletamin, isobutylthiphene and 
terthiphene, and has found extensive use in the field of medicinal chemistry.21 Many of the 
reactions leading to thiophene substrates have been achieved via the Suzuki coupling approach. 
A few examples of Negishi coupling employing zincyl-thiophenes, prepared by insertion of 
Rieke zinc into the C-Cl bond, were found.22 We were interested in investigating 3-zincyl-
thiophene as a coupling partner in Negishi coupling reactions. 
We investigated the preparation 3-zincyl-thiophene, from 3-bromothiophene by, lithiation with 
n-BuLi, and transmetallation with ZnCl2. The putative Zn-substrate and quinoxaline 7 were 
subjected to our Negishi coupling conditions, and following separation, by flash chromatography 
on flash silica, two fractions were isolated and analyzed by NMR and mass spectroscopy. 
The first eluting fraction, a yellow solid (m.p. 91-92oC), had two molecular ion peaks of roughly 
equal intensity at m/z 290 amu [M]+ and 292 amu [M+2]+ evident in the EI-mass spectrum. The 
roughly equal intensity of these molecular ion peaks suggests the presence of a bromine atom in 
the molecule. Bromine is known to exist as 79Br and 81Br in equal proportions and hence a 
molecular ion of a mono-brominated molecule is characterized by a characteristic pattern. The 
peak at m/z 292 is slightly bigger than the peak at 290, and this could be attributed to the 
presence of 34S atom in the molecule which has 6% natural abundance. 
The 1H NMR spectrum integrated for 7H, with a downfield singlet at δ 9.78 ppm, suggesting 
incorporation of a quinoxaline ring. Two downfield doublets at δ 7.15 and 7.50 ppm, with 
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identical coupling constants (J) of 5.4 Hz, suggesting 3-bond coupling (J3), were observed. Two 
multiplet signals, integrating for two protons each, were observed at δ 7.77 and 8.11 ppm. These 
peaks were previously assigned to correspond to the 5-, 6-, 7- and 8-H protons in the quinoxaline 
ring, from reported quinoxaline structures. From these NMR and mass spectral data we 
tentatively assigned the structure of the compound to be 2-(3’-bromothiophen-2’-yl)quinoxaline 
53 (Scheme 3.8). 
The second eluting fraction, also a yellow solid (m.p. 112-113oC), had a 1H NMR and mass 
spectra that appeared consistent with the coupled structure and that reported in literature of 2-
(thiophen-3’-yl)quinoxaline 54 (Scheme 3.8).23 The two products were each isolated 30% yield. 
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Scheme 3.8 
These results suggest that there is a competition between the metal-halogen exchange reaction, 
involving 3-bromothiophene and n-BuLi, and a deprotonation of the hydrogen at the 2-position 
of the 3-bromothiophene. The equal product distribution suggests that the two competing 
reactions are of comparable rates. Research has shown that 3-lithiothiophene can be obtained 
exclusively from 3-bromothiophene when the reaction is performed at -78oC.24 However, 
repeating these reactions in our laboratory, resulted in equal product distribution to that described 
above. We attempted varying the lithiation temperature from -78oC to -20oC but, no change in 
product distribution and yield were observed. 
It is likely that the α-acidifying effect of the thiophene sulfur, combined with a small ortho-
directing ability of the bromine allows the formation of the thiophene-2-zincyl to compete with 
production of thiophene-3-zincyl. The facile nature of this side reaction might suggest why the 
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production of 3-zincylthiophenes, employing a BuLi insertion into a C-Hal bond, has not been 
reported before. 
With these unexpected results, we investigated a chemically similar motif to 3-bromothiphene, 3-
bromofuran. Using our previously attempted method of preparing the zincyl-thiophenes, 3-
bromofuran was lithiated with n-BuLi followed by transmetallation with ZnCl2, to give a 
solution containing the putative 3-zincyl-furan. To this solution was added quinoxaline 7 and 
catalytic PdCl2(PPh3)2, and heating at reflux maintained for 18 hours. Following aqueous work-
up and separation by flash chromatography on flash silica, one product was isolated. 
Mass spectral analysis of the compound gave two molecular ion peaks at m/z 275 and 277amu in 
roughly equal intensities, suggesting the presence of a bromine atom in the molecule. The 1H 
NMR spectrum gave similar patterns to those observed in the spectrum of 2-(3-bromothiophen-
2-yl)quinoxaline 53, where two downfield doublets at δ 6.71 and 7.65 ppm with equal coupling 
constants (J = 1.8 Hz), were observed. We tentatively assigned the structure of this compound to 
be 2-(3’-bromofuran-2’-yl)quinoxaline 55 (Scheme 3.9), and the product was isolated in 21% 
yield. No trace of the desired 2-(furan-3’-yl)quinoxaline 56 was detected. 
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Scheme 3.9 
Similar results of competition between metal-halogen exchange at the 3-position, and 
deprotonation at the 2-position on furan ring has been reported by Marcos et al.25 where a 1:1 
ratio of n-BuLi and 3-bromofuran favoured metal-halogen exchange, while a 1:2 ratio favoured 
deprotonation.  When attempting the conditions of Marcos et al.25, favouring exclusively the 
metal-halogen exchange, followed by transmetallation with ZnCl2, and subjecting the putative 3-
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zincyl-furan to our Negishi coupling conditions, no desired coupled product 56 was obtained. 
TLC analysis showed dark material settling at the base line, and we believe that they could 
polymers.  
We then attempted the conditions that favoured, exclusively, the deprotonation of 3-bromofuran, 
and transmetallation of the putative 2-lithio-3-bromofuran with ZnCl2. Subjecting this substrate 
to our Negishi coupling conditions gave the coupled product 2-(3-bromofuran-2-yl)quinoxaline 
55 in 20% yield. The quinoxaline starting material 7 was recovered along with substantial 
amounts of polymeric material.  
We postulate that competition reaction between deprotonation and metal-halogen exchange is 
taking place but, polymerization of the putative 3-zincyl-furan or the coupled product from this 
precursor is occurring, resulting in the absence of 56. No polymerization of the 3-lithiofuran has 
been reported in literature, and we did not observe any polymerization during the 
transmetallation reaction, leading us to conclude that the Negishi product 56 forms but under the 
reaction conditions, polymerization of this product occurs. No quinoxaline 7 was detected on 
TLC, when the putative 2-zincyl-3-bromofuran is used, further supporting our claims. The 
mechanism of this polymerization however, is still unknown to us. Further studies might involve 
monitoring the progression of the reaction on HPLC-MS spectrometer to identify the species 
being formed during the reaction.   
We then investigated the direct lithiation of furan in the two position, preceding a 
transmetallation and an attempt at Negishi coupling with the quinoxaline 7. Starting with furan, 
deprotonation with n-BuLi and transmetallation with ZnCl2 gave a solution containing a putative 
2-zincyl-furan. Subjecting the Zn-substrate and quinoxaline 7 to our Negishi coupling 
conditions, normal work-up and purification on flash silica led to the isolation of one fraction. 
The 1H NMR and mass spectra of the compound was consistent with both the structure and data 
reported for 2-(furan-2-yl)quinoxaline 57 (Scheme 3.10),26 which was obtained in 73% yield. No 
polymer formation was observed on the TLC plate and reaction flask, further suggesting that 2-
(3-furyl)-quinoxaline is undergoing polymerization or other side reactions giving polar and 
insoluble products. 
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Scheme 3.10 
Having some success of Negishi coupling with oxygen and sulfur containing heteroaryl-Zn 
substrates, we then investigated the N-heterocyclic substrates as potential Negishi coupling 
partners with the quinoxaline 7. N-heterocyclic motifs, such as pyrrole, indole and pyridine are 
incorporated into many of naturally occurring compounds, and have found extensive use in 
medicinal chemistry.  
We began our investigations with N-benzenesulfonyl pyrrole. Lithiation with n-BuLi followed 
by transmetallation with ZnCl2, according to previous work, gave a solution containing a 
putative zincated-pyrrole. Following our Negishi coupling conditions, the Zn-substrate, Pd 
catalyst and quinoxaline 7 were refluxed in THF for 18 hours, purified on flash silica to give one 
isolated product. The mass spectrum of the sample gave a molecular ion peak at m/z 336 amu, 
consistent with the calculated molecular weight of the desired product. The 1H NMR spectra of 
the compound integrated for 13 H, with a downfield singlet at δ 9.07 ppm, consistent with the 3-
H proton from quinoxaline. Signals at δ 6.48 and 6.77 ppm were tentatively assigned to be two 
of the 3- and 4-pyrrole-H, as previously found in our laboratory. From these results, we assigned 
the structure of the product as 2-[1-(benzenesulfonyl)-1H-pyrrol-2-yl]quinoxaline 58, obtained in 
10% yield (Scheme 3.11). No starting materials was observed on TLC or isolated from the 
column during purification but, dark material was evident on the base line following TLC 
analysis of the crude product, suggesting that polymerization could have occurred, and 
explaining the poor yield of the quinoxaline 58. 
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Scheme 3.11 
Attempts to improve the yield of quinoxaline 58 by either an increase in reaction time or by 
increasing the mole equivalents of the Zn-pyrrole with respect to the quinoxaline 7, did not 
improve the reaction yield, where 7% and 9% yields were obtained respectively. Polymerization 
was observed in both attempts, as evidenced by significant baseline polar material. 
We then investigated an indole substrate as a potential Negishi coupling partner to quinoxaline 7. 
The N-tosyl-indole was treated sequentially n-BuLi and ZnCl2 to give a THF solution containing 
the putative zincyl-indole derivative. Subjecting the quinoxaline 7 and the zincyl-indole to our 
Negishi coupling conditions, following the reaction by TLC where consumption of starting 
material and formation of one new product was observed after 18 hours. Following separation by 
flash chromatography on silica gel, one new compound was isolated. The mass spectrum of the 
sample gave a molecular ion peak at m/z 400 amu, in agreement with that calculated for desired 
product. The 1H NMR spectrum integrated for 19 H, with a an upfield singlet (3H) at δ 2.28 
ppm, tentatively assigned to be the methyl protons from the tosyl group, and downfield singlet 
(1H) at δ 9.27 ppm, consistent with a 3-H of the quinoxaline proton. With these results, we 
assigned the structure of the compound as 2-{1-[(4-methylbenzene)sulfonyl]-1H-indol-2-
yl}quinoxaline 59 (Scheme 3.12), obtained in 15% yield. TLC analysis of the crude product had 
again showed dark material on the baseline, suggesting that polymerization had occurred, and 
which might have accounted for the poor mass recovery. 
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Scheme 3.12 
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The attempted coupling of an electron deficient pyridine ring system was investigated. 
Production of 2-lithiopyridine has previously been reported and we undertook to repeat this 
procedure, prior to addition of ZnCl2 which we intended would provide a partner for a Negishi 
coupling reaction using our optimal conditions. Attempts to prepare 2-zincyl-pyiridine, starting 
from pyridine, were unsuccessful when using the common procedure for preparing Zn-reagents 
as judged by TLC and HPLC-MS analysis of the crude Negishi coupling reaction mixture, which 
showed starting the quinoxaline starting material 7 to be main species present. Separation of the 
crude mixture on flash chromatography recovered 95% of the quinoxaline starting material 7. 
Due to time constraints, this was not pursued further and we cannot say if the putative zinc-
pyridyl was present, and would not undergo Negishi coupling or perhaps that the zinc-pyridine 
was not present in solution. 
In conclusion, we have demonstrated Negishi coupling reactions to occur between 
benzenesulfonyloxy-quinoxaline 7 with various heteroaryl-Zn substrates. Competition reactions 
between metal-halogen exchange and deprotonation with n-BuLi were observed when using 3-
bromofuran and 3-bromothiophene, resulting in low reaction yields. As judged by both poor 
mass recovery and the presence of polar baseline material, we suggest that polymerization of 
cross-coupled products was observed in a number of reactions, resulting in low isolated yields of 
these desired products, in some cases none at all. Future work might involve further investigation 
of the stability of the cross-coupled products to, for instance, stoichiometric zinc cation and 
catalytic Pd, under the conditions of our optimized Negishi coupled reactions. 
Finally we investigated the ability of quinoxaline-O-mesylate as a leaving group in the Negishi 
coupling reactions as it carries the advantage of being relatively cheap and more atom economic 
that the corresponding O-benzenesulfonate leaving group. 
Treatment of the mesyloxy-quinoxaline 15 with phenyl-Zn, under our Negishi coupling 
conditions, showed consumption of quinoxaline 15 and formation of one principal new 
compound after heating at reflux for 18 hours. Following aqueous work-up and purification by 
flash chromatography, the desired 2-phenylquinoxaline 50 was obtained in 91% yield (Scheme 
3.13 a). The melting point, 1H, 13C NMR and mass spectra were identical to those obtained from 
samples of quinoxaline 50 obtained previously from benzenesulfonate 7, as described above. 
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Scheme 3.13 a) PhZn; b) (MeO)3PhZn 
Similarly 2-(3,4,5-trimethoxybenzene)quinoxaline 52 was obtained in an 80% yield, when 
coupling 2-mesyloxy quinoxaline 15 with zincyl-trimethoxybenzene under our Negishi coupling 
conditions (Scheme 3.13 b). The yield is identical to the yield obtained when starting with 
benzenesulfonyloxy-quinoxaline 7. The product had a 1H NMR and mass spectra that were 
identical to our previously obtained results. 
Having shown the success of Negishi coupling reaction employing benzenesulfonyloxy-
quinoxaline 7 and mesyloxy-quinoxaline 15 as coupling partners with alkyl-, aryl- and 
heteroaryl-Zn substrates, we then investigated the benzenesulfonyloxy-pteridine and mesyloxy-
pteridines as potential coupling partners in Negishi coupling reactions.  
3.2.3 Negishi coupling of pteridine-O-sulfonates 
When working with the pteridines, two challenges were faced; firstly that the amidine protected 
pteridine-O-sulfonates were not soluble in THF and secondly that the amidine  protecting groups 
are easily removed by both mild acid and mild base, as we have discovered during the 
investigation of Sonogashira coupling in chapter 2. 
The Negishi coupling conditions which were successful with the quinoxaline-O-sulfonates would 
expose the amidine protected pteridine to conditions involving a stoichiometric organometallic 
reagent. Both the amidine protecting groups and the electron deficient pteridine nucleus possess 
electrophilic sites which would potentially react with the polarized Zn-carbon bond. To make 
matters worse, the Lewis acid nature of the zinc cation could further activate the pteridine by 
coordination. On paper at least, the fully protected pteridine appeared to offer a number of bi-
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dentate coordination modes some of which are shown in Figure 3.1. The prospects did not appear 
good.  
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Figure 3.1 
With these formidable issues in mind we began examining the reaction of benzenesulfonyl 
pteridine 27 with phenyl-Zn under the Negishi coupling conditions in refluxing THF under dry 
argon. It appeared that the bulk of the pteridine 27 dissolved, to give a dark solution, but within 
an hour a bulky precipitate was evident. After two hours at reflux, the flask was cooled and the 
precipitate and supernatant separated by filtration. HPLC-MS analysis of both the precipitates 
and the mother liquor suggested the main components present to be the deprotected pteridines 
derived from the pteridine-O-sulfonate (27b and 27c) and significantly, a trace amount of what 
we tentatively assigned as the mono-deprotected  cross-coupled product 61 as judged by an 
apparent molecular ion at m/z 294 amu [M+H+]  (Figure 3.2). 
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Figure 3.2 
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Encouragingly too, we did not detect any products which might have been expected had addition 
of the PhZn reagent occurred to either the amidine protecting group or the pteridine nucleus. 
Possible structures for such-byproducts might, we reasoned, be benzaldehyde (following 
hydrolysis of an aminal resulting from addition of phenyl to the amidine) or the 7-phenyl-7,8-
dihydropteridine shown in Scheme 3.14 
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Scheme 3.14 a) reaction on the amidine; b) reaction on the 7-C atom  
It appeared likely, given the absence of proton donors under the Negishi coupling conditions, 
that simple precipitation of, presumably a different crystalline isomorph, of the starting pteridine-
O-sulfonate 27 was occurring under our Negishi coupling conditions. The hydrolysis products 
were those formed during the HPLC-MS analysis, which we had already confirmed could occur, 
as described in Chapter 2. If this was the case, then we would require a solvent which would 
dissolve the pteridine and allow the Negishi coupling reaction to occur. 
Dichloromethane was investigated as an alternative solvent to THF due to its ability to solubilise 
protected pteridines. The quinoxaline model was chosen to investigate the Negishi coupling in 
DCM, where quinoxaline 7 was treated with phenyl-Zn (prepared in THF, as previously 
described, followed by removal of solvent in vacuo and dissolving the salt in dry DCM). After 
refluxing in DCM for 18 hours, aqueous work and purification on flash silica, the desired 2-
phenylquinoxaline 50, identical as judged by 1H NMR and mass spectral analysis to that 
obtained before, was obtained in 65% yield. No other side products were detected.  
We then prepared the PhZn reagent in DCM and added the pteridine 27 and Pd catalyst, and the 
mixture was heated at reflux for 18 hours. No precipitates were observed, however, HPLC-MS 
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analysis of the reaction mixture showed the main component to be starting material and a trace 
amount of desired coupled product. From these results it was evident that the Zn-reagent was not 
interfering with the protecting groups of the pteridines as observed from HPLC-MS analysis. 
We then investigated solvent combinations of DCM/THF where the pteridine and Pd were 
dissolved in DCM and the PhZn prepared in THF, prior to mixing. Precipitation was observed 
within the first hour and HPLC-MS analysis of the crude mixture and precipitates showed the 
presence of both starting material and deprotected starting material, with no desired coupled 
products detected. 
Increasing the temperature of the reaction by performing the reaction in DCM in a sealed tube 
did not yield any desired Negishi coupled product either. When using chloroform as solvent, 
apparent polymerization was observed as judged by the formation of precipitates which proved 
insoluble in all solvent systems, and no trace of Negishi coupling product or starting pteridine 27 
were observed on HPLC-MS analysis of the supernatant. Changing the Zn-reagent to 3,4,5-
trimethoxybenzene-ZnCl gave similar results to those obtained when using phenyl-ZnCl. 
A dipolar aprotic solvent appeared as a possible choice and to investigate this, we attempted the 
Negishi coupling reactions in DMF. We dissolved quinoxaline 27 and Pd catalyst in DMF, and 
to this solution was added PnZn in THF. The reaction was warmed to 80oC under dry Ar for two 
hours after which TLC showed complete consumption of pteridine 27 and the formation of new 
species. After purification of the crude mixture on flash chromatography, two close eluting 
fractions were isolated. HPLC-MS analysis of the mixture showed the products to be desired 
coupled phenyl-pteridine 60 along with the mono-deprotected phenyl-pteridine 61 (Scheme 
3.15),as judged by the peaks at m/z 349 and 294 amu [both M+H+]. Further purification of the 
mixed products employing flash chromatography gave a product mixture that was mainly 
pteridine 61 (>90%), with 1H NMR showing downfield proton at δ 9.60 ppm and two methyl 
peaks at δ 3.08 (3H) and 3.19 ppm (3H). The products were isolated in an overall yield of 80%, 
with no recovered starting material. 
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Scheme 3.15 
Having had Negishi coupling success with PhZn and pteridine 27, we investigated the Negishi 
coupling between the zincyl-trimethoxybenzene and pteridine 27 employing our new conditions. 
The zincyl-trimethoxybenzene was prepared in THF, as previously reported, and the solution 
was added to a DMF solution containing the pteridine 27 and catalytic Pd, warmed to 80oC under 
Ar and stirred for two hours. Following full consumption of starting material and formation of a 
new product, as judged by TLC, the crude mixture was purified by flash chromatography, and 
two close running fractions were isolated. HPLC-MS analysis of the two close fractions gave 
peaks at m/z 439 and 384 amu [both M+H+] as the only peaks. Further purification by flash 
chromatography, gave product mixture that had the m/z 384 amu peak. 1H NMR spectrum gave a 
downfield singlet (1H) at δ 9.59 ppm, consistent with 7-H pteridine signal, and four upfield 
singlets between δ 3.08 and 3.94 ppm (15H) consistent with the methyl protons on the protecting 
group and the benzene ring. A singlet in the aromatic region at δ 7.66 (2H) was consistent with 
the two equivalent protons in the phenyl ring. We then assigned the structures of the compound 
to be the coupled trimethoxyphenyl-pteridine 62 along with the mono-deprotected pteridine 63. 
The overall yield of the reaction was 65%. 
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Figure 3.3 
We then investigated the Negishi coupling between pteridine 27 and 2-zincyl-furan. The solution 
containing zincyl-furan, prepared as described previously, was added to a DMF solution 
containing the pteridine 27 and catalytic Pd, and final solution warmed to 80oC under Ar and 
stirred for two hours. Following full consumption of starting material and formation of new 
product, as judged by TLC, the crude mixture was purified by flash chromatography, and two 
close running fractions were isolated. HPLC-MS and 1H NMR analysis of the mixture, showed 
the two close fractions to contain the desired coupled furyl-pteridine 65 along with mono-
deprotected furyl-pteridine 65 (Figure 3.4), as the only components. Further purification on flash 
chromatography gave a product mixture that contained more mono-deprotected furyl-pteridine 
65, with an overall yield of 67%. 
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Figure 3.4 
Investigating the ability of mesylate as a leaving in pteridine system, we treated the mesyl-
pteridine 26 with phenyl-Zn under the coupling conditions and obtained the mixed coupled 
phenyl-pteridines 60 and 61 in 78% yield, results similar to those obtained in the quinoxaline 
experiments. The 1H NMR and HPLC-MS spectral analysis of the products were identical to 
those of phenyl-pteridines obtained from benzenesulfonate 27. 
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However, the attempted coupling of the zincated-trimethoxyphenyl and furan rings with the 
mesyloxy-pteridine 26 were unsuccessful as judged by the TLC and HPLC-UV-APCI-MS. This 
could be due to the presence of lithium (Li) ions in solutions that have been reported to be 
poisonous to the palladium catalyst in certain cross-coupling reactions.2 The furan-2-ylzinc and 
trimethoxyphenylzinc are prepared by transmetallation from their corresponding lithio-
derivatives and are never purified meaning that Li ions are still present, in stoichiometric 
amounts, in solution during the Negishi coupling reaction. The extent of poisoning by Li and 
sometimes Mg is not fully understood and is also dependant of the substrates attached to the zinc 
metal and also the leaving group.2 
From these results, we postulate that although the yields in Negishi couplings obtained when 
using benzenesulfonate-substrate and mesylate-substrate are almost identical, the 
benzenesulfonate-substrates are more reactive than the mesylate. When using benzenesulfonyl-
pteridine 27 as substrate, the reactions proceed smoothly in the presence of a potential poison, 
lithium, while mesyl-pteridine 26 does not give desired products in the presence of Li ions. This 
might imply that the rate of coupling is faster in benzenesulfonyl-pteridine 27 when compared to 
poisoning while in mesyl-pteridine 26, rate of poisoning is faster than rate of coupling. More 
work needs to be done to substantiate which of the possible explanations for the failure of the 
attempted Negishi couplings under these conditions. 
In conclusion, we have demonstrated Negishi coupling reactions between pteridine-O-sulfonates 
and aryl or heteroaryl-Zn substrates in moderate to good yields. The reactions were performed in 
a potentially reactive solvent, DMF, but remarkably, no side reactions with the DMF or the 
amidine protecting groups were observed. The success of these reactions allow for the 
introduction of various aryl- and heteroaryl-substituents at the 6-position of the pteridine 
nucleus. We then investigated the conversion of these amidine protected 6-(hetero)arylpteridines 
into the corresponding 2,4-diaminopteridine and pterin derivatives.  
 
3.2.4 Conversion of Pteridines to Pterins 
In Chapter 2, methods for removing the protecting groups to give the 2,4-diamino-6-ethynyl-
pteridines and pterins were discussed. With our Negishi coupled products in hand, we 
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investigated their deprotection and hydrolysis to the corresponding 2,4-diamino-6-
(hetero)arylpteridines and pterins, respectively. 
Treatment of the protected phenyl-pteridines 60 and 61 with1M NaOH/EtOH mixture, heating at 
a gentle reflux for 8 hours and precipitation by addition of AcOH gave, after filtration, a yellow 
solid. 1H NMR and mass spectral analysis of the compound were consistent with those 
previously reported for 6-phenyl-pterin 66, with a m/z peak at 239 [M-1] obtained on the APCI 
negative mode spectrum, and a downfield singlet at δ 9.26 ppm obtained from the 1H NMR 
spectrum (Scheme 3.16).27 The product was obtained in 61% yield. 
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Scheme 3.16 
In a similar manner, the protected trimethoxypteridines 62 and 63 were treated with with1M 
NaOH/EtOH mixture, with gentle reflux for 8 hours and precipitation by addition of AcOH to 
give a yellow solid. The APCI mass spectrum of the compound gave a [M+H]+ at m/z 330 amu 
and the 1H NMR spectrum gave a downfield singlet at δ 9.23 ppm (1H) and two upfield singlets 
at δ 3.72 (3H) and 3.89 ppm (6H). We assigned the structure of the compound to that of 6-(3,4,5-
trimethoxyphenyl)pterin 67, obtained in 59% yield (Figure 3.5). 
The mixture of the protected furanyl-pteridines 64 and 65 were treated with with1M 
NaOH/EtOH mixture, with gentle reflux for 8 hours and precipitation by addition of AcOH to 
give a yellow solid. The 1H NMR spectrum integrated for four hydrogens, with a downfield 
singlet at δ 8.97 ppm, consistent with 7-H pterin proton, and upfield singlet at δ 6.68 ppm, 
consistent with the furan ring. The APCI mass spectrum gave a peak at m/z 230 amu [M+H+] 
which is in agreement with the molecular ion calculated for 6-(furan-2-yl)pterin 68 (Figure 3.5). 
The product was obtained in 63% yield. 
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Figure 3.5 
Treatment of the protected phenyl-pteridines 60 and 61 with1M NH3/EtOH mixture, with gentle 
reflux for 8 hours and precipitation by addition of AcOH gave, after filtration, a yellow solid. 1H 
NMR and mass spectral analysis of the compound were consistent with those previously reported 
for 2,4-diamino-6-(phenyl)pteridine 69, with a m/z peak at 239 [M+H+] obtained on the APCI 
spectrum, and a downfield singlet at δ 9.30 ppm obtained from the 1H NMR spectrum (Scheme 
3.17).28 
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Scheme 3.17 
Treatment of the trimethoxypteridines 62 and 63 with ammonia solution with gently reflux gave, 
surprisingly, the trimethoxyphenyl-pterin 67, as judged by 1H NMR and mass spectral analysis.  
Similar results were observed when the furanylpteridines 64 and 65 were refluxed in 1M NH3/ 
EtOH solution, where 6-furan-2-yl-pterin 68 was obtained, as judged by NMR and mass spectral 
analysis, instead of the 2,4-diaminopteridine derivative.  
These results suggest that the groups attached at the 6-position have a direct effect in the 
reactivity of the pterin ring. When electron rich substituents, relative to phenyl, are attached at 
the 6-position, the hydrolysis of the 4-amino group is easily achieved under weak basic 
conditions such as ammonia. It is likely that the pteridine ring becomes more basic and the first 
111 
 
step will be the protonation of the ring, followed by an attack by a weak nucleophile (water) and 
the loss of ammonia gives the pterin ring. 
 
3.2.5 Conclusion 
We have demonstrated that Negishi coupling chemistry can be performed on quinoxalines and 
pteridines bearing a benzenesulfonate and mesylate leaving groups. Different substituents i.e. 
Aryl, heterocycles, and alkyl, can be attached at the 2-position for quinoxaline, and 6-position for 
pteridines. There seem to be little difference in yields when changing the leaving group from 
benzenesulfonate to mesylate in the quinoxaline system but the presence Li ions does affect the 
Negishi coupling when mesylate is a leaving group on pteridines. This method allows for new 
pterin molecules, possessing various substituents e.g. heterocycles, at the six position to be 
synthesized and can open new routes towards the total synthesis of natural pterin molecules. 
 
3.3 Experimental 
3.3.1 Preparation of Zn-reagents 
Phenyl-Zn 
To a flame dried 3-neck 250 ml round bottom flask equipped with a stirrer bar, reflux condenser 
and a positive pressure of dry argon and containing magnesium turnings (2.02 g, 83.33 mmol) 
was transferred a solution of bromobenzene (9.70 ml, 91.45 mmol, 1.1 eq.) in THF (20 ml) and 
stirred at room temperature until reaction starts (3 – 5 minutes). Gentle reflux was maintained by 
cooling in a room temperature water bath and after the reaction had begun to subside (20 
minutes) further THF (25 ml) added, and reaction stirred for 2 hours. Further THF (25 ml) was 
added, the fine precipitates allowed to settle, and the supernatant transferred to a flame dried 150 
ml schlenk tube using a canular. The concentration of the phenyl-MgBr was assumed to be 1.15 
M.  
A typical procedure for preparing PhZn was undertaken as follows ZnCl2 (anhydrous grade, 
Aldrich chemical company 99.99%)(0.214 g, 1.575 mmol) in THF (5 ml) was placed in a 3-neck 
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25 ml r.b. flask, equipped with a stirrer bar under an atmosphere of dry argon. The flask was 
evacuated to a high vacuum and cautiously heated with a Bunsen flame, concentrating the heat 
on the solid ZnCl2 until fusion occurred, accompanied by some sublimation (CAUTION, see 
safety note 1, below). The flask was then allowed to cool to room temperature and a positive 
pressure of argon applied. Dry THF (5ml) was added and flask stirred until complete dissolution. 
Phenyl-MgBr (1.3 ml, 1.514 mmol, of the ~1.15 M solution prepared as described above) was 
added by syringe to the ZnCl2 solution, and the final solution was stirred for 30 minutes to give a 
solution assumed to contain Phenyl-Zn (1.514 mmol). 
Note 1. CAUTIO, IMPLOSION AND INJURY IS VERY POSSIBLE USING THIS 
PROCEDURE. ALL THE FOLLOWING SAFETY ADVICE MUST BE FOLLOWED. The 
round bottom flask should only be used if free from star cracks and imperfections. It is not 
advised that any larger volume flask be subjected to this heating regime. If possible, a 
transparent blast proof screen should be used, but as a minimum requirement, a blast resistant 
full face visor and thick protective gloves must be worn by the experimenter. Excessive heating 
should be avoided, and slow warming of the flask body is preferred. The m.p. of a good grade of 
ZnCl2 is ~ 350
oC and heating to just attain the fusion point, in a high vacuum, is sufficient, in our 
experience to provide an entirely anhydrous sample. 
During the course of the work described in Chapter 3, we investigated a number of methods 
preparing and handling zinc salts and reagents. The preparations described above describe our 
optimum available anhydrous conditions. We later found that the ZnCl2 could be kept anhydrous 
in an oven, maintained at ~ 150oC and rapidly weighed before being added as a solid to a 
prepared lithium (hetero)aryl without any apparent compromise in recovered yield. These 
variations are described below. 
 
Toluenyl-ZnCl 
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon, 2-
bromotoulene (190 µl, 1.575 mmol) in THF (5ml) (cooled in cryostat / acetone bath maintained 
at -78oC) was treated with n-BuLi (1.2 ml, 1.89 mmol, 1.6 M solution in hexanes) at -78oC and 
allowed to warm to room temperature over 15 minutes. ZnCl2 (0.214 g, 1.575 mmol, taken 
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directly from oven) was added to the flask and final solution stirred for 30 minutes to give a 
solution of which was presumed contain 2-toluenyl-ZnCl (1.575 mmol), ready for use. 
 
3,4,5-Trimethoxyphenyl-ZnCl 
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon, 3,4,5-
trimethoxybromobenzene (389 mg , 1.575 mmol) in THF (5ml) (cooled in cryostat / acetone bath 
maintained at -78oC) was treated with n-BuLi (1.2 ml , 1.89 mmol, 1.6 M solution in hexanes) at 
-78oC and allowed to cool to room temperature over 15 minutes. ZnCl2 (0.216 g, 1.575 mmol, 
taken directly from oven) was added to the flask and final solution stirred for 30 minutes to give 
a solution which was presumed to contain 3,4,5-trimethoxyphenyl-ZnCl (1.575 mmol). 
 
Furan-2-yl-ZnCl 
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon, furan (115 
µl,1.575 mmol) in THF (5ml) (cooled in cryostat / acetone bath maintained at -78oC) was treated 
with n-BuLi (1.2 ml, 1.89 mmol, 1.6 M in hexanes) at -78oC and allowed to cool to room 
temperature over 15 minutes. ZnCl2 (0.214 g, 1.575 mmol, taken directly from oven) was added 
to the flask and final solution stirred for 30 minutes to give a solution presumed to contain furan-
2-yl-ZnCl (1.575 mmol). 
 
Thiophen-3-yl-ZnCl and 2-zincyl-3-bromothiophene  
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon, 3-
bromothiophene (148 µl ,1.575 mmol) in THF (5ml) (cooled in cryostat / acetone bath 
maintained at -78oC) was treated with n-BuLi (1.2 ml, 1.89 mmol, 1.6 M in hexanes) at -78oC 
and allowed to cool to room temperature over 15 minutes. ZnCl2 (0.214 g, 1.575 mmol) was 
added to the flask and final solution stirred for 30 minutes to give a solution containing 
thiophene-3-yl-ZnCl and 3-bromothiophen-2-yl-ZnCl (1.575 mmol), as judged by the Negishi 
coupled products obtained. 
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[1-(Benzenesulfonyl)-1H-pyrrol-2-yl]ZnCl 
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon,1-
(benzenesulfonyl)pyrrole ( 351 mg ,1.575 mmol) in THF (5ml) was treated with n-BuLi (1.2 ml 
,1.89 mmol, 1.6 M in hexanes) at -78oC and allowed to cool to room temperature over 15 
minutes. ZnCl2 (0.214 g, 1.575 mmol) was added to the flask and final solution stirred for 30 
minutes to give a solution presumed to contain [1-(benzenesulfonyl)-1H-pyrrol-2-yl]ZnCl (1.575 
mmol). 
 
{1-[(4-Methylbenzene)sulfonyl]-1H-indol-2-yl}ZnCl 
In a flame dried 2-neck r.b. flask, equipped with a stirrer bar and under dry argon,1-
(benzenesulfonyl)pyrrole (214 mg, 0.788 mmol,) in THF (5ml) was treated with n-BuLi (0.76 
ml, 0.788 mmol, 1.04 M in hexanes) at -78oC and allowed to cool to room temperature over 15 
minutes. ZnCl2 (0.107 g, 0.788 mmol) was added to the flask and final solution stirred for 30 
minutes to give a solution presumed to contain {1-[(4-methylbenzene)sulfonyl]-1H-indol-2-
yl}ZnCl (0.788 mmol). 
 
3.3.2 Negishi coupling of quinoxalines 
General procedure for the Negishi coupling 
To a solution of Zn-substrate (1.575 mmol) in THF (5 ml) was added 2-
benzenesulfonylquinoxaline 7 (300 mg, 1.05 mmol) and PdCl2(PPh3)2 (38.0 mg, 0.052 mmol, 5 
mol%). The solution was heated to reflux and stirred under Ar for 18 hours, allowed to cool to 
room temperature, diluted with EtOAc (10 ml), filtered through a pad of silica gel and the pad 
washed further with aliquots of EtOAc (3×10 ml). The combined filtrate and washings were 
evaporated in vacuo on a rotary evaporator and subjected to flash chromatography on flash silica 
gel, eluting with 5% EtOAc/hexane. 
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2-Ethylquinoxaline (49)
15 
Diethyl zinc (0.5 ml, 1.575 mmol, 2.86 M in toluene) was treated with 7 according to the general 
method and after purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-
ethylquinoxaline as a clear oil (97 mg, 58%); Rf  0.40; δH (CDCl3, 300 MHz) 1.45 (3H, t, J = 7.8 
Hz), 3.06 (2H, q, J = 7.5 Hz), 7.73 (2H, m), 8.07 (2H, m) and 8.77 (1H, s); δC (CDCl3, 100 MHz) 
13.4, 29.6, 128.8, 128.9, 129.1, 129.9, 141.2, 142.2, 145.6 and 158.5. Physical and spectroscopic 
data agree with those reported elsewhere.15 
 
2-Phenylquinoxaline (50)
17 
Phenyl-ZnCl (1.575 mmol) was treated with 7 according to the general method and after 
purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-phenylquinoxaline 
as a white solid (209 mg, 95%); Rf  0.35; m.p 73
oC (Lit. 73-74oC); δH (CDCl3, 300 MHz) 7.53 – 
7.59 (3H, m), 7.75 – 7.81 (2H, m), 8.12 – 8.22 (4H, m) and 9.34 (1H, s); δC (CDCl3, 100 MHz) 
127.6, 129.1, 129.2, 129.6, 129.7, 130.2, 130.3, 136.8, 141.6, 142.3, 143.4 and 151.9, we 
expected 14C environments but only 12 were evident from the spectrum. It is likely that the 
symmetry on the phenyl ring is responsible for the few C environment on the spectra; m/z (LREI) 
206.1 (M+, 100). Physical and spectroscopic data agree with those reported elsewhere.17 
 
2-(o-Toluenyl)quinoxaline (51)
19 
2-Toluenyl-ZnCl (1.575 mmol) was treated with 7 according to the general method and after 
purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-(o-
toluenyl)quinoxaline as a light yellow solid (123 mg, 55%); Rf  0.34; m.p. 80 – 81
oC (Lit. 81-
82oC); δH (CDCl3, 300 MHz) 2.48 (3H, s), 7.30 – 7.31 (3H, m), 7.47 (1H, m), 7.71 – 7.74 (2H, 
m), 8.07 – 8.11 (2H, m) and 8.94 (1H, s); δC (CDCl3, 100 MHz) 20.4, 126.4,129.0, 129.2, 129.5, 
130.0, 130.1, 130.4, 131.3, 136.6, 137.0, 140.7, 142.0, 145.6 and 155.0; HRESI found 
221.10742, C15H13N2 requires 221.10733. Physical and spectroscopic data agree with those 
reported elsewhere.19 
116 
 
2-(3,4,5-Trimethoxyphenyl)quinoxaline (52) 
3,4,5-Trimethoxyphenyl-ZnCl (1.575 mmol) was treated with 7 according to the general method 
and after purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-(3,4,5-
trimethoxyphenyl)quinoxaline as a yellow solid (230 mg, 80%); Rf 0.28; m.p. 82 – 83
oC; δH 
(CDCl3, 300 MHz) 3.90 (3H, s), 4.03 (6H, s), 7.44 (2H, s), 7.73 – 7.83 (2H, m), 8.12 – 8.20 (2H, 
m) and 9.30 (1H, s); δC (CDCl3, 100 MHz) 56.3, 61.0, 104.9, 129.0, 129.4, 129.5, 130.5, 132.1, 
140.3, 141.3, 142.1, 143.0, 151.4 and 153.9; m/z (APCI, +ve) 298 [M+H+, 100]; (HREI Found: 
297.12336. C17H17N2O3 require 297.12337) 
 
2-(3-bromothiophen-2-yl)quinoxaline (53) and 2-(Thiophen-3-yl)quinoxaline (54)23 
Thiophene-3-yl-ZnCl and 3-bromothiophen-2-yl-ZnCl (1.575 mmol) was treated with 7 
according to the general method and after purification by flash chromatography, eluting with 5% 
EtOAc/hexane, gave 2-(3-bromothiophen-2-yl)quinoxaline as a brown solid (90 mg, 30%); Rf  
0.30; m.p.113oC; δH (CDCl3, 300 MHz) 7.15 (1H, d, J = 5.4 Hz), 7.50 (1H, d, J = 5.4 Hz), 7.77 
(2H, m), 8.11 (2H, m) and 9.78 (1H, s); δC (CDCl3, 100 MHz) 109.7, 111.0, 127.1, 129.3, 129.4, 
130.0, 130.5, 130.0, 141.2, 142.2, 142.9 and 146.9; m/z (LR-FAB) 291 (M+, 100), 293 (M+ + 2, 
100). 
and  2-(Thiophen-3-yl)quinoxaline as a yellow solid (60 mg, 30%); Rf 0.27; m.p. 91 – 92
oC (Lit. 
91oC); δH (CDCl3, 300 MHz) 7.21 (1H, dd, J = 5.1 and 3.6 Hz), 7.56 (1H, dd, J = 5.1 and 1.2 
Hz), 7.74 (2H, m), 7.88 (1H, dd, J = 5.1 and 1.2 Hz), 8.10 (2H, m) and 9.25 (1H, s); δC (CDCl3, 
100 MHz) 127.1, 128.5, 129.0, 129.1, 129.3, 130.0, 130.6, 141.1, 141.9, 142.1, 142.2 and 147.4; 
Physical and spectroscopic data agree with those reported elsewhere.23 
  
2-(3-Bromofuran-2-yl)quinoxaline (55)
 
3-Bromofuran-2-yl-ZnCl (1.575 mmol) was treated with 7according to the general method and 
after purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-(3-
Bromofuran-2-yl)quinoxaline as a yellow solid (60 mg, 21%); Rf  0.31; m.p. 92
oC; δH (CDCl3, 
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300 MHz) 6.71 (1H, d, J = 1.8 Hz), 7.65 (1H, d, J = 1.8 Hz), 7.78 (2H, m), 8.17 (2H, m) and 
9.56 (1H, s); δC (CDCl3, 100 MHz) 102.3, 117.3, 129.0, 129.2, 130.1, 130.7, 140.7, 142.1, 142.2, 
143.6, 144.8 and 146.6; m/z (LR-FAB) 274.8 (M+, 100), 276.8 (M+ + 2, 100). 
 
2-(Furan-2-yl)quinoxaline (57)
26 
Furan-2-yl-ZnCl (1.575 mmol) was treated with 7 according to the general method and after 
purification by flash chromatography, eluting with 5% EtOAc/hexane, gave 2-(Furan-2-
yl)quinoxaline as an orange solid (150 mg, 73%); Rf  0.28; m.p. 100
oC (Lit. 97-98oC); δH (CDCl3, 
300 MHz) 6.64 (1H, dd, J = 3.3 and 1.5 Hz), 7.33 (1H, d, J = 3.3 Hz), 7.70 – 7.75 (3H, m), 8.10 
(2H, m) and 9.26 (1H, s); δC (CDCl3, 100 MHz) 111.9, 112.5, 129.2, 129.4, 130.5, 141.3, 142.1, 
143.9, 145.1 and 151.6; (Found: 196.06357, C12H8N2O requires 196.06366). Physical and 
spectroscopic data agree with those reported elsewhere.26 
 
2-[1-(Benzenesulfonyl)-1H-pyrrol-2-yl]quinoxaline (58)  
[1-(Benzenesulfonyl)-1H-pyrrol-2-yl]ZnCl (1.575 mmol) was treated with 7 according to the 
general method and after purification by flash chromatography, eluting with 5% EtOAc/hexane, 
gave 2-[1-(benzenesulfonyl)-1H-pyrrol-2-yl]quinoxaline as a brown solid (46 mg, 10%); Rf  0.31; 
m.p. 180oC; δH (CDCl3, 300 MHz) 6.48 (1H, apparent t, J = 3.6 Hz), 6.77 (1H, dd, J = 3.6 and 
1.5 Hz), 7.51 (2H, m), 7.63 (2H, m), 7.77 – 7.87 (5H, m), 8.12 (1H, m) and 9.07 (1H, s); δC 
(CDCl3, 100 MHz) 112.9, 119.3, 126.9, 127.2, 128.9, 129.1, 129.3, 129.9, 130.3, 132.5, 133.8, 
139.5, 141.1, 141.4 and 145.8, we expected 18C environments but only 15 were evident from the 
spectrum. It is likely that the symmetry on the phenyl ring is responsible for the few C 
environment on the spectra and some quaternary carbons might not be visible; (HRESI Found: 
336.08136, C18H14N3O2
32S requires 336.08012) 
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-{1-[(4-Methylbenzene)sulfonyl]-1H-indol-2-yl}quinoxaline (59) 
{1-[(4-Methylbenzene)sulfonyl]-1H-indol-2-yl}ZnCl (0.788 mmol) was treated with 7 according 
to the general method and after purification by flash chromatography, eluting with 5% 
EtOAc/hexane, gave -{1-[(4-Methylbenzene)sulfonyl]-1H-indol-2-yl}quinoxaline as a brown 
solid (36 mg, 15%); Rf  0.28; m.p. 191
oC; δH (CDCl3, 300 MHz) 2.28 (3H, s), 7.11 (3H, m), 7.31 
(2H, m), 7.41 – 7.54 (5H, m), 7.83 - 7.85 (2H, m), 8.15 – 8.27 (3H, m) and 9.27 (1H, s); δC 
(CDCl3, 100 MHz) 21.6, 116.3, 117.8, 121.8, 124.8, 126.2, 127.0, 129.4, 129.5, 130.2, 130.3, 
130.4, 133.7, 138.2, 138.5, 141.5, 141.7, 145.1, 147.1 and 147.3, we expected 23C environments 
but only 20 were evident from the spectrum. It is likely that the symmetry on the phenyl ring is 
responsible for the few C environment on the spectra and some quaternary carbons might not be 
visible; (Found 400.11162, C23H18N3O2
32S requires 400.11142). 
 
3.3.3 Negishi coupling on pteridines 
General method 2 
To the solution of Zn-reagent (3.15 mmo) in DMF/THF mixture (15 ml, 2:1) was added 
benzenesulfonyl-pteridine 27 (2.1 mmol, 900 mg), Pd2dba3CHCl3 (125 mg, 0.1575 mmol, 5 
mmol%) and PPh3 (125 mg, 0.477 mmol). The final solution was warmed to 80
oC and stirred 
under Ar for 2 hours, concentrated on a rotary evaporator and purified on flash silica, eluting 
with 5% MeOH/DCM. 
 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(phenyl)pterin-4-yl (61) 
Phenyl-ZnCl (3.15 mmol) was treated with 27 according to general method 2 to give 850 mg of 
mixed 60 and 61. Further purification on flash silica, eluting with 5% MeOH/DCM gave 4-
amino-2-( N,N-dimethylaminomethyleneamino)-6-(phenyl)pterin-4-yl as an orange solid (494 
mg, 80%); Rf  0.28; m.p. 180
oC; δH (d6-DMSO, 300 MHz) 3.08 (3H, s), 3.19 (3H, s), 7.51 – 7.53 
(3H, m), 8.41 – 8.43 (2H, m), 8.76 (1H, s), 9.60 (1H, s), the –NH2 signal was too broad to be 
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assigned and a clean 13C NMR could not be obtained; m/z (APCI) 294 (M + H+, 100), 239 (80) 
(HRESI +ve mode Found: 294.14736, C15H16N7 requires 294.14620)  
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(3,4,5-trimethoxyphenyl)pterin-4-yl 
(63) 
3,4,5-Trimethoxyphenyl-ZnCl (3.15 mmol) was treated with 27 according to general method 2 to 
give 672 mg of mixed products 62 and 63. Further purification on flash silica, eluting with 5% 
MeOH/DCM gave 4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(3,4,5-
trimethoxyphenyl)pterin-4-yl as an orange solid (520 mg, 65%); Rf  0.25; m.p. 160
oC; δH (d6-
DMSO, 300 MHz) 3.08 (3H, s), 3.18 (3H, s), 3.74 (3H, s), 3.94 (6H, s), 7.66 (2H, s), 8.76 (1H, 
s), 9.59 (1H, s), the –NH2 signal was too broad to be assigned and a clean 
13C NMR could not be 
obtained; m/z (APCI) 384 (M + H+, 100), 329 (40) (HRESI +ve mode found: 384.17772, 
C18H22N7O3 requires 384.17786). 
 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(furan-2-yl)pterin-4-yl (65) 
Furan-2-yl-ZnCl (3.15 mmol) was treated with 27 according to general method 2 to give 700 mg 
of mixed products 64 and 65. Further purification on flash silica, eluting with 5% MeOH/DCM 
gave 4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(furan-2-yl)pterin-4-yl as a dark-red 
solid (400 mg, 67%); Rf  0.27; m.p.(dec) 300
oC; δH (d6-DMSO, 300 MHz) 3.06 (3H, s), 3.16 (3H, 
s), 6.75 (1H, m), 7.31 (1H, m), 7.42 (1H, m), 8.73 (1H, s) and 9.22 (1H, s), the –NH2 signal was 
too broad to be assigned and a clean 13C NMR could not be obtained; m/z (APCI) 284 (M + H+, 
100), 229 (30) (HRESI +ve mode Found: 284.1232, C13H14N7O) requires 284.1254). 
 
2,4-Diamino-6-(phenyl)pteridine (69)
28 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(phenyl)pterin-4-yl 61 (150 mg, 0.512 
mmol) was treated with 1M NH3/EtOH (8 ml, 1:1) and gently refluxed for 8 hours, allowed to 
cool to room temperature, acidified with AcOH and placed in a fridge (2oC) for 18 hours. The 
solution was filtered, crystals washed sequentially with water, EtOH and Et2O to give 2,4-
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diamino-6-(phenyl)pteridine as a dark green solid (70 mg, 57%); m.p. > 300oC; δH (d6-DMSO, 
300 MHz) 7.50 (3H, m), 8.18 (2H, m) and 9.30 (1H, s), the two –NH2 signals were too broad to 
be assigned and a clean 13C NMR could not be obtained; m/z (APCI) 239 (M + H+, 100) (HRESI 
Found: 239.1046, C12H11N6 requires 239.10397). Physical and spectroscopic data agree with 
those reported elsewhere.28 
 
6-(Phenyl)pterin (66)
27 
4-Amino-2-( N,N-dimethylaminomethyleneamino)-6-(phenyl)pterin-4-yl 61 (150 mg, 0.512 
mmol) was treated with 1M NaOH/EtOH (8 ml, 1:1) and gently refluxed for 8 hours, allowed to 
cool to room temperature, acidified with AcOH and placed in a fridge (2oC) for 18 hours. The 
solution was filtered, crystals washed sequentially with water, EtOH and Et2O to give 6-
(phenyl)pterin as a yellow solid (60 mg, 61%); m.p. > 300oC;λmax (nm) 296, 369; δH (d6-DMSO, 
300 MHz) 7.51 (3H, m), 8.12 (2H, m) and 9.26 (1H, s), the –NH2 and –NH signals were too 
broad to be assigned and a clean 13C NMR could not be obtained; m/z (APCI) 239  (M+, 100). 
Physical and spectroscopic data agree with those reported elsewhere.27 
 
6-(3,4,5-Trimethoxyphenyl)pterin (67) 
4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(3,4,5-trimethoxyphenyl)pterin-4-yl (63) 
(150 mg, 0.391 mmol) was treated with 1M NaOH/EtOH (8 ml, 1:1) and gently refluxed for 8 
hours, allowed to cool to room temperature, acidified with AcOH and placed in a fridge (2oC) for 
18 hours. The solution was filtered, crystals washed sequentially with water, EtOH and Et2O to 
give 6-(3,4,5-Trimethoxyphenyl)pterin as a green-yellow solid (74 mg, 59%); m.p. > 300oC; δH 
(d6-DMSO, 300 MHz) 3.72 (3H, s), 3.89 (6H, s), 7.38 (2H, s) and 9.23 (1H, s), the –NH2 and –
NH signals were too broad to be assigned and a clean 13C NMR could not be obtained; λmax (nm) 
305, 379; m/z (APCI) 330 (M + H+). Attempts to get high resolution mass measurements were 
unsuccessful in both HREI and HRESI instruments. 
 
121 
 
6-(furan-2-yl)pterin (68) 
4-amino-2-( N,N-dimethylaminomethyleneamino)-6-(furan-2-yl)pterin-4-yl (65) (150 mg, 0.530 
mmol) was treated with 1M NaOH/EtOH (8 ml, 1:1) and gently refluxed for 8 hours, allowed to 
cool to room temperature, acidified with AcOH and placed in a fridge (2oC) for 18 hours. The 
solution was filtered, crystals washed sequentially with water, EtOH and Et2O to give 6(furan-2-
yl)pterin as a brown solid (76 mg, 63%); m.p. > 300oC; δH (d6-DMSO, 300 MHz) 6.68 (1H, 
apparent s), 7.14 (1H, apparent s), 7.86 (1H, apparent s) and 8.97 (1H, s), the –NH2 and –NH 
signals were too broad to be assigned and a clean 13C NMR could not be obtained; λmax (nm) 
309, 395; m/z (APCI) 230 (M + H+, 100). Attempts to get high resolution mass measurements 
were unsuccessful in both HREI and HRESI instruments. 
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Chapter 4    An investigation of Suzuki coupling of quinoxaline 
and pteridine-O-sulfonates 
 
4.1 Introduction 
The Suzuki cross-coupling reaction, sometimes referred to as Suzuki-Miyaura reaction, was first 
reported in 1979 by Suzuki and Miyaura1 as a cross-coupling reaction between an aryl- or vinyl-
boronic acid with an aryl- or vinyl-halide, catalyzed by a palladium (0) complex. The reactions 
have received much attention and have been used to produce olefins, styrenes, substituted bi-
phenyls and bi-aryls. Many key steps in natural product synthesis have included the Suzuki 
coupling reaction.2,3 A recent Reaxys database search(December 2010) revealed over 100 000 
hits of reactions employing the Suzuki coupling conditions and the pioneer of the reaction 
Professor Akira Suzuki was awarded the Nobel prize in chemistry for 2010. 
                          
R B(OH)2 R
' X' R R'+
 Pd(0)
X' = Cl, Br, I, OTf  
Scheme 4.1 
The Suzuki reaction was reported shortly after the discovery of the Kumada4 and Negishi5 
coupling reactions where it was demonstrated that organomagnesium and organozinc substrates 
can be coupled, in the presence of palladium catalyst, with organohalide substrates. The 
replacements of the metals (Zn and Mg) with metalloid boron (B) lead to the development of the 
Suzuki reaction. Over the past three decades, much attention to improve the Suzuki reaction has 
been given by many research groups. The boronic acid group has been replaced by boronic 
esters, which made the organoboron substrates more reactive and thus improving the yields.2,3, 6, 7 
The ligands for the palladium complex (usually triphenylphosphine) is replaced by more bulky, 
electron-rich phosphine ligands8-13 (Figure 4.1) which have been shown to improve the reaction 
rates and allowed for coupling reactions between less reactive substrates. 
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Figure 4.1 Electron rich phosphines for Suzuki coupling 
The use of sulfonyloxy ligands as alternative to the halogens and triflate leaving group has 
received recent attention. Aryl-sulfonates and mesylates have been shown to undergo Suzuki 
coupling reactions with the less reactive boronic acids in high yield reactions8-12 and in some 
cases the reactions have been shown to occur in water.14 In all these reactions, the bulky 
electron-rich phosphine ligands were required to achieve these results. With these recent 
developments, we were interested in investigating Suzuki coupling reactions on 
benzenesulfonyl-pteridine 27 where model studies will first be performed on the 
benzenesulfonyl-quinoxaline 7. To our knowledge there are no Suzuki coupling reactions 
involving pteridine or pterin substrates, reported to date (Reaxys database search Nov 2010). 
The reaction conditions for Suzuki coupling and those of previously reported coupling reactions, 
i.e. Sonogashira and Negishi, are similar. All these reactions can be performed in THF and DMF, 
they all require palladium catalyst and all require similar leaving groups i.e. halogens and 
sulfonates. The rate determining step in Suzuki reactions is the transmetallation step between 
palladium and boron, and this step is very slow compared to transmetallation on Negishi 
reactions. Suzuki reactions are usually performed at temperatures above 80oC while Negishi 
reactions are usually performed at room temperatures. Suzuki reactions have the advantage of 
being tolerant to wide range of functional groups unlike the Negishi and Kumada coupling 
reactions. 
The drawback in Suzuki reactions, like most coupling reactions, is that the boronic acid-reagents 
usually have to be prepared from Li-reagents. This might limit the type of functional groups to 
be attached on the boronic acid-reagents. In this chapter, we report Suzuki coupling reactions on 
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benzenesulfonyl-quinoxaline and the challenges faced when attempting the coupling on 
benzenesulfonyl-pteridine. 
 
4.2 Results and Discussion 
The Suzuki coupling reactions usually require the presence of a relatively strong base such as 
NaOH and potassium carbonate (K2CO3), to make the organoboranes more reactive. The 
negatively charged base coordinates with the boron atom and increase the nucleophilic character 
of the organic group attached and thus increases its reactivity.2,6-9 The presence of inorganic base 
will not be suitable for the pteridine reactions as they have been shown to remove the protecting 
groups and also hydrolyze pteridines to pterins. We were interested in using Et3N, a mild base, 
used for Sonogashira coupling reactions to avoid the problem of deprotection. Research has 
shown the use of Et3N as base in a number of Suzuki coupling reaction but, these reactions 
employed Pd catalysts possessing bulky phosphine ligands.15 
Starting with the benzenesulfonyl quinoxaline 7 and treating with phenylboronic acid, 
Pd2(dba)3CHCl3, PPh3 and Et3N and refluxing in THF under Ar for 20 hours when no trace of 
starting material was detected on TLC. Purification by flash chromatography gave one isolated 
compound which had 1H NMR and mass spectra identical to those previously found for 2-
phenylquinoxaline 50. The product was obtained in 78% (Scheme 4.2). The results were very 
promising as the conditions used are very similar to those used for Sonogashira coupling 
reactions (Chapter 2, section 2.2.1).  
Using the same conditions, quinoxaline 7 was treated with 2-formylphenyl boronic acid to give 
2-(quinoxalin-2-yl)benzaldehyde 70 in 20% yield after refluxing in THF for 20 hours, when 
consumption of starting material was evident by TLC analysis. 1H NMR and mass spectral 
analysis of the compound were in agreement with the desired structure. The accurate mass 
measurement gave a molecular ion peak at m/z 234.0785 amu which is in agreement to that 
calculated for C15H10N2O, while the 
1H NMR gave two downfield protons at 8.10 and 9.85 ppm 
which are consistent with the 3(H) and aldehyde proton, respectively.  Attempts to improve the 
yields included changing the catalyst to (Pd(PPh3)4, changing the phosphine ligands and 
changing the solvent but, no improvements were observed. 
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Scheme 4.2 
We investigated variation of the Pd-catalyst.  When the coupling of the quinoxaline 7 and 
phenylboronic acid was repeated employing Pd(PPh3)4 as the catalyst, the yield of 50 was 
reduced to 50% yield. Replacing triphenylphosphine with a phosphonic acid diester ligand, 2-
oxo-4,4,5,5,-tetramethyl-1,2,3-dioxaphospholane 71 (Figure 4.2),16 shown to be a better ligand in 
a  Kumada coupling reaction,17 did not improve the yields. The yield of 50 was reduced to 40%. 
Changing the solvent from THF to DMF also resulted in a reduced yield where 50 was obtained 
in 50% yield. In all these reactions, no starting materials were detected on TLC and were never 
recovered during purification. 
                                                                  
OO
P
O
H
71   
Figure 4.2 
We then investigated the benzenesulfonyloxy-O-pteridine 27 as a coupling partner in Suzuki 
reactions. Treatment of the benzenesulfonyl pteridine 27 with phenylboronic acid, in the above 
mentioned conditions, did not give the desired 6-phenylpteridine 60. Increasing the reaction time 
to 4 days could not improve on the yields. HPLC-MS studies on the reaction mixture showed the 
presence of two main species, i.e. fully deprotected starting material (m/z 319, M + H) and fully 
deprotected product (m/z 243, M + H), with the fully deprotected starting material as main 
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component (Figure 4.3). With these results, we concluded that Suzuki coupling reactions can not 
be performed on pteridines under these conditions. The mild basic conditions did not give the 
desired coupled products and we envisage that the use strong base such as NaOH will result in 
hydrolysis of the amidine protecting group on the pteridine and no further investigations were 
performed. 
 
Figure 4.3 HPLC-UV and TIC chromatograms for the attempted Suzuki coupling of 
pteridine 27, along with the extracted APCI mass spectrum. 
For future work, an attempt to perform the Suzuki coupling reaction in aqueous base medium 
will be investigated. In these reactions, fully deprotected pteridines will be used and they have 
been shown to be soluble in basic and acidic mediums. For Suzuki reactions to occur, an 
inorganic base is required to make the boronic acid more reactive and this in turn make the 
solvent medium to be basic. The success of these reactions will eliminate the use of protecting 
groups.   
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4.3 Experimental 
2-Phenylquinoxaline 50 
2-Benzenesulfonylquinoxaline 7 (100 mg, 0.35 mmol), Pd2dba3CH3Cl (20.11 mg, 1.75 x 10
-5 
mmol, 5 mol%), PPh3 (8.75 x 10
-5 mol, 23 mg), phenylboronic acid (64 mg, 0.525 mmol, 1.5 eq.) 
and Et3N (0.2 ml), were dissolved in dry THF (5 ml). The final solution was heated to reflux and 
stirred under Ar for 20 hours, allowed to cool to room temperature, diluted with EtOAc (10 ml), 
filtered through silica gel and purified on flash silica, eluting with 5% EtOAc/hexane to give 
pure 2-phenylquinoxaline as a white solid (42 mg, 78%). The material had identical m.p., 1H 
NMR and mass spectra to the 2-phenylquinoxaline prepared earlier and the full characterization 
in Chapter 3. 
 
2-(Quinoxalin-2-yl)benzaldehyde (70) 
2-Benzenesulfonylquinoxaline 7 (200 mg, 0.70 mmol), Pd2dba3CH3Cl (41 mg, 3.5 x 10
-5 mmol, 
5 mol%), PPh3 (17.5 x 10
-5
 mol, 46 mg), phenylboronic acid (157.4, 1.05 mmol, 1.5 eq.) and 
Et3N (0.2 ml), were dissolved in dry THF (5 ml). The final solution was heated to reflux and 
stirred under Ar for 20 hours, allowed to cool to room temperature, diluted with EtOAc (10 ml), 
filtered through silica gel and purified on flash silica, eluting with 5% EtOAc/hexane to give 
pure 2-(quinoxalines-2-yl)benzaldehyde as an off-white solid (30 mg, 20%); Rf 0.30; Vmax / cm
-1 
1670; δH (CDCl3, 300 MHz) 7.35 – 7.43 (4H, m), 7.61 – 7.72 (4H, m), 8.10 (1H, dd, J = 7.5 and 
1.2 Hz) and 9.85 (1H, s); δC (CDCl3, 100 MHz) 125.5, 128.4, 128.6, 129.0, 130.5, 131.7, 133.4, 
134.6, 141.2, 143.3 and 191.0; m/z (LREI) 234 (M+, 70), 181 (100) and 147 (40) (Found 
234.0785. C15H10N2O requires 234.0793). 
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Chapter 5    Tetramethylformamidine Chloride (TMFAC) as a 
potential diaminocarbene 
 
5.1 Introduction 
Carbenes are defined as neutral compounds of divalent carbon where the carbon atom has only 
six valence electrons, instead of eight.1 Carbenes are classified as either singlets or triplets 
depending of their electronic structure. The triplet carbenes have an sp-hybridized carbon and a 
linear geometry while the singlet carbenes have an sp2-hybridized carbon and a non-linear 
geometry.1,2 Triplet carbenes have two unpaired electrons and are sometimes referred to as  di-
radicals while singlet carbenes have paired electrons and are relatively more stable than triplets. 
Factors that favor triplets over singlets include steric and electronic effects of the substituents at 
the carbene carbon atom. The singlet state is stabilized by σ-electron withdrawing (X), generally 
more electronegative substituents while σ-electron donating (Z) triplet state. Substituents that can 
donate π-electrons to the carbene carbon stabilize the singlet state with the opposite applying to 
the triplet state. The most common atoms or substituents that stabilize the singlet state are the 
halogens, oxygen-containing and nitrogen-containing groups with the later most common. 
Triplets state is commonly stabilized by Li, BH2 and BeH.
1 
                                                                              
R R
R = Z, triplet
R = X, singlet  
Figure 5.1 
The first generations of carbenes were the simple methylene and dichloromethylene carbenes 
which were and still used in the formation of cyclopropanes.3,4 Methylene is generated in situ 
from diazomethane under heat or UV radiation while dichloromethylene is generated in situ from 
the treatment of chloroform with a strong base (Scheme 5.1). These carbenes, however, are never 
isolated and are only studied in situ. Introduction of stabilizing groups on the carbene carbon 
atom i.e. σ-electron withdrawing and π-electron donating, led to the formation of more stable 
133 
 
carbenes with half lives of more than 1 minute. The nitrogen containing carbenes, in particular 
the N-heterocyclic carbenes, were widely explored and the first isolated carbene was imidazol-2-
ylidene in 1991.5 
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Scheme 5.1 
N-Heterocyclic carbenes (NHC) have been shown to make stable metal complexes and these 
complexes have found many applications in C-C cross-coupling reactions,6-10 ring opening 
polymerization reactions11 and many other reactions1. NHC have been used as an alternative to 
phosphine ligands in Suzuki6,7 and Negishi8 cross-coupling reactions and in all these reactions, 
the NHC were shown to be superior ligands. The catalyst loading, reaction time and temperature 
are also reduced by the introduction of NHC. Perhaps the most notable use of NHC have been in 
the olefin metathesis reactions, which have been a subject of comprehensive review articles over 
the last years.12,13 The development of carbene-metal complexes for olefin metathesis proved to 
be an organometallic  success story leading to the award of the 2005 Nobel Prize to Chauvin, 
Grubbs and Schrock. 
NHC have been widely studied due to their relative stability and ease of preparation, however, 
recent studies have shown the N-heteroacyclic carbenes (NHAC) carbenes to be better ligands 
than NHC and much work is currently underway to prepare stable NHAC.14-18 Challenges that 
are faced with the preparations of NHAC is the relative ease of dimerization of the carbenes in 
solution resulting in low concentrations of metal-carbene complexes. Tetraalkylformamidinium 
salts have been used to prepare carbenes with the more stable carbenes coming from bulky alkyl 
groups while dimer formation is prevalent with the small alky groups. In this chapter we report 
attempts to prepare bis(dimethylamino)carbene 72 from tetramethylformamidinium chloride 
(TMFAC) 73 using reported methods for the preparation of carbenes. 
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5.2 Results and Discussion 
The most common procedure for preparing metal-carbene complexes is by treatment of the 
carbene precursor with silver oxide (Ag2O) to generate silver-carbene complex then 
transmetallation with transition metal of choice to give the required complex.19-23 The reactions 
proceed smoothly in THF and DCM but, to our knowledge, these reactions have only been 
reported on NHC. Mechanistic studies have shown the Ag2O to act as a base generating the 
carbene which is then complexed by the generated silver ion.21-22 Treatment of 73 with Ag2O in 
DMF under Ar did not yield the desired carbene complex and no starting material was recovered. 
Changing the temperature, counter ion and reaction times gave no improvement. The use of THF 
as solvent also gave similar observations. The absence of starting material and carbene-complex 
could imply that 72 could be forming and quickly dimerize, and the dimerized product lost 
during the work-up stages. The dimerized product, tetrakis-(dimethylamino)ethylene 74 is a low 
boiling liquid which is very reactive towards oxygen and water making it difficult to isolate.24 
We did not have instrument techniques that enabled the study of the reaction in situ under inert 
conditions and thus we could not validate our hypothesis.  
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Scheme 5.2 
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 Another common procedure for preparing carbenes is treatment of the carbene precursor with a 
strong base, usually alkyl-lithium bases, and complexing the carbene with metal of choice to give 
the required complex. NHAC have been prepared using this method, although free carbenes have 
never been isolated however, reported in situ studies have shown the relative stability and rate of 
dimerization of these carbenes.15,16 Bis(dimethylamino)carbene 72 has been reported by Alder15 
to be stable in THF solution for up to 1 minute but no complexation to transition metals was 
reported. We subjected 73 to the same conditions reported by Alder by treatment with n-BuLi at 
-78oC to generate the carbene and added various metals to the solution but no desired carbene-
metal complexes were isolated. The metals investigated were palladium, silver, nickel and 
copper. No starting material was recovered suggesting that dimerization could have occurred as 
previously shown by Alder that dimerization occurs easily on tetraalkylaminocarbenes.15  
 
Finally, we investigated the use of Bredereck’s reagent 24 as precursor for the formation of 
carbene 72. The studies were inspired by the work of Waymouth et.al.25 where the 24 was used 
as catalyst in a ring-opening polymerization and tranesterification reactions. The proposed 
mechanism was that an equilibrium exists at high temperatures, between the carbene 72 and 24 
(Scheme 5.3) with the carbene responsible for ring-opening. 
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Scheme 5.3 
The Bredereck’s reagent was heated with PdCl2 in THF under Ar for 18 hours but no metal-
carbene complex was formed and no products were isolated. Attempts to prepare complexes with 
Ni, Ag and Cu were unsuccessful with no products isolated. 
In conclusion, attempts to synthesize bis(diamino)carbene 72 from TMFAC and the Bredereck’s 
reagent were unsuccessful.  
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